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ABSTRACT 
 Anthraquinone-xanthone heterodimeric natural products are a diverse family of 
polyketides highlighted by a unique bicyclo [3.2.2] ring system which links both 
anthraquinone and xanthone moieties. Both the connectivity of the unique bicyclic ring 
system and the oxidation state of the two heterocycles vary among the members of this 
family of natural products. These molecules have been generally isolated as fungal 
metabolites and also have shown anticoccidial (xanthoquinodin A:0.02 g/mL), antibiotic 
(acremonidins A and C; 32 M and acremoxanthone, MIC; 12.5 g/mL), and 
cytotoxicity against various human cancer cell lines. Both anthraquinone and xanthone 
heterocycles are derived from the anthraquinone chrysophanol, a common biosynthetic 
intermediate for polyketide synthesis. To date, there have been no reported synthetic 
efforts or total syntheses of the anthraquinone-xanthone heterodimeric natural products. 
Related synthetic examples include complex anthraquinone-xanthone biaryls, 
 ix 
 
anthraquinone dimers, and monomeric xanthone and benzophenone-derived natural 
products.  
 We describe an initial proposed synthesis wherein we aimed to prepare the unique 
bicyclo [3.2.2] ring system in a late stage operation of functionalized anthraquinone and 
xanthone units through a photo-mediated cycloaddition. We achieved synthesis of both 
an anthraquinone-derived oxanthrone ester fragment and the synthesis of several 
xanthone related natural products, namely graphisin A, sydowinin B, acremonidin E, and 
pinselin. Key steps involve aryl anion addition to substituted benzaldehyde derivatives, 
subsequent methyl ester installation, and dehydrative cyclization. Although we have not 
yet achieved the desired cycloaddition, we contributed to this area by developing 
efficient, reliable syntheses of various benzophenone and xanthone natural products.   
 We will also describe an alternative strategy to access the bicyclo [3.2.2] core of 
these natural products via various proposed rearrangements of an anthraquinone-
xanthone biaryl intermediate. Cross-coupling of substituted xanthone and naphthalene 
fragments established the desired biaryl linkage which was further elaborated to afford 
anthraquinone-xanthone biaryl structures. Attempts to rearrange these biaryls are ongoing 
to produce the unique core structure of the parent natural products. 
 Initially discovered as a byproduct of the aforementioned cross-coupling reaction, 
we have achieved homo-coupling of substituted naphthalene fragments. The resulting 
naphthalene dimers could be further advanced to a series of novel 2,2’-linked 
anthraquinone dimers including the natural product chrysotalunin.  
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Background and Related Syntheses of Anthraquinone-Xanthone Hetereodimeric 
Natural Products 
 
1.1  Overview 
Anthraquinone-xanthone heterodimeric natural products are a diverse family of 
polyketides highlighted by their unique bicyclo [3.2.2] ring system, which links 
anthraquinone and xanthone-derived heterocycles (Figure 1.1). Key variations among 
these members include the anthraquinone-derived ring system existing as either an 
oxanthone ester moiety on the B ring (natural products 1-4 and 6) or the parent 
anthraquinone (5, 7-8). Moreover, the other heterocycle can exist as a xanthone 1, a 
benzophenone (2 and 3), or a reduced dihydroxanthone 4 or tetrahydroxanthone (5- 8) on 
the terminal F ring. Finally, the location of the unique bicyclo [3.2.2] can differ from 
ortho or para position with respect to the free phenol of the xanthone moiety. This 
chapter will serve to review the isolation, bioactivity, biosynthesis, and related synthetic 
work of anthraquinone-xanthone natural products. The remaining chapters will describe 
our synthetic efforts and contributions by first showing the synthesis of related 
benzophenone and xanthone monomers and then outlining our plan to build the core 
bicyclo [3.2.2] structure of acremoxanthone (1) and acremonidin A (2) through an 





Figure.1.1: Representative Anthraquinone-Xanthone Heterodimeric Natural Products.  
 
 
1.2 Isolation of Anthraquinone-Xanthone Heterodimeric Natural Products 
The xanthoquinodins (cf. xanthoquinodin A1 (5) shown in Figure 1.1) were the 





fungal strain Humicola sp. FO-888 in Japan.
1
 The physio-chemical properties of 
xanthoquinodin A1 (5) matched that of a previously isolated antibiotic M-4126.
2
 
Xanthoquinodins A-D were separated by preparative HPLC and yielded xanthoquinodin 
A 5 as the major isolate. These natural products were structurally related to beticolin (7) 
and cebetin (8) (Figure 1.1), natural products already isolated owning a similar bicyclo 
[3.2.2] ring core structure but further oxidation on the anthraquione and alkene moieties.
3
 
These natural products also possess an aryl chloride on the xanthone ring system. An X-
ray crystal structure was obtained for both beticolin (7) and cebetin (8) and was used to 
determine the absolute configuration of cebetin 8 (Figure 1.2). An X-ray crystal structure 
of beticolin (7) was obtained in the di-magnesium ion salt form due to the propensity of 
 




beticolin (7) to bind Mg
2+ 
ions. The absolute configuration was determined using the R 
method described by Hamilton and coworkers.
3





xanthoquinodin A3 (9) and related natural products were reported using X-ray 
crystallography and electron circular dichroism (ECD) techniques (Figure 1.3).
4 
Figure 1.3: X-ray Crystal Structure of Xanthoquinodin A3 (9) 
 
 
No other related natural products were discovered until 2003, when an effort to 
discover new antibiotic natural products by fermentation in hetereogeneous medium was 
carried out by He and coworkers.
5
 The fungus Acremonium sp. LL-Cyan 416 was 
cultivated in heterogeneous phases and new fungal metabolites acremonidins A (2) and C 
(3) were isolated from the methanol extract. In 2009, these natural products were also 
isolated in a similar fungal strain, Acremonium sp. BCC 31806, along with a previously 
unknown isolate, acremoxanthone A (1).
6
 These fungal metabolites were isolated in the 






using preparative reverse-phase HPLC. Further search for bioactive fungal metabolites 
led to the discovery and isolation of JBIR-97 (6) in 2010 from Tritirachium sp. 
SpB08112MEf2,
7
 a fungus associated with a marine sponge of the shore off Japan, and to 
acremoxanthone C (4) from fungus Hypocreales in 2011.
8
  
1.3 Structure Determination of the Anthraquinone-Xanthone Heterodimeric 
Natural Products 
The structure of xanthoquinodin A1 (5) was determined by first establishing 
several fragments of the molecule by mass spectrometry and 2-D NMR spectroscopy.
9
 In 
order to complete the structure, [
13
C]xanthoquinodins were prepared biosynthetically by 







enriched xanthoquinodins were then unambiguously obtained and charachterized by 
rigorous 1 and 2-D NMR experiments. The relative stereochemistry was determined 
through NOE experiments and the absolute stereochemistry determined by X-ray and 
ECD techniques.
4
 These natural products are the first examples of heterodimers derived 
from polyketides where the xanthone and anthraquinone moieties are connected in an 
“end-to-body” fashion.  
The structure determination for acremonidin A (2) began by analyses of the 
molecular formula determined by high resolution Fourier transform ion cyclotron 
resonance (FTICR) mass spectrometry to be C33H26O12. The 33 
13
C were assigned to 2 
(CH3), 1 OCH3, 1 OCH, 1 CH2, 1 CH, 7 CH=, and 12 quaternary sp
2 
carbons using a 
DEPT experiment. The 
1










C NMR data and relevant HMBC correlations are shown below 
in Table 1.1. Some key strong HMBC correlations to establish the structure of the E ring 
stemmed from methine H-2 (acremonidin numbering, Table 1.1), both methylene H-15’ 
hydrogens, aromatic H-4’, and phenolic 1’-OH and 5’-OH hydrogens. The F ring 










H (400 MHz, mult, J) 
13
C HMBC 
1  187.6  
2 4.69 (br, d, 6.6) 37.9 C-1, C-4, C-13, C-14, C-1', C-2', C-3' 
3 6.48 (dd, 8.8, 6.6) 132.0 C-1, C-2, C-4, C-5, C-14, C-2', C-15' 
4 6.10 (d, 8.8) 132.7 C-1, C-2, C-3, C-5, C-6, C-14, C-2' 
5  41.4  
6 5.99 (s) 72.8 C-1, C-4, C-5, C-7, C-8, C-12, C-13, 
C-15, C-1(Ac) 
7  137.0  
8 6.89 (br s) 123.5 C-6, C-7, C-9, C-10, C-11, C-12, 
C-13, C-15 
9  147.6  
10 6.83 (br s) 119.2 C-8, C-11, C-12, C-13, C-15 
11  160.8  
11-
OH 
11.35 (br s)  C-10, C-11, C-12 
12  112.4  
13  183.8  
13-
OH 





14  105.8  
15 2.32 (3H, br s) 21.9 C-8, C-9, C-10 
1'  159.9  
1'-OH 13.41 (br s)  C-1', C-2', C-6' 
2'  113.5  
3'  146.0  
4' 5.78 (br s) 109.8 C-2', C-5', C-6', C-7', C-15' 
5'  158.8  
5'-OH 10.13 (br s)  C-4', C-5' 
6'  109.0  
7'  201.0  
8'  131.4  
9'  145.9  
9'-OH 9.19 (br, s)  C-8', C-9', C-10' 
10' 6.91 (d 8.8) 122.4 C-7', C-8', C-9', C-12' 
11' 6.79 (d, 8.8) 118.0 C-9', C-12', C-13', C-14' 
12'  151.4  
12'-
OH 
9.60 (br s)  C-11', C-12', C-13' 
13'  112.8  
14'  168.0  
15' 2.86 (d, 18.0) 34.2 C-4, C-5, C-6, C-14, C-2', C-3', C-4' 
 2.41 (d, 18.0)  C-4, C-5, C-6, C-14, C-2', C-3', C-4' 
OMe 3.56 (3H, s) 52.4 C-14' 




H-10’, H-11’ hydrogens to the corresponding carbon shifts (Table 1.1). The 
benzophenone moiety was established by a key 4-bond coupling between H-4’ and H-10’ 
to the carbonyl shift at 201.0 ppm, which required the keto linkage between C-6’ and C-
8’. The A, B, C, D rings of acremonidin A (2) were determined by HMBC correlations 
analogous to that reported for the xanthoquinodins, with the key differences being an 





(183.8 ppm) indicated a tautomer form in the -diketo system. The D-ring connectivity 
was confirmed by HMBC correlations between H-2 and C-1, C-3, and C-14 and also C-
1’, C-2’, and C-3’, indicating a bond between C-2 and C-2’. Likewise, correlations 
between the 2 H-15’ hydrogens and C-2’-4’ and C-4-6 and C-14 indicated a bond 
between C-5 and C-15’. The HMBC signals from OH H-11 to C-10-12 and H-15 to C-8-
10 established the A-B ring system, analogous to the xanthoquinodins. The relative 
stereochemistry of the bicyclo [3.2.2.] linkage (C-2 and C-5) was determined by an NOE 
signal between the methane hydrogen H-6 on C-6 and the methylene hydrogen H-15’ on 
C-15’, indicating the relative configuration shown (Figure 1.3). 
Figure 1.3 Determination of Relative Stereochemistry of Acremonidin A (2) by nOe 
Analysis 







The structure of acremoxanthone A (1) was elucidated in a very similar manner to 
that described for acremonidin A (2). Key differences between the two structures 
included the molecular formula of 1 being C33H24O11, which represents the formula of 2 
minus a molecule of water and that the 
1
H NMR only showed the presence of 4 phenolic 
OH signals.
6





a fully cyclized xanthone moiety with the same carbon connectivity. 2-D NOESY 
experiments of acremoxanthone (1) confirmed the same relative configuration of the 
bicyclo [3.2.2] ring system, possessing the diagnostic signal between H-6 and H-15’.  
Acremoxanthone C (4) was also found to contain anthraquinone and xanthone 
moieties similar to acremoxanthone A (1). However the location of the bicyclo [3.2.2] 
linkage was para to the xanthone phenol (C-2 bond to C-4’) and there also exists an 
additional unsaturation on the F ring. The full structure was elucidated through NMR 
experiments analogous to that described above for acremonidin A (2). Interestingly, when 
the author attempted to determine the absolute configuration of 4 via Mosher ester 
installation in pyridine, they found that the major product of the reaction was 
acremonidin A (2) (Scheme 1.1). The additional double bond in the dihydroxanthone 
moiety made this ring system more susceptible to aromatization under basic conditions, a 
phenomenon not observed for the xanthoquinodins.
9
  






The structure of JBIR-97 (6) was elucidated in a similar manner to that already 
described above for related natural products 1-5. Interestingly, the structure of JBIR-97 
(6) is similar to that of beticolin (7) and cebetin (8) wherein the methyl group on the 
anthraquinone ring is located within the bicyclic [3.2.2] ring system. 
1.4 Selected Bioactivity of various Anthraquinone-Xanthone Natural Products 
The xanthoquinodins were first isolated and elucidated in 1993 and were found to   
exhibit anticoccidial activity. Specifically, xanthoquinodin A1 (5) showed inhibition 
against the growth of parasites in chicken kidney cells at a 0.02 g/mL minimum 
concentration. Additionally, 5 also showed antimicrobial activity against bacteria 
Bacillus subtilis (8 mM), Micrococcus luterus (8 mM), Staphylococcus aureus (9 mM), 
Acholeplasma ladlawli (10 mM) and Bacteroides fragilis (8 mM).
1 
Recently, 
xanthoquinodin A1 (5) showed cytotoxicity in human cancer cell lines HL-60 (leukemia, 
IC50 = 6.2 M), SMMC-7721 (hepatocellular carcinoma, IC50 = 8.0 M) and A-549 
(lung, IC50 = 3.3 M).
4 
Acremonidins A (2) and C (3) displayed moderate antibiotic activity (32 M) 
against Gram-positive bacteria, including the methicillin-resistant staphylococci and 
vancomycin-resistant enterococci. Interestingly, the importance of the C-6 acetyl group 
was investigated and it was found when longer-chain acyl group analogs of acremonidin 
A (2) were prepared, a 4-fold increase in activity was observed in the same bacterial 





however this effect was limited to a maximum with the isobutyrate and pentanoate 
derivatives.
5 
The authors did not provide an explanation for this increase in activity. 
However, it is possible that the longer acyl chains help prevent oxidation to the 
anthraquinone at the reactive carbinyl position. When Oberlies and coworkers co-isolated 
acremonidin A (2), acremonidin C (3), and acremoxanthone C (4) in 2011, they reported 
cytotoxic activity against a panel of human tumor cells. The biological activities are listed 
below in Table 1.2 for the following human cancer cell lines; MCF-7 (human breast 
carcinoma), NCI-H460 (human large cell lung carcinoma), SF-268 (human astrocytoma), 
HT-29 (human colorectal adenocarcinoma), and MDA-MB-435 (human melanoma).
8 
Table 1.2: IC50 Values (in M) for 2-4 in Various Human Cancer Cells 
 MCF-7 H460 SF268 HT-29 MDA-MB-435 
2 18.1 13.6 21.4 >25 >25 
3 >25 20.6 21.0 NT* NT* 
4 21.0 10.9 16.1 >25 >25 
*NT= not tested. 
 Acremoxanthone (1) was demonstrated antibacterial activity against 
Staphylcoccus aureus (MIC, 12.5 g/mL), antifungal activity against Candida albicans 
(IC50, 1.7 g/mL) and antimalarial activity against Plamodium falciparum (IC50, 10 
g/mL).6 Despite the antibacterial activity, 1 also showed cytotoxicity in all of the cell 
lines tested. Acremoxanthone (1) also showed cytotoxicity to three cancer cell lines (KB, 





 Finally, JBIR-97 (6) was reported to exhibit cytotoxicity against human cervical 
carcinoma HeLa cells (IC50 11 g/mL) and human malignant pleural mesothelioma cells 
(IC50 31 g/mL). The authors did not report any other biological data.
7 
1.5 Biosynthesis of Anthraquinones 
1.5.1 Chrysophanol (10) 
 Polyketides constitute a vast array of secondary metabolites with significant 
structural diversity and biological properties, which arise biosynthetically from small acyl 
units that are assembled by polyketide synthases.
10
 From these polyketide synthases 
(PKS), a staggering number of natural products and structurally unique bioactive  







molecules are constructed and are found in a variety of fungi, lichen, higher order 
plants,certain insects, and in microorganism in soil. Biosynthetically, polyketides are 
built through iterative Claisen condensation of an acetyl-CoA starter unit with the 
extender units derived from malonyl-CoA, similar to fatty acid synthesis. Usually in 
PKS, a synthesized linear polyketide will be ‘folded’ in one of two different folding 
mechanisms, having either an S or F classification.
11
 Bringmann and coauthors recently 
reviewed the biosynthetic pathway for the polyketide-derived anthraquinone 
chrysophanol (10).
10
 In this review, they described that chrysophanol (10) exists as a 
defense compound in a variety of eukaryotic organisms, including fungi, lichen, plants, 
and insects, and recently in prokaryotic organisms. Due to this discovery, it was proposed 
(Scheme 1.2) that chrysophanol (10) may be the product of two independent biosynthetic 
pathways occurring in different organisms through the same intermediate, linear 
polyketide 11. In order to determine the biosynthetic folding modes of 11 leading to 10, 
13
C2-labeled acetate were fed to eukaryotic fungus (Drechslera catenaria), plants 
(Kniphofia uvaria), lichens (Parmeliaceae), insects (Chrysomedlidae) and prokaryotic 
bacteria (Nocardia Acta 1057 and Streptomyces AK 671) followed by 2D-
INADEQUATE NMR measurements of the isolated 7 (Scheme 1.3). These results for the 
eukaryotic organisms clearly indicated that the single carbon atom of the “last acetate 
unit” remaining after decarboxylation was at C-2 on chrysophanol 10a. Another 
indication was the paired labeling on the other carbon atoms and incorporation of two 





of linear polyketide 11 to intermediate 12 in eukaryotic organisms to provide 
chrysophanol (10). 
Scheme 1.3: Biosynthetic Occurrence of Chrysophanol (10) in Eukaryotes and 
Prokaryotes. 
 
In contrast, the 2D-INADEQUATE NMR results for the prokaryotic organisms differed 
in the location of the last acetate unit prior to decarboxylation and the location of C-2 
units in the first aromatic ring. In the case of Streptomyces, the 
13
C2 incorporation pattern 
possessed three intact C2 units in the leftmost ring of 10b and the site of decarboxylation 
at the methyl carbon, consistent with the S mode of folding for intermediate 13. Finally, 
for Norcardia, the 
13
C2 incorporation pattern possessed three intact C2 units in the 





at C-4, which infers intermediate 14. Thus, chrysophanol (10) is formed through a related 
S’ folding of linear polyketide 11 in the prokaryotic bacteria Norcardia.10 While there are 
other important pathways and intermediates in polyketide biosynthesis, the authors of this 
review state that chrysophanol (10) is the first natural product that is formed through 
more than one polyketide pathway.  
 Another recent report by Muller proposes an alternative formation of 
chrysophanol (10) via a reduction-elimination-oxidation sequence of another PKS 
intermediate, emodin (17) (Scheme 1.4).
12
 The authors propose the biosynthesis of 
benzophenone 21, a biosynthetic intermediate in xanthone synthesis in the fungi 
Aspergillus nidulans FGSC A4. The biosynthesis stems from PKS of malonyl derivatives  
Scheme 1.4: Muller and Coworkers Proposal for Biosynthetic Generation of 







to intermediate 15 facilitated by gene clusters MdpG and F. Acid 15 is then 
decarboxylated, dehydrated, and oxidized to afford emodin (17), a pivotal intermediate in 
the biosynthesis of a variety of xanthone natural products.
13
 Reduction of 17 leads to a 
tautomer of 18a/b, which is then further reduced and dehydrated via gene clusters MdpC 
and B to chrysophanol hydroquinone 20. This can undergo further oxidation to 
chrysophanol (10) or alternative oxidative cleavage to generate the benzophenone 
monodictyphenone 21, which will be discussed further in the next section.  
1.5.2 Xanthones 
Xanthones (derivatives of 9H-xanthen-9-one, “xanthone” from the Greek 
“xanthos”, for “yellow”) are polyphenolic, tricyclic compounds that are found in nature 
in higher order plants, fungi, bacteria, and lichens.
14
 The tricyclic xanthone can either be 
fully aromatic or reduced with a di, tetra, or rarely seen hexahydro C-ring (Figure 1.5). 
Xanthones are referred to as ‘privileged structures’ due to their prevalence as biologically 
interesting molecules across a wide variety of diseases, and their interaction with a large 
variety of target biomolecules. As of 2009, there were 1464 known xanthone based 
compounds in the literature,
15
 which can generally be divided into two categories: 
monomers and dimers/heterodimers. These can further be split into subclasses based on 





Figure 1.5: The 9H-Xanthen-9-one Ring System. 
 
 The biosynthesis of xanthones occurs in distinctive pathways depending on the 
organism. In a higher plant species, the biosynthetic origin is from a polyketide, derived 
from iterative acetate Claisen condensations similar to that of anthraquinones shown 
previously (Scheme 1.2).  In fungi and lichen organisms, the acetate building blocks form 
the common intermediate chrysophanol (10) which can then undergo a Baeyer-Villiger-
type oxidative cleavage to produce the highly substituted benzophenone 23. 
Benzophenone 23 can, depending on the organism, either cyclize and decarboxylate 
directly to dihydroxyxanthone 24. It has also been proposed that 23 may oxidize further  






and then undergo cyclization to dihydroxanthone 24, followed by 
elimination/decarboxylation to access xanthone 24. Alternatively, 23 may undergo an 
oxidation/cyclization/reduction sequence to tetrahydroxanthone 26.
16
 Following a 
different biosynthetic pathway in the higher order plant Gentiana lutea, the xanthone core 
is formed from mixed units. In this case 3-hydroxybenzoic acid 27 (derived from 
phenylalanine) is combined with three acetate units to form polyketide intermediate 29.  
Scheme 1.6: Biosynthesis of Xanthones in Higher Order Plant Gentiana lutea.
14 
 
This compound aromatizes to construct the freely rotating benzophenone 30 which can 
then undergo an intramolecular phenol coupling from either conformation to provide 
either polyhydroxyxanthone 31 or 32. This final cyclization is reported to be catalyzed by 
xanthone synthase, a membrane-bound enzyme involving cytochrome P-450.
17
 Other 
related biosynthetic pathways are known and are described in the literature,
15 
moreover 




 and their 






1.5.3 The Xanthoquinodins: 
Despite the increasing number of isolated members of anthraquinone-xanthone 
heterodimer natural products,
14
 the only comprehensive biosynthetic study was conducted 
by Omura and coworkers on the xanthoquinodins shown below (Figure 1.6).
9
 This 
family consists of an anthraquinone derived fragment and a xanthone derived fragment 
bound together by a unique bicyclo [3.2.2] ring system. The individual members differ by 
the either the relative configuration of the secondary alcohol and methyl ester moieties on 
the tetrahydroxanthone ring system (see 5 vs 34, Figure 1.5), or the position of the 
linkage of the [3.2.2] ring system as ortho or para to the phenol of the 
tetrahydroxanthone (cf. 5 vs 33).  






The origin of all the carbons of xanthoquinodin A1 5 was determined by 
13
C-
labeled feeding experiments, which showed that it is a heterodimer of octaketide-derived 
xanthone and anthraquinone moieties. The proposed biosynthesis is shown in Scheme 
1.7. Two chrysophanol (10) anthraquinone units are constructed from the polyketide 36, 
one of which will undergo the previously discussed Baeyer-Villiger type oxidative 
cleavage to produce the highly substituted benzophenone 23. The dihydroxy-aromatic 
ring is freely rotating about the acyl bond, which is similar to that of the biosynthesis of 
related natural products.
20
 Benzophenone 23 may undergo 
oxidation/cyclization/reduction to tetrahydroxanthone 26 which may then merged with 
another equivalent of 10 to provide the core structure of the xanthoquinodins. 








The authors describe this as an ‘end to body’ linkage to differentiate it from other related 
natural products.
9
 Subsequent methylation of the acid by a methionine residue affords the 
title compound, xanthoquinodin A1 5. This initial report coined the phrase ‘heterodimers’ 
in terms of describing anthraquinone-xanthone natural product as a dimer of two 
anthraquinone-derived units whose biosynthesis is well characterized.  
One additional note about the xanthoquinodins is their propensity to interconvert 
to each other upon heating. Treating xanthoquinodin A1 (5) with heat in methanol 
yielded a new mixture of the xanthoquinodins after 85 minutes. This phenomenon could 
occur through a retro-Michael addition on the enol ether to cleave the tetrahydroxanthone 
ring (Scheme 1.8). The resulting phenoxide can either undergo Micheal addition back 
into the enone, providing a mixture of diastereomers 5 and 34, or the anion can be placed 
on the neighboring phenol for the Michael addition to provide a mixture of diastereomers 
33 or 35. When other isomers instead of xanthoquinodin A1 (5) were treated under 
similar conditions, a separate mixture of xanthoquinodins (5), (33-35) was obtained 
suggesting that all of the isomers are interconvertable through a retro-Michael-Michael 





Scheme 1.8: Interconversion of Xanthoquinodin A1 (5) to 33-35 by Heating 
 
1.6 Related Syntheses of Anthraquinone-Derived Natural Products 
1.6.1 Chemical Synthesis of Bicyclo [3.2.2] Ring Systems 
  There have not been any reported synthetic efforts toward any of the 
aforementioned anthraquinone-xanthone heterodimer natural products.
14
 However, there 
has been one report of a methodology developed for the synthesis of bicyclo [3.2.2] 
nonenes, inspired by the structures of beticolin (7) and cebetin A (8) (Figure 1.1).
3 
Duffault and Tellier report
21
 a radical process initiated by reduction of aryl iodide 36 to 
aryl radical 37, which cyclizes either through a 7-endo or 6-exo mode to 38 or 39 
respectively. In all cases reported, the 7-endo process was favored, presumably due to 
addition of the radical to themore electron deficient position of the -unsaturated 
ketone. The substrates with the methylene linker gave the best yields of 38 due to the 
conformational flexibility of the C-sp
3
 compared to the sp
2





Scheme 1.9: Radical Cyclization toward Bicyclo[3.2.2]nonenes. 
 
methodology represents the only example to give the bicyclo[3.2.2]nonene core structure 
of beticolin (7) and cebetin (8), the products substantially lack the functionality required 
to complete the synthesis of the natural products.  
1.6.2: Suzuki and Matsumoto’s Enantioselective Synthesis of (-)-Euxanmodin B (40) 
   Despite the growing number of anthraquinone-xanthone natural products isolated 
containing a bicylco [3.2.2] core structure, there are surprisingly few examples (isolation 
or synthesis) of analogous anthraquinone-xanthone biaryl natural products.
14
 In 2011, 
Suzuki and Matsumoto reported the first enantioselective total synthesis of the axially 
chiral anthraquinone-xanthone biaryl (-)-euxanmodin B (40) (Scheme 1.10).
22
 Their 





enantioselective hydrolysis of known -symmetric biaryl diacetate 41.23 This was 
achieved with porcine pancreas lipase (PPL) in the presence of a pH 7 phosphate buffer 
and iPr2O at 35 ºC for 11 hours to provide the monoacetate 42 in quantitative yield and > 
99% ee. The axial chirality within 42 is locked due to the tetra-substitution about the 
biaryl bond which blocks free rotation. The remainder of the synthesis was carried out in 
a bi-directional manner. Silyl protection of the free phenol followed by a palladium(0)-
catalyzed deprotection of the allyl ether and subsequent acetate protection and ortho-
selective iodination afforded iodide 43 in good overall yield. A series of protecting group 
manipulations provided the fully protected biaryl 44 which retained the high ee from the 
previous enzymatic hydrolysis. Lithium-halogen exchange with n-BuLi and iodide 44, 
followed by addition of ketone
24
 45 afforded alcohol 46 as an inseparable mixture of 
diastereomers in 89% combined yield. Acid-catalyzed MOM ether deprotection and 
subsequent oxidation with IBX provided benzaldehyde 47 which was then combined with 
the in situ prepared Grignard reagent of aryl iodide 48 to afford diol 49 in 56% yield as a 
mixture of diastereomers. In order to install the anthraquinone moiety, benzocyclobutenol 





Schene 1.10: Suzuki and Matsumoto’s Enantioselective Synthesis of Euxanmodin B (40) 
 
expansion. Subsequent air oxidation followed by an IBX oxidation provided 





with HCl to deprotect the phenolic MOM ether. Cesium carbonate was then added to 
facilitate the SNAr cyclization to complete the protected xanthone. Finally, treatment with 
boron tribromide gave (-)-euxanmodin B (40) in 70 % yield. It was noted that the 
rotational barrier of the biaryl linkage was considerably high, as no racemization was 
observed in refluxing toluene for six hours. 
1.6.3: Nicolaou’s Synthesis of (+)-2,2’-epi-Cytoskyrin A (51) and (+)-Rugulosin (52)  
  While there are few synthetic examples of anthraquinone-xanthone biaryl 
reported in the literature, other anthraquinone-derived natural products have been 
synthesized. Recently, the cytoskyrin and rugulin family of anthraquinone dimer natural 
products were isolated
25
 and were found to have a cage-like architecture derived from an 
anthraquinone biaryl dimer. In 2005, Nicolaou and coworkers reported the first total 
synthesis of (+)-2,2’-epi-cytoskyrin A (51) and (+)-rugulosin (52) via an impressive 
cascade reaction initiated by acid-induced tautomerization and dimerization of a keto-
quinone (Scheme 1.12).
26
 Both cytoskyrin A (51) and rugulosin (52) are derivatives of 
bisanthraquinone dimers isolated from fungi and lichens and exhibit a wide array of 
biological activity including antibacterial, insecticidal, anti-influenza, and anti-HIV 
properties. The synthesis began by first examining the potential cascade reaction of 
model substrate 53 (Scheme 1.11). This compound was prepared by Hauser annulation
27
 
of nitrile 54 and cyclohexenone 55, followed by CAN oxidation to provide keto-quinone 
53. After a significant amount of reaction screening and optimization, the  “cytoskrin 





excess manganese dioxide to afford rugulin model system 61 in 75 %. The model 
anthraquinone 53 tautomerizes to dienol 56 upon treatment with CSA, which undergoes a 
double-Michael type dimerization to form intermediate 57, an isolable compound.  
Scheme 1.11: Nicolaou’s “Cytoskyrin Cascade” from Model Anthraquinone 53 
 
Upon addition of excess manganese dioxide and heating to 45 ºC, oxidative cleavage of 





completed a dual Michael addition from the enol tautomers to afford the penultimate 
intermediate 60. The excess manganese dioxide performed the intramolecular enol 
coupling to the final skyrane product 61. With the model cascade in hand, Nicolaou 
Scheme 1.12: Total Syntheses of (+)-2,2’-epi-Cytoskyrin A (51) and (+)-Rugulosin (52). 
 
and coworkers then set out to apply the chemistry to the forward synthesis of cytoskyrin 
A (51) and rugulosin (52) (Scheme 1.12). Aldehyde 62 was combined with (-)-
methoxydiisopinocamphenylborane and allyl magnesium bromide to afford a 
enantioenriched alcohol, which after a protection/deprotection/oxidation sequence gave 





provided enantioenriched cyclohexene 64. This compound was combined with either 65a 
or 65b in the presence of base to provide the Hauser annulation products 66a (80 %) and 
66b (91 %). The cascade reaction was optimized using freshly prepared manganese 
dioxide in CH2Cl2 at room temperature for 30 minutes, followed by addition of 
triethylamine and heating to 45 
o
C to complete the cascade process previously shown 
(Scheme 1.11) to afford 67a (50 %) and 67b (34 %). Global deprotection under acidic 
conditions led to the completion of (+)-2,2’-epi-cytoskyrin A (51) (93 %) and (+)-
rugulosin (52) (98 %). This strategy allowed for rapid syntheses of two bisanthraquinone 
derived natural products and set a benchmark in terms of producing molecular 
complexity in a short synthetic sequence.  
1.7 Benzophenone-Derived Natural Products. 
 As previously discussed, anthraquinones are important intermediates in 
polyketide synthesis and many natural products have been isolated with anthraquinone 
core structure. Further down the chain in polyketide biosynthesis exist several other key 
intermediates for complex natural products including highly substituted benzophenones. 
In nature, benzophenones are thought to be products of a Baeyer-Viliger type oxidative 
ring-opening of anthraquinone precursors (Schemes 1.4-1.7).  This type of biosynthetic 
process would place an acyl moiety ortho to the benzophenone carbonyl that may 
undergo further functionalization. Figure 1.7 highlights some natural products that 
contain a highly substituted benzophenone with an ortho acyl group, all of which are 





Figure 1.7: Examples of Benzophenone-Containing Natural Products. 
 
Graphisin A (68) and acremonidin E (69) were isolated in 2009 from the lichen 
Graphis tetralocularis. Acremonidin E (69) was found to display antitubercular activity 
(MIC50 g/mL) and showed cytotoxicity against BC, KB, and NCI-H187 (IC50 = 12-27 
g/mL), while graphisin A (68) showed no such activity.28 Isosulochrin (70) and 
chloroisosulochrin (71) were isolated in 2001 from the fungus Pestalotiopsis theae and 
are also precursors to the related spiro-dieneone maldoxin.
29
 Balanol (72) was isolated in 
1993 from the fungus Verticillium balanoides and was found to have potent activity 
against human protein kinase enzymes (IC50 4-9 nM).
30
 Balanol (72) was prepared 
synthetically by Nicolaou and coworkers in 1994
31
 and has been extensively studied in 
regard to its inhibition activity of human protein kinases.
32
  Pestalone (73) was isolated in 
2001 from a marine fungus of genus Pestalotia and was found to possess in vitro 





activity against methicillin-resistant Staphylococcus aureus (MIC= 37 ng/mL) and 
vancomycin-resistant Enterococcus faecium (MIC = 78 ng/mL).
33
 The compound has 




 Finally, mumbaistatin (74) was 
isolated in 1997 from cultures of Streptomyces sp. DSM 11641 and is of great interest 
due to its potent (IC50 = 5 nM) inhibition of enzyme glucose-6-phosphate translocase 
(G6P-T1), a target for the treatment of type two diabetes.
36 
1.7.1 Nishiyama’s and Schmaltz’s Syntheses of Pestalone (73) 
 Nishiyama
34
 reported the first synthesis of pestalone (73) through a convergent 
route of substituted aromatic fragments whereby the benzophenone moiety was installed 
in a late-stage coupling/oxidation sequence (Scheme 1.13). Choosing simple 
dihydroxybenzoic acid 75 as the starting point for both aryl ring fragments, Nishiyama 
and coworkers are able to prepare protected oxazoline 76 in four steps and then proceed 
to protected benzaldehyde 77 in five more steps. Hexasubstituted aryl ring 78 was 
prepared in eight total steps from acid 75 via dichloride 79 in good yield throughout. 
Lithium-halogen exchange of 78 followed by trapping with aldehyde 77 and silyl 
deprotection provided diol 80 in 90 % The diol 80 was then oxidized with IBX to install 
the benzophenone and aldehyde groups simultaneously to avoid the primary alcohol 
anion adding into the ortho carbonyl to give retro-addition products. Subsequent 












reported a rapid synthesis of pestalone (73) and facile 
conversion to two other natural products, pestalachloride (81) and pestalalactone (82) 
(Scheme 1.14). The route began from similar aryl building blocks as Nishiyama, but was 
able to construct the highly substituted benzophenone with more efficiency. Trihalide 83 
was prepared in three steps from commercially available orcinol 84 in good yield and 
dibromobenzaldehyde 85 is derived from 3,5-dimethoxybenzaldehyde 86. These 











provide benzophenone 87. At this point, it was observed that although the prenyl and 
formyl groups could be installed with the methoxy protecting groups present, any 
nucleophilic conditions used to deprotect the methyl ethers suffered from an undesired 
Cannizzaro-Tishchenko type reaction to provide lactone product 88. This occurred by 
first nucleophilic attack onto the aldehyde followed by intramolecular hydride shift to the 
benzophenone carbonyl and then lactonization, a process Schmaltz and coworkers found 
to be general for ortho acyl benzophenones.
37
 Additionally, the authors commented on 
the bromides ortho to the benzophenone carbonyl being very difficult to functionalize 
with a formyl equivalent due to the steric hindrance caused by bisection of the aryl 
ketone. To overcome this reactivity, it was found that installation of MOM ether 
protecting groups as part of the benzophenone system allowed for subsequent lithiation of 
89 with phenyl lithium followed by transmetalation with copper cyanide and reaction 
with prenyl bromide to afford 90 in excellent yield. Lithiation of the remaining bromide 
was followed by an ethyl formate quench. This successfully installed the necessary 
formyl group ortho to the benzophenone. The MOM ethers were easily removed under 
acidic conditions to avoid the previously mentioned side reactivity to furnish pestalone 
(72) in 10 overall steps and 16% total yield. Pestalone (73) was then used to form 
pestalalactone 82. Irradiation with light in DMSO generated 82 in excellent yield, which 
presumably occurs through photoinduced enol intermediate 91 and then further cyclized 
to a lactone. Comparatively, treatment of 73 with ammonia in ammonium chloride 









1.7.2 Snider’s Synthesis of Maldoxin (123) 
 In 2012, Snider and Yu
 
reported their total synthesis of isosulochrin (70) and 
chloroisosulochrin (71) and their biomimetic conversion to the spiro-lactone containing  






natural product maldoxin (93).
29
 Both isosulochrin (70) and chloroisosulochrin (71) were 
built from either aldehyde 94 or chlorobenzaldehyde 95 (Scheme 1.15). Deprotonation of 
bis-MOM aryl ether 96, followed by nucleophilic addition into aldehyde 97 or 98 
provided the coupled benzyl alcohol, which was oxidized to the benzophenone with 
Dess-Martin periodinane (DMP) in good yield over two steps. Subsequent deprotection 
of the benzyl group was achieved using either Pearlman’s catalyst for 97 or poisoned 
palladium on carbon for 98 to afford the primary benzyl alcohols 99 and 100 
respectively. The undesired dihydroisobenzofurans 101 and 102 were observed after 
prolonged reaction time. These products resulted from intramolecular attack of the 
primary alcohol onto the benzophenone followed by the elimination of water and  
Scheme 1.16: Snider’s Biomimetic Conversion to Maldoxone (109) and Maldoxin (93) 
 
reduction of the resultant oxonium ion. Conversion of alcohols 99 and 100 to the methyl 





deprotected under acidic conditions to provide isosulochrin (70) (65 %) and 
chloroisosulochrin (71) (80 %). The benzophenones 70 and 71 were subsequently 
oxidized with potassium ferricyanide to provide spirodienones 105 and 106, which after 
quenching with sulfuric acid were ring-opened to acids 107 and 108. Acid 108 could be 
further converted to maldoxone 109 upon heating in the presence of sulfuric acid. Finally, 
treatment of either acid 107 or 108 with hypervalent iodine oxidized the phenol, which 
was trapped intramolecularly by the free acid to provide dechloromaldoxin 110 or 
maldoxin (93) in 31 % overall yield from chloroisosulochrin (71). This route efficiently 
constructs benzophenone natural products isosulochrin (70) and chloroisosulochrin (71) 
and then elaborated them through a biomimetic oxidation-rearrangement sequence to 
acetal-containing natural products dechloromaldoxin (110) and maldoxin (93).   
1.8 Reported Syntheses of Xanthone Natural Products 
 As previously stated (Section 1.5.2), as of 2009 there were 1464 naturally 
occurring xanthone containing structures reported in the literature. With regard to 
xanthones biosynthetically derived from polyketides, this topic has recently been 
extensively reviewed by Brase and coworkers.
14
 Another review by Sousa and 
coworkers
38
 discusses many of the key strategies used in classical xanthone synthesis 
from various intermediates shown in Figure 1.8. This review contains research spanning 
100 years after the first reported xanthone synthesis by Michael and Kostanecki
39
 





Figure 1.8: Various Synthetic Intermediates Reported in Xanthone Synthesis. 
 
As xanthones became more prevalent and important in terms of their pharmacological 
activity, more attention has been paid to both discovering new methods to synthesize 
xanthones and install functionality about the core structure.  
1.8.1 Tam’s Synthesis of Pinselin (111)  
 The xanthone natural product pinselin (111) was initially isolated in 1943 from 
the mold Penicillium amarum by Munekata,
40
 however the exact chemical structure 
remained unknown until 1979 when Tam and coworkers reported the first synthesis and 
confirmed the tricyclic xanthone structure.
41
 The authors reported addition of the lithium 





Scheme 1.17: Tam’s Synthesis of Pinselin (111) 
 
acid 114 in 17 % yield (Scheme 1.17). Subsequent deprotection of two methyl ethers 
with boron trichloride and then cyclization to form the xanthone under basic conditions 
afforded xanthone 115 in 15 % yield over two steps. The remaining methyl ether was 
deprotected with boron tribromide followed by Fischer esterification of the acid in 
methanol to provide pinselin 111. Although the route was low yielding, this represents a 
classic example of preparing the xanthone core from a highly substituted benzophenone 
intermediate. 
 1.8.2 Kelly’s Synthesis of Cervinomycin (116) 
 A landmark synthesis of a polycyclic xanthone natural product is Kelly and 
coworker’s 1989 synthesis of cervinomycin (116).42 The synthesis commenced with a 
base-mediated ipso substitution reaction of diiodobenzoquinone 117 and phenol 118 to 
provide aryl ether 119 in good yield. Reduction of the benzoquinone followed by acidic 
methyl ester deprotection and Friedel-Crafts cyclization led to the xanthone core 





was prepared in eight steps and was combined with xanthone iodide 120 in an 
intermolecular Heck reaction followed by photo-induced cyclization of the resultant  
Scheme 1.18: Kelly’s First Total Synthesis of (+/-)-Cervinomycin (116) 
 
olefin in air to afford cervinomycin (116) in 65 %. This rapid assembly of the heptacyclic 
xanthone natural product was a pioneering synthesis in the larger family of natural 
products and has influenced synthetic strategy in this family to the present day.
14
 
1.8.3 Snider’s Synthesis of an Advanced Xanthone Model for Parnafungin 117 
 A more recent synthesis of a functionalized xanthone was conducted by Snider 
and coworkers wherein they prepared an advanced model of the antifungal agent 
parnafungin (117) (Scheme 1.19).
43





ring system within its hexacyclic framework and has been reported to equilibrate readily 
to other regioisomers via a similar mechanism to that of the xanthoquinodins (cf. Scheme 
1.8). Snider and coworkers proposed hexacyclic xanthone 118 as a suitable model target 
to establish a synthetic methodology to parnafungin A (117). Orcinol 84 was condensed 
with salicylic acid 119 in the presence of neutral alumina and methansulfonic acid at 150 
ºC to afford xanthone 120 in excellent yield. Xanthone 120 was protected with an acetate 
and then brominated at the benzylic position with AIBN and NBS. This was then 
converted to the benzyl alcohol with concomitant acetate deprotection under basic 
conditions to afford xanthone 121 in 50 % yield over three steps. Ortho-selective 
iodination of xanthone 121 provided iodide 122. This was combined with aryl boronate 
123 under Suzuki conditions to provide biaryl 124 in moderate yield. The authors 
reported high catalyst loading (30-50 % Pd(OAc)2) due to a sluggish conversion with the 
hindered aryl iodide. Subsequent reduction of the aryl nitro group with zinc metal 
followed by mesylation of the benzylic alcohol resulted in the benzisoxazolinone ring of 
the hexacyclic xanthone model 118. Analogously to parnafungin A (117), the authors 
reported the benzisoxazolinone ring of model xanthone 119 decomposed to a 
phenanthridine via elimination at the benzylic position over two days in CDCl3. The 
synthesis of xanthone 118 highlights an efficient methodology (13 % overall yield for 8 





Scheme 1.19: Snider’s Synthesis of a Xanthone Model of Parnafungin (117) 
  
1.9 Reported Syntheses of Tetrahydroxanthone Natural Products 
1.9.1 Brase’s Synthesis of Diversonol (125) 
 Tetrahydroxanthones share the same carbon connectivity as xanthones; however 
the terminal ring exists in a reduced form whereby the substitution has a defined stereo-
chemical configuration. A pioneering example of the synthesis of a complex 
tetrahydroxanthone was achieved by Brase and coworkers in their reported first total 
synthesis of (+/-)-diversonol (125) (Scheme 1.20).
44
 They were able to prepare 





sequence from p-benzoquinone. These synthons were combined in their key domino oxa-
Michael-aldol cascade reaction to provide tetrahydroxanthene 128 as a 1.5:1 mixture of 
diastereomers in 61 % yield. The authors noted that other basic conditions resulted in 
decomposition of enone 127. Intermediate 128 was converted to tetrahydroxanthone 129 
in four steps. Enone 129 was subjected to cuprate conditions to install the tertiaty methyl 
group anti to the protected secondary alcohol. Protodehalogenation conditions removed 
the aryl bromide to provide tetrahydroxanthone 130. The enol moiety was oxidized with 
magnesium monoperoxophthalate (MMPP) followed by treatment with BBr3 to remove 
the aryl methoxy group. Subsequent diastereoselective reduction of the ketone with 
sodium borohydride provided (+/-)-diversonol (125). This signified the first synthesis 
within this family of natural products through a key oxa-Michael-aldol cascade to 
establish the tricyclic ring system. Since this intial report, Nicolaou has also reported the  
 
Scheme 1.20: Brase’s Synthesis of Diversonol (125) 
 total synthesis of diversonol (125) and other closely related natural products starting 






1.9.2 Porco’s Syntheses of Blennolides B and C. 
 An additional example of a tetrahydroxanthone synthesis was recently reported by 
Porco and Qin.
46
 Their approach was highlighted by a vinylogous addition of a 
siloxyfuran 131 into an activated benzopyrilium ion 132 derived from chromone 133 to 
gain access to a variety of tetrahydroxanthone precursors 134 and 135 (Scheme 1.21). 
Diisopropylsilylditriflate activates the chromone, forming the oxidopyrilium ion 132 
shown. Upon addition of 131 at -78 ºC provides a 20:1 mixture of the diastereomers 134 
and 135 after deprotection, 134 being the kinetic favored isomer. This same reaction  
Scheme 1.21: Porco’s Vinylogous Siloxyfuran Addition into Benzopyrilium 132. 
 
process run at 0 ºC provides a 1:2 mixture of diastereomers 134 and 135, 135 being 
thermodynamically favored under equilibrium conditions. The change in 
diastereoselectivity is thought to occur by an epimerization process that occurs at 
elevated temperatures and prolonged reaction times.
46 





was subjected to conjugate reduction conditions to afford chromone lactone 136 in 61 %. 
This was subjected to basic conditions to promote a Dieckmann reaction to afford 
racemic blennolide C (137) in 37 % (Scheme 1.22). Chromone 138 was prepared 
Scheme 1.22: Porco’s Syntheses of Blennolide C (137) and Blennolide B (138) 
 
analogously to 134 as a 1:2 mixture of diastereomers with a methyl group residing on the 
siloxyfuran reagent. This was also treated with conjugate reduction conditions to afford 
chromone lactone 139 in 37 %. Similarly, 139 cyclized in a Dieckmann reaction under 
basic conditions to racemic blennolide B (140) in 76 %. The authors describe this 
approach as a ‘retro-biomimetic’ process because substituted benzophenones are 
biosynthetically precursors to tetrahydroxanthones which are then thought to rearrange to 
the thermodynamically more stable chromone lactone derivatives. This addition 
methodology greatly contributes to the area of tetrahydroxanthone natural product 
synthesis by building up the structures from Nature’s endpoint, which has proven general 






 Anthraquinone-xanthone heterodimeric natural products are a growing family of 
natural products isolated mainly from fungi and lichen sources. The molecules consist of 
an anthraquinone-derived moiety and xanthone derived moiety linked through a unique 
bicyclo [3.2.2] ring system. Biosynthetically, this family of natural products is derived 
from a central polyketide synthesis intermediate, chrysophanol 10. The biosynthesis for 
the entire family is based on the seminal report by Omura for the xanthoquinodins.
9 
While there have been no synthetic efforts reported for this family, related synthesis are 
known which include the anthraquinone-xanthone biaryl (-)-euxanmodin (40) and the 
rearranged anthraquinone dimers epi-cytoskyrin (51) and rugulosin (52). More literature 
examples exist for syntheses of xanthone and benzophenone natural products, which 
include pestalone (73), isosulochrin (70) and chloroisosulochrin (71), pinselin (111), 
cervinomycin (116), advanced xanthone model 118, and tetrahydroxanthones diversonol 
(125), blennolide B (140) and blennolide C (137). In the following chapters, we describe 
our approach toward the total synthesis of anthraquinone-xanthone heterodimeric natural 
products 1-2 (Figure 1.1). Our initial strategy relied on a late stage photo-mediated 
cycloaddition approach from anthraquinone and xanthone derived units. Chapter two will 
discuss this approach in greater detail, specifically as to how we planned to activate both 
the anthraquinone and xanthone units under photochemical conditions. We will discuss 
the syntheses of benzophenone natural products, graphisin A and acremoxanthone E, and 
the related xanthone natural products, sydowinin B and pinselin. Chapter three will 





through construction of an anthraquinone-xanthone biaryl model system. We will also 
summarize our synthetic attempts to convert the biaryl model system to the bicyclo 
[3.2.2] ring system under various conditions. Chapter four will discuss the discovery of a 
symmetrical naphthalene intermediate, which was implemented in the total synthesis of a 







Initial Proposal Toward Anthraquinone-Xanthone Natural Products: Total 
Synthesis of Graphisin A and Sydowinin B  
 
2.1 Literature Reported Tautomerism of Anthraquinone Derivatives 
 Anthraquinones and their derivatives have been shown to be important 
biosynthetic and synthetic intermediates for complex molecule synthesis (Section 1.5-
1.6). There is also considerable literature concerning photo- and base-mediated 
tautomerism of anthraquinones and related compounds.
47 
We became interested in the 
tautomerism of anthraquinones as a potential means to discover new reactivity for the 
synthesis of anthraquinone-containing natural products. Figure 2.1 shows two ground 
state anthraquinone derivatives, anthralin 1 and chrysazin 2, and their respective  
Figure 2.1: Ground and Photoexcited State Forms of Anthralin (1) and Chrysazin (2) 
 
photoinduced tautomer forms, 3 and 4. These tautomer forms arise from a process called 
excited state intramolecular proton transfer (ESIPT), whereby upon irradiation with light, 
the acidity of the phenolic proton is enhanced due to charge transfer.
48
 The increased 





production of the tautomer forms illustrated in Figure 2.1. A common way of 
establishing whether a molecule is able to undergo ESIPT is to measure its fluorescence 
spectrum and determine if the fluorescence emission has a significant Stokes shift. A 
Stokes shift is the difference in wavelength between positions of the maxima of the 
absorption and emission spectra of the same electronic transition. If a Stokes shift is 
present, this is indicative of geometrical changes in the molecule upon photoexcitation.
48
  
Figure 2.2: Jablonski Diagram for Chrysazin (2)  
 
For instance, chrysazin 2 absorbs light at a maximum of 430 nm in hexanes and 
undergoes conversion from the ground state normal form (N0) 2 to the excited state 
normal form (N1) 2* (Figure 2.2). The excited state N1 2* will undergo a Stokes shift 
fluorescence at 500 nm resulting from a vibrational energy transition. Due to charge 
transfer in the excited state, 2* also undergoes tautomerization to the excited state 





state proton transfer’.49 Excited tautomer 4* has an observed Stokes shift fluorescence at 
580 nm with a decay of 127 ps to afford the ground state tautomer form (T0) 4. This 
tautomer then undergoes back proton transfer to provide the ground state normal form 
(N0) 2. Anthralin 1 possesses similar absorption and Stokes shifted fluorescence upon 
irradiation and occurs on a similar time scale.
50
  
Analogously, deprotonated anthraquinones are also reported to undergo 
tautomerism to various forms, which is apparent by drastic changes in the UV 
absorption.
51
 Solvation increases the probability of formation of structures 5-8 which can 
either be mono or dianion depending on the pH of the medium(Figure 2.3). Additionally,  
Figure 2.3: Calculated and Observed Tautomer Forms of Dihydroxyanthraquinones 
 
various metal ions, including Al(III), Fe(II), Fe(III), Ca(II), Mg(II), Cu(II), Zn(II), and 
Sm(III), can coordinate to the tautomer form of an anionic anthraquinone, such as 9.
52
 
Depending on the metal ion in solution, either the mono or dianion can be observed by an 
absorption band using UV spectroscopy. While there is ample literature pertaining to 
hydroxyanthraquinone tautomerism, very few synthetic examples have been reported. 





Scheme 2.1: a) Trauner’s Synthesis of Variecolortide A (10) b) Mechanistic Rationale 
 
the natural product variecolortide A (10).
53
 The authors reported a hetero-Diels-Alder 
cycloaddition between the anthrone hydroxyviocristin (11) and the indole-bearing natural 
product isoechinulin B (12) in refluxing dichlorobenzene in the presence of air to provide 
variecolortide A (10) in 48% (Scheme 2.1A).  The authors studied the model hetero-





calculated energies and transition states to explain the reactivity. It was calculated that 13 
would undergo a concerted Diels-Alder reaction with 14 to form product 15 in an 
endothermic process (13.2 kcal/mol) and would have to overcome a high transition state 
energy (31.8 kcal/mol).  
In contrast, the shifted tautomer 16 (4.0 kcal/mol of energy higher than 13) was 
calculated to undergo the same reaction to product 17 in an exothermic (-11.9 kcal/mol) 
process with a much lower (17.7 kcal/mol) calculated transition state energy. Subsequent 
oxidation of the highly labile C-H bond of the anthrone 17 would lead to the observed 
product 18. Therefore, the authors propose the tautomer of hydroxyviocristin (19) to be 
the reacting form in the key hetero-Diels-Alder step toward variecolortide A (10). As part 
of our studies, we planned to further investigate anthraquinone tautomerism to explore 
potential new reactivity for the synthesis of complex molecules with an anthraquinone-
derived moiety.  
2.2 Literature Reported Photo-Activation of Hydroxyphenols: ESIPT 
While photoinduced activation of anthraquinones and related substrates has been 
well documented, much less is known for xanthones, benzophenones, and other poly-
phenolic systems. Berson and coworkers reported the photochemical or thermal 
conversion of enone 20 to a reactive intermediate, either zwitterion 21 or diradical 22. 
This intermediate reacted with isobutylene 23 to afford a 2:1 mixture of cycloadducts 24 
and 25 in 54 % yield (Scheme 2.2).
54
 The reactive intermediate was determined to be the 





Scheme 2.2: Reported Cycloadditions of m-Quinonemethane Intermediates 
 
In 1995, Wan and coworkers reported a photoinduced process (excited state 
intramolecular proton transfer) whereby a phenol ortho to a benzylic alcohol 26 may 
undergo a proton transfer followed by conversion to the ortho quinone methide 
intermediate 27 (Scheme 2.3).
55
 In the presence of ethyl vinyl ether, this reactive 
intermediate 27 underwent cycloaddition to provide ethyl ketal 28 in 95 % yield and 
Scheme 2.3: Wan’s Initial Report of ESIPT of Hydroxymethylphenols.  
 
9:1 dr. The authors also performed this reaction on the meta-substituted hydroxymethyl 
phenol 29 in the presence of methanol and observed conversion to the benzylic methyl 





forming upon irradiation, which was assigned as m-quinonemethane 31. Further studies 
by Wan have indicated that this intermediate is formed from intramolecular proton 
transfer from the phenol to the alcohol moiety followed by ionization.
56
 This zwitterion 
was found to have a lifetime of 30 ns; however increasing the electronic donation of the 
benzylic substituent (e.g. adamantyl) increased the lifetime.
57
 Wan later reported similar 
reactivity on phenolic styrenes 32, wherein the phenolic proton is transferred to the -
position of the styrene to form zwitterion 33, which was trapped by water to form tertiary 
alcohol 34.
58
 This proton transfer is facilitated by water molecules in an array to transfer 
a hydrogen from the phenol to the styrene. Additionally, biaryl 35 can also be activated  
Scheme 2.4: Wan’s Report of ESIPT of Styrenes 32 and Biaryls 35. 
 
 
by UV-light to form intermediate 37, which can either be trapped by solvent to form ether 
38 or undergo 6-electrocyclization to form benzo-2H-pyran 39.56 Resubjecting 39 to 
photo-irradiation opens the ring and generates intermediate 37, which can either be 





This work and others have shown that ESIPT does occur in simpler phenol systems, more 
complex biaryl, and even BINOL
59
 systems. This specific type of reactivity has not been 
implemented in any natural product synthesis thus far and presents an opportunity for 
further application in complex molecule synthesis.  
2.3 Initial Approach Toward Anthraquinone-Xanthone Natural Products 
 Our initial synthetic plan for constructing the anthraquinone-xanthone 
heterodimer acremonidin A (40) is highlighted by a [4+3] photo-induced cycloaddition 
between oxanthrone ester 41 and benzophenone natural product graphisin A (42)
28 
(Scheme 2.5). This proposed cycloaddition would construct the bicyclo [3.2.2] core in a  
Scheme 2.5: Initial Retrosynthesis and Proposed [4+3] Photocycloaddition to 
Acremonidin A (40) 
 
single step and allow the synthesis of several members of the family through a unified 
strategy. We planned to utilize the literature reported phenomenon of anthraquinone 
derivatives undergoing an excited state intramolecular proton transfer (ESIPT) upon 





Scheme 2.5). Additionally, we planned to expand upon a related literature reported 
ESIPT of hydroxymethyl substituted phenols that led to intermediate zwitterionic m-
quinonemethides upon irradiation with light (Section 2.2) by attempting this on more 
complex systems with similar functionality (i.e. 44, Scheme 2.5).  We first set out to 
determine if oxanthrone ester 41 would undergo ESIPT under photochemical conditions 
and if it could be reacted in the tautomeric form. We also planned a synthesis of graphisin 
A (42) to determine if ESIPT was possible on this system and if it would react under 
photochemical irradiation. We planned to prepare the benzophenone synthon as opposed 
to its respective xanthone because the benzophenone has two free phenols on the 
hydroxymethyl substituted ring. We imagined that only one of the phenols would 
hydrogen bond to the carbonyl, leaving the other phenol free to interact with the benzyl 
alcohol as described in the literature.
56 
2.4 Synthesis and ESIPT Studies of Oxanthone Ester 41 
 Commercially available chrysophanol (45) was selectively reduced with tin (II) 
chloride in HCl/AcOH to an intermediate anthrone, which was oxidized to oxanthone 
ester 41 with one equivalent of DDQ in AcOH at room temperature in 70 % overall 
yield.
60
 Upon synthesizing 41, UV-Vis absorption spectra were obtained in various  






solvents. Polar solvents such as methanol or acetonitrile resulted in the clearest UV-Vis 
spectrum. Figure 2.4 shows the absorption spectrum for oxanthrone ester 41 in 
acetonitrile, with the maximum absorbance centered at approximately 380 nm.  
Figure 2.4: UV-Vis Absorption Spectrum for 41 in MeCN 
 
 We acquired fluorescence spectra of oxanthrone ester 41 in order to determine if 
ESIPT occurred upon irradiation with light. Fluorescence spectra of oxanthrone ester 41 
were obtained in a variety of solvents (MeCN, MeOH, CHCl3) at different excitation 
wavelengths corresponding to local maxima in the absorption spectra (Figure 2.4). The 
most intense fluorescence emission was observed, with a maximum at 568 nm, upon 
excitation of oxanthrone ester 41 at 380 nm (Figure 2.5). This fluorescence emission at 
568 nm is similar to the fluorescence emission of anthralin 46 (Figure 2.6), a closely 
related anthrone derivative that is known to readily undergo ESIPT.
50


























Figure 2.5: Fluorescence Emission Spectrum of 35 in MeCN (ex.=380 nm) 
 
Figure 2.6: Maximum Wavelengths of Absorption and Fluorescence Emission of 46 and 
41 
 
suggests that oxanthrone ester 41 does undergo ESIPT upon photochemical irradiation to 
tautomer 41b, which is in equilibrium with the ground state tautomer 41a (Figure 2.6). 
Experiments designed to potentially trap and react the photoinduced tautomer form will 
be described in detail (vida infra). 
2.5 Initial Synthetic Routes Toward Graphisin A (42) 
2.5.1 Attempted Nucleophilic Addition to an Aromatic Phthalic Anhydride 48 
 Our initial plan for the synthesis of the benzophenone graphisin A (42) was 
inspired by the reported synthesis of pinselin by Tam,
41 























deprotonated electron rich aryl ring 47 was added to the methoxy-protected phthalic 
anhydride 48 to directly form the benzophenone moiety 49 (Table 2.1). We prepared the 
methoxy-protected phthalic anhydride 48 in two steps from commercially available 
dicyanohydroquinone.
61
 Various bis-methoxy aryl ring nucleophiles were readily 
prepared or used from commercial sources. Initial conditions (entry 1-3, Table 2.1), 
analogous to similar reactions in the literature,
41,62 
were unsuccessful and resulted only in 
minor byproducts such as ester 50. Comins-type conditions utilizing a benzaldehyde 
nucleophile were also unsuccessful.
63
 Changing the nucleophile to the aryl bromide for 
lithium halogen exchange with alkyl lithium reagents also did not afford benzophenone 
49 and resulted in protodehalogenation and deprotection of the TBS ether group.  
Attempted Friedel-Crafts reaction with aluminum trichloride did afford to a new product 
in trace amount; however, it was identified as the regioisomeric benzophenone acid 51. 
The aryl ring was found to be nucleophilic ortho and para to the methoxy groups, as in 
the case of resorcinol. After much experimentation, we concluded that the bis-ortho-
methoxy substituents on the phthalic anhydride 48 were deactivating it towards 





Table 2.1: Attempted Addition of Aryl Nucleophile 47 to Phthalic Anhydride 48 
 
anhydride synthons (bis-OAc, OH) also did not react with any of the aryl nucleophiles 
shown, possibly due to poor solubility in the organic solvents used. It is worth noting that 







were not reproducible in our hands. We ultimately decided to explore an alternative, 
more reliable route to access graphisin A (42). 
2.5.2: Attempted Benzophenone Synthesis via an Acyl Nucleophile Addition to an 
Acyl Benzoquinone 53 
 One alternative route that was explored involved intermolecular addition of acyl 
nucleophile 52 to the known activated acyl benzoquinone electrophile 53 to provide  
Scheme 2.7: Proposed Acyl Nucleophilic Addition to Acyl Benzoquinone 53.  
 
benzophenone 54 (Scheme 2.7). Acyl benzoquinones have been reported to undergo 
nucleophilic attack by a variety of alcohols and aromatic systems.
64
 We first attempted 
intermolecular Stetter reaction of aldehyde 52 and benzoquinone 53 using either 
thiazolium catalyst 55 or 56 (Table 2.2).
65
 Both the fully protected 52 or the deprotected 
52 in the presence of catalyst 55 or 56 and base resulted in no conversion and full 
recovery of starting materials.  
We next prepared dialkylhydrazones 57 due to their reported “aza-enamine” 
reactivity. The acyl position is nucleophilic as the aza-enamine is isoelectronic to an 
enamine.
66
 Heating the protected and deprotected 57 in acetonitrile resulted in no new 





yield. However, the new product was determined to be the biaryl lactone 58, a result of 
aryl addition into the acyl benzoquinone analogous to a process reported by Kraus and  







64 Repeating Kraus’s conditions employing aqueous TFA provided 58 in 40 % 
isolated yield. Attempts to deactivate the nucleophilicity of the aryl ring by acetate 
protection of the phenols resulted in full recovery of starting materials. Preparing other 
dialkylhydrazones had no effect on this reaction. Additionally, preparing the TBS-
cyanohydrin of aldehyde 52 and treating with base followed by addition of benzoquinone 
53 resulted in the formation of multiple byproducts, none of which were the desired 
benzophenone.
67
 Due to the fact that we could not achieve the desired reactivity between 
aldehyde 52 or hydrazone 57 and benzoquinone 53, we elected to explore alternative 
routes synthesize graphisin A (42). 
2.6: Development of a Synthetic Route to Sydowinin B (60) via Nitrile 59 
 Our revised plan (Figure 2.7) was to prepare benzophenone nitrile 59 via aryl 
anion addition to a substituted benzaldehyde according to literature precedent.
68
 We 
envisioned that acidic methanolysis
69
 of aryl nitrile 59 followed by global deprotection 
should provide graphisin A (42). Sydowinin B (60)
70
 could then be accessed through  









 In our forward synthesis, benzaldehyde 61 was regioselectively 
brominated and protected as a bis-MOM ether in 82% yield over two steps (Scheme 2.8). 
Regioselective deprotonation of 62 with n-BuLi, followed by addition of aldehyde 63 at 0 
˚C, provided benzylic alcohol 64 in 56 % yield with the remainder of the mass balance 
consisting of byproducts derived from competitive lithium-halogen exchange of the ortho 
aryl bromide. Oxidation of 64 with IBX provided bromobenzophenone 65 in 75 % after 
purification on silica gel. We had initially planned to utilize 65 directly in palladium-




Scheme 2.8: Synthesis of Aryl Nitrile 59.  
 
 However, this substrate was found to be unreactive likely due to the highly 
electron rich and bis-ortho-substituted aryl ring. Efforts to install the methyl ester on 
either bromobenzaldehyde 63 or its corresponding acetal-protected derivatives were also 





formation) of aryl bromide substrates were also found to be unproductive.
35
 However, 
compound 65 underwent smooth cyanation (ipso-substitution) using Pd(PPh3)4 and 
Zn(CN)2 under microwave heating to afford aryl nitrile 59 in 60 % yield.
73 
Initial attempts at hydrolyzing aryl nitrile 59 to the acid (aq. NaOH or H2SO4) 
resulted in either decomposition or partial MOM deprotection (Scheme 2.9). Efforts to 
partially hydrolyze to the primary amide with K2CO3 and H2O2
74
 also resulted in no 
reaction. Similarly, treatment of 59 with methyl triflate in CH2Cl2 followed by 
methanolysis to access the imidate in a Ritter-type reaction was also unsuccessful.
75
  









) resulted in mixtures of partially and fully MOM-deprotected compounds  
Scheme 2.9: Synthesis of Sydowinin B (60) via Aryl Nitrile 59 
 
with the aryl nitrile remaining intact. In light of the apparent incompatibility of the MOM 





benzophenone 59 to tetraphenol 67 prior to hydrolysis (Scheme 2.8). Accordingly, 
treatment of nitrile 59 with p-TsOH in MeOH at 40 °C produced a deep red solution 
whereby the protecting groups were globally removed to afford benzophenone 67 in 50 
% yield. Purification of polyphenol 67 on silica gel was difficult due its high polarity and 
propensity to form an intractable, red-colored salt with residual p-TsOH. An example of 
hydrolysis of a highly substituted benzophenone nitrile hydrolysis has been reported.
80
 
However, standard acidic hydrolysis
68
 (H2SO4 or HCl, MeOH, 60 ˚C) of 67 resulted in 
recovery of starting material and minor formation of xanthone 68, whereas standard basic 
conditions
81
 (NaOH) resulted in decomposition.  
 We further probed the observation of a red solution of nitrile 67 when treated 
with acid (Scheme 2.10). We imagined that if the nitrogen of the nitrile was protonated  






however we were not successful. We then attempted to observe the proposed 
intermediates by conducting 
1
H NMR experiments of 67 in acetic acid-d4 to determine if 









H NMR Spectra of Nitrile 67 a) in CD3CO2D b) CD3CO2D 
with TFA  
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by an acid to form the nitrilium ion pair 69, a phenol on the neighboring aryl ring may 
participate in an intramolecular Pinner reaction
82
 to afford cyclic imidate 70. This imidate 
may form other tautomers such as 71 which may account for the observed deep red color 
of the solution. We attempted to isolate and characterize the proposed intermediates  
hydrogens 1-4 were observed in acetic acid-d4 alone suggesting that acetic acid was not a 
strong enough acid. However, upon the addition of trifluoroacetic acid (5 equiv.) to the 
sample we did observe a downfield shift of hydrogens 1-4. We observed four aromatic 
signals, indicating that the hydroxymethylaryl ring lost its degree of symmetry and H-3 
and H-4 are two distinct singlets (Figure 2.8b). This loss of symmetry implies that one of 
the phenols may have added onto the nitrilium ion to form a cyclic imidate. After 
quenching this sample with aqueous sodium bicarbonate, extraction with ethyl acetate, 
and resubmission of a 
1
H NMR in acetic acid-d4, we only observed signals correspdoning 
to benzophenone nitrile 67.  
The effectiveness of the proposed Pinner cyclization may be due to the bisected 
nature of the benzophenone nitrile (Figure 2.9) whereby once the nitrilium is formed by 
strong acid, the phenol on the neighboring aryl ring is in close proximity (3.34 Å) to the 
nitrilium carbon. This product may be further stabilized by various mesomer forms 
possible due to the polyphenolic system. This phenomenon may also explain why this 





Figure 2.9: DFT-Minimized Model of Nitrile 67 
 
 At this juncture, we elected to optimize the xanthone formation / nitrile 
methanolysis sequence. We observed dehydrative cyclization to the xanthone when 
attempting to hydrolyze nitrile 67 with DOWEX-50 resin in water under microwave 
conditions.
83
 We later observed clean conversion of 67 to xanthone 68 using microwave 
heating with aqueous ZnCl2.
84
 A ground state model of nitrile 67 (Figure 2.9) shows that 
the benzophenone exists substantially in a bisected conformation with hydrogen bonding 
maintained between the C-6 and C-10 phenols and the C-8 ketone. However, internal 
hydrogen-bonding of the phenols may be disrupted in water such that rotation can occur 
prior to cyclization to form xanthone 68 which was subjected to acidic methanolysis 
conditions (3M H2SO4, MeOH, 60 ˚C) to afford sydowinin B (60) in 50 % yield (two 
steps) (Scheme 2.9).  
2.7: Development of a Synthetic Route to Graphisin A (42) and Sydowinin B (60) 
 To install the requisite methyl ester and access graphisin A (42) without 
dehydrative cyclization, we implemented the alternative route shown in Scheme 2.11.  
Bromoaldehyde
85






yield (two steps). Regioselective deprotonation of 62 and subsequent quenching with 
DMF provided benzaldehyde 73 (78 %). Lithium halogen exchange of aryl bromide 72 at 
-78 ˚C in ether with t-BuLi followed by a rapid quench with aldehyde 73 provided benzyl 
alcohol 74 (61 %). Subsequent IBX oxidation afforded ketone 75 in 78 % yield (Scheme 
2.12). Initial attempted conditions for selective benzyl deprotection of 75 (H2, Pd(OH)2, 
Scheme 2.11: Alternative Route to Graphisin A (42) 
 
MeOH) resulted in complete conversion to the over-reduced product 76, analogous to a 
product
29
 reported by Snider and coworkers for a similar substrate. We found that 
hydrogenolysis of 75 using Pd/C in THF/MeOH (3:1) led to the desired 
hydroxybenzophenone 77 in 36 hours at room temperature (89 %). To decrease the time 
of this reaction, we used 8 % Pd(OH)2 in THF under an atmosphere of H2 which afforded 
the desired benzyl alcohol in 75% in 90 minutes at room temperature (Scheme 2.13). It is 
apparent that sole use of a polar protic solvent activates 77 toward hemiketal formation 





Scheme 2.12: Formation of Dihydroisobenzofuran 76. 
 
A three-step oxidation-methylation sequence was then conducted on the protected 
benzophenone 77. Sequential Dess-Martin and Pinnick oxidations followed by treatment 
with excess TMSCH2N2 in 1:1 MeOH/Et2O to provide methyl ester 66 in 65 % yield over 
3 steps (Scheme 2.13).
29
 Benzophenone 66 was fully deprotected with p-TsOH in MeOH 
to provide graphisin A (42) in 77 % yield.
86





NMR spectra were in agreement with those reported for the natural product.
28
 Graphisin 
A (42) could also be converted to sydowinin B (60) in 58 % yield by dehydrative 
cyclization with aqueous ZnCl2 under microwave conditions (120 ºC).
84
 






2.8: Syntheses of Acremonidin E (78) and Pinselin (79) 
 With a scalable and reliable synthetic route to graphisin A (42) and sydowinin B 
(60) in hand, we wanted to synthesize the related natural products acremonidin E (78) 
and pinselin (79) (Figure 2.10).
5,41
 Acremonidin E (78) was isolated along with other 
acremonidins (Section 1.2, Figure 1); however it was found to be a less potent antibiotic. 
Pinselin (79) was previously synthesized by Tam and coworkers through a low yielding 
route and has recently been reported to have moderate immunosuppressant activity (IC50 
5.1 g/mL) against mouse splenic lymphocytes,87 a similar bioactivity reported for other 
hydroxyl-substituted xanthones.
88 
Figure 2.10: Natural Products Acremonidin E (78) and Pinselin (79)   
 
 Lithium halogen exchange of aryl bromide 72 was then quenched with aldehyde
89
 
80 to form the benzyl alcohol (72 %), which was oxidized to benzophenone 81 with IBX 
(85 %) (Scheme 2.14). This was subjected to Pearlman’s catalyst in THF under an 
atmosphere of hydrogen to effect hydrogenolysis of the benzyl group. The resultant crude 





Scheme 2.14: Synthesis of Acremonidin E (78) and Pinselin (79) 
 
A Pinnick reaction provided the benzoic acid, which was methylated with TMS-
diazomethane to provide methyl ester 83 (62 % yield, 2 steps). Benzophenone 83 was 
then globally deprotected with p-TsOH in methanol to provide acremonidin E (78) as a 
grayish solid in 95 % yield. This was then subjected to the zinc chloride dehydrative 















2.9: Attempted Biomimetic Conversion of Highly Substituted Benzophenones to 
Dihydroxanthones via Oxidation and Cyclization 
 As was previously discussed (Scheme 1.5, 1.7), highly substituted benzophenones 
are thought to be intermediates in the biosynthesis of tetrahydroxanthones via an 
oxidation-cyclization-reduction pathway. This was confirmed synthetically by Franck 
and coworkers when they successfully converted benzophenone 84 to tetrahydroxanthone 
85 (Scheme 2.15).
90
 The authors first oxidized the hydroquinone functionality of 84 with 
iron trichloride to the isolable benzoquinone which readily cyclized in 6-endo-trig 
fashion to dihydroxanthone 86 (70 %). The alkene was reduced (Pd/C, H2) which was 
followed by treatment with sodium borohydride to afford tetrahydroxanthone 85 as a  
Scheme 2.15: Franck’s Synthesis of Tetrahydroxanthone 85 from Benzophenone 84. 
 
single diastereomer (30 %). This remains a rare example of this biomimetic process, 
which Franck proposed occurs in the biosynthesis of the secalonic acid family of natural 
products.
91
 We intended to determine if this pathway was viable for benzophenone 
natural product graphisin A (42) via an oxidation using similar conditions to those of 
Franck and coworkers to the intermediate benzoquinone. We envisioned subsequent 
cyclization of a phenol to the tricyclic dieneone 87, followed by a potential reduction to 





Scheme 2.16: Proposed Biomimetic Conversion of 42 to Tetrahydroxanthone 88 
 
The results of our oxidation conditions are summarized in the table below (Table 
2.3). We found that graphisin A (42) readily oxidized under all of the conditions tried. 
However, we were not able to isolate the proposed benzoquinone intermediate even at 
low temperatures (-78 ºC, entry 3, Table 2.3). The major product that we initially isolated 
from oxidation with silver (I) oxide (entry 1) was consistent with what we expected in 
dieneone 87, however we later determined by 2D NMR experiments that the major 
product was the spirodienone 89. Oxidations of hydroxybenzophenones to similar 
spirodienones are known and are thought to occur via a phenoxide radical that is aligned 
to favor the 5-memberd ring due to a bisected conformation of the highly substituted 
benzophenone.
29,92 
We found that oxidation with one equivalent of phenyliodine diacetate 
(PIDA) in THF was the optimal condition for conversion to spirodieneone 89 (72 %). 
Repeating Franck’s reported conditions of iron trichloride in acetone:water provided a 
mixture of new products, which were determined to be acid 90 and depsidone 91 (entry 
4). Following reported dehydrogenation conditions that likely proceed through quinone 
intermediates,
93










* Value in parenthesis is isolated yield. % Conversion as determined by UPLC analysis 
65 % and 89 % yield respectively (entry 5 and 6). Other oxidants including CAN or 












89, 100 (70) 
2 Ag2O 
(1.1 equiv.) 5 H2O 90, 50 
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5 10 % Pd/C, O2 48 THF 89, 100 (65) 
6 10 % Pd/C, O2 24 EtOAc 89, 100 (89) 
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20 % AlCl3, 1.1 
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24 MeCN 92, 100 (60) 












adding a Lewis acid and an oxidant may alter the regioselectivity of the cyclization. Such 
conditions to oxidize hydroquinones have been reported
94
 with AlCl3 and KBrO3 (entry 
13), however this oxidized the alcohol selectively to aldehyde 92. Attempting other 
reported conditions
95
 (Fe or La “doped” K-10 clay, entry 14 and 15) resulted in 
production of a mixture of the similar products 89-91.  
 After optimizing the conversion of graphisin A (42) to spirodienone 89 (entry 3), 
we subjected it to acidic conditions and observed both acid 90 (57 %) and depsidone 91 
(12 %) (Scheme 2.17). Acid 90 was easily converted to depsidone 91 with trifluoroacetic 
anhydride (68 %). We also observed conversion of 89 to both 90 and 91 on silica gel 
when using a 5 %-methanol in methylene chloride eluent during purification. This did not 
occur cleanly; accordingly we switched to a 10%-EtOAc in CH2Cl2 eluant.  
Scheme 2.17: Conversion of Spirodienone 89 to Carboxylic Acid 90 and Depsidone 91. 
 
 We believe this oxidation proceeds through a transient acyl benzoquinone 
intermediate 93 (Figure 2.11) based on literature precedent for similar systems.
93 
Conditions using PIDA or Pd/C-O2 (entries 3, 5-6, Table 2.3) cleanly converted 42 to 
spirodieneone 89, which may have resulted from a 5-exo-trig cyclization of a phenol onto 





bisected nature of the benzophenone quinone 93. One phenol is aligned with the * of the 
sp
2 
carbon adjacent to the benzophenone carbonyl, the position where the bond is formed. 
This inherent twisting of the highly-substituted benzophenone system governs the 
selectivity of cyclization,
96
 which we were not able to overcome by altering the oxidant, 
adding Lewis acids, or changing the solvent.  
Figure 2.11: Spartan Model of Proposed Benzoquinone Intermediate of Graphisin 
Oxidation 93.  
        
Because of the similarity of our system to the system studied by Franck (Scheme 
2.16), we examined other substrates to ascertain whether conversion of the benzophenone 
containing a methyl ester to the corresponding tetrahydroxanthone would be possible. For 
example, we prepared a graphisin A model system 94 using the same synthetic route 
highlighted above (Scheme 2.11, 2.13), starting from the MOM-protected 
salicylaldehyde 95 and aryl bromide 72. We wished to determine if eliminating 
substitution on the bis-phenol ring had any effect on the selectivity of the cyclization. 
Subjection of benzophenone 94 to similar conditions from Table 2.3 resulted in the 





benzoquinone intermediate from oxidation of 94 adopts a twisted conformation similar to 
93, resulting in the same 5-exo-trig cyclization. Not surprisingly, oxidation of 
acremonidin E 78 with PIDA in methylene chloride resulted in formation of spirodienone 
97 as the major product. Similarly, oxidization of 78 with Pd/C –O2 produced 97 in 
excellent yield.  
Scheme 2.18: Other Substrates Attempted under Oxidation Conditions. 
 
2.10: Attempted Photochemistry of Graphisin A (42) and Related Xanthones 
 Previously (Section 2.6-2.7), we described our syntheses of graphisin A (42) and 
sydowinin B (60) with the ultimate goal of determining whether these would be suitable 
substrates for a proposed photocycloaddition with oxanthrone ester 41 (Scheme 2.5). 
Upon synthesizing 42, we planned to irradiate it with light under a variety of conditions 
to ascertain whether it could serve as a precursor to m-quinonemethane intermediate 98 
and be trapped with methanol to form ether 99 (Scheme 2.19).
54,55





reactivity was based on precedent for simpler phenol systems discussed above (Scheme 
2.3).  
Scheme 2.19: Proposed Photo-induced Activation of 42 to Form Zwitterionic m-
Quinonemethane 98  
 
The photochemistry setup used for our reaction screen consisted of a 450-W 
hanovia lamp inserted into a quartz-glass cooling finger surrounded by a metal stand to 
place reaction tubes. A Pyrex glass filter was inserted around the lamp to absorb UV light 
below 275 nm. No filter was used when and the reactions were run in a quartz tube to 
allow full transmittance of high energy light. The table below (Table 2.4) summarizes 
attempted photolysis conditions for graphisin A (42). We screened different solvents and 
pH levels at two different exposures of UV light (entries 1-10). Unfortunately, we never 
observed any conversion to methyl ether 99. Trying different substrates prepared from 
fully deprotected intermediates of the graphisin A (42) forward synthesis also did not 






Table 2.4: Attempted Formation of Methyl Ether 99 via Photolysis of Graphisin A (42) 
 
conditions on xanthones sydowinin B (60) and a known model xanthone
43
 100 under 
similar photolysis conditions in methanol (Scheme 2.20); however, we still did not 
observe any formation of methyl ether products 101 or 102. 
After scouring the literature for other related examples, we found reports that 
described a photolysis process with benzylic phosphates 103 being converted to ethereal 
products 104 and 105 (Scheme 2.21). The mechanism for this solvolysis reaction based 





diradical 106. The triplet state diradical then undergoes a homolytic cleavage of the 
benzylic bond to form a radical pair 107. The radical pair 107 is thought to undergo 
electron transfer to form ion pair 108 which is trapped by solvent (alcohols, nitriles, etc.) 
to products 104 and 105.
98
 The electron transfer to form the ion pair occurs rapidly due to 
no isolated products resulting from radical cyclization.  
Scheme 2.20: Photolysis of Xanthones 60, 100 and 109 and Formation of Ether 102 
 
We next prepared the phosphate-protected benzyl alcohol 109 and irradiated it 
under similar conditions. This led to the production of methyl ether 102 in 20 % yield. 
We believe the mechanism is consistent with what has been reported for benzylic 
phosphates by Givens and coworkers
98
 and does not necessarily involve formation of a 






Scheme 2.21: Photosolvolysis of Phosphate 103 to Ethereal Products 104 and 105 
 
Additionally, we prepared benzylic phosphate 110 from graphisin A (42) and 
subjected it to similar photolysis conditions in methanol (Scheme 2.22). We observed a 
new product forming by TLC analysis that was determined to be the corresponding 
methyl ether 111 by crude 
1
H NMR and mass spec analyses. However, the conversion to 
product 111 was less than 10 % and was isolated with a mixture of related byproducts. 
Substrate 111 was not used for any further studies. 








2.11 Attempted Photochemistry of Graphisin A (42) and Oxanthrone Ester 41  
 We previously discussed oxanthrone ester’s 41 (Section 2.1) absorption and 
fluorescence properties and determined that it readily undergoes ESIPT when irradiated 
with a light source, analogous to other related anthraquinones.
47 
What is not well 
understood is whether the tautomer forms of anthraquinones react differently than their 
ground state forms. We tested our proposed photoinduced cycloaddition of oxanthrone 
Scheme 2.23: a) Oxidation of Oxanthrone Ester 41 upon Photo-irradiation b) Attempted 
Photo-activation of Chrysophanol (45) 
 
ester 41 and graphisin A (42) (Scheme 2.23a). However, under all photochemical 
conditions we attempted, anthraquinone chrysophanol (45) and a known oxanthrone 





from excitation of the carbonyl moiety of 41 followed by acetate cleavage to form the 
persistent radical 114 (Scheme 2.24). The radical intermediate 114 was either oxidized in 
the presence of oxygen to afford chrysophanol (45) or underwent homodimerization to 
afford 112.
99
 We also examined other nucleophiles/electrophiles in combination with 41 
under photoirradiation. The major products in all of these reactions were 45 and 112. The 
parent anthraquinone chrysophanol (45) also readily undergoes ESIPT in the presence of 
light to form dienone tautomer 115;
100
 however any attempt to react this tautomer or the 
ground state form under photochemical conditions resulted in no reaction (Scheme 
2.23b). 
Scheme 2.24: Oxidative Products Formed from Photolysis of Oxanthrone Ester 41 
 
We also investigated basic conditions as anthraquinones are known to tautomerize 
when deprotonated (Scheme 2.25).
51,52 
Both oxanthrone ester 41 and chrysophanol (45) 





the formation of the reported tautomers. In spite of this, no reaction was observed when 
combined with graphisin A (42) or subjected to a variety of nucleophiles/electrophiles 
under normal or photo-irradiation conditions. In reactions where 41 were used, hydrolysis 
and oxidation products 45 and 112 were isolated.  
Scheme 2.25: Attempted Activation of Base-induced Tautomers of 41 and 45 
 
We believe that although we are forming tautomer forms of both anthrone ester 
41 and chrysophanol (45), they were not reactive under the attempted conditions. There 
may be too high of an energy barrier for a tautomer of 43 or 115 to react and break 
aromaticity in the system. The closest literature example is Trauner’s reported synthesis 
of variecolortide (10) (Scheme 2.1) wherein he reported a related anthraquinone 




Although graphisin A (42) contains a hydroxymethyl group meta to a phenol 





ring at the benzyl position greatly raises the energy barrier to form the intermediate 
carbocation. Also, the acyl moiety of the benzophenone system may deter formation of 
any carbocation intermediate on the para hydroxymethyl position. Thus, graphisin A (42) 
does not form the m-quinonemethane intermediate and is apparently unreactive under the 
attempted photochemical conditions. 
2.12 Conclusion. 
 In this chapter, we described literature tautomerism via ESIPT of anthraquinones 
and related molecules under photochemical, basic, and thermal conditions. The latter 
mode of thermal proton transfer was highlighted by Trauner and coworkers in their 
expedient total synthesis of variecolortide A (10).
53
 We also described a related ESIPT 
studied by Wan and coworkers of simple hydroxymethyl phenols and hydroxyl biaryls. 
These literature precedents inspired our initial proposal for formation of the bicyclo 
[3.2.2] core structure of the anthraquinone-xanthone hetereodimeric natural products via 
a photoinduced cycloaddition of graphisin A (42) and oxanthrone ester 41. We described 
literature reported ESIPT of related anthraquinones and photophysical characterization of 
41 by fluorescence spectroscopy which indicated that ESIPT does occur. We also have 
described initial synthetic routes toward the benzophenone graphisin A (42) and 
ultimately its total synthesis. Using our developed synthetic route, we also synthesized 
xanthone sydowinin B (60), acremonidin E (78), and pinselin (79). Attempted biomimetic 
conversion of highly substituted benzophenones to their corresponding dihydroxanthones 





spirodienone products. This is likely due to the bisected conformation of the oxidized 
benzophenone intermediates favoring 5-endo-trig cyclization. We also conducted 
photochemical reactions of graphisin A (42) to determine whether it could form a 
potentially reactive m-quinonemethane intermediate. However, this intermediate was not 
observed under all attempted conditions. Finally, we tested our proposed 
photocycloaddition of oxanthrone ester 41 and graphisin A (42). In this case, the major 
products of these experiments were the result of oxidation of 41. We feel that the 
proposed idea of activating two separate molecules under photochemical conditions to 
perform an intermolecular reaction would be an impressive achievement, although it was 
not realized as planned. In the following chapter, we will discuss our plans and progress 
to synthesize the bicyclo [3.2.2] core of these natural products through an intramolecular 















2.13 Experimental Section 
 Instrumentation and methods-
1
H NMR spectra were recorded at 500 MHz at ambient 
temperature with CDCl3 (Cambridge Isotope Laboratories, Inc.) as the solvent unless 
otherwise stated. 
13
C NMR spectra were recorded at 100.0 MHz at ambient temperature 
with CDCl3 as the solvent unless otherwise stated. Chemical shifts are reported in parts 
per million relative to CDCl3 (
1
H, δ 7.26; 13C, δ 77.0). Data for 1H NMR are reported as 
follows: chemical shift, integration, multiplicity (app = apparent, br = broad, par obsc = 
partially obscure, ovrlp = overlapping, s = singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet) and coupling constants. All 
13
C NMR spectra were recorded with complete 
proton decoupling. Infrared spectra were recorded on a Nicolet Nexus 670 FT-IR 
spectrophotometer. Crude mass spectra were obtained using a Waters Acquity Ultra-
Performance Liquid Chromatography (UPLC) system with PDA, ELC, and SQ detectors. 
High-resolution mass spectra were obtained in the Boston University Chemical 
Instrumentation Center using a Waters Q-TOF mass spectrometer. Melting points were 
recorded on a Mel-temp (Laboratory Devices). Analytical thin layer chromatography was 
performed using 0.25 mm silica gel 60-F plates. Flash chromatography was performed 
using 200-400 mesh silica gel (Sorbent Technologies, Inc.). Yields refer to 
chromatographically and spectroscopically pure compounds, unless otherwise stated.  All 
other reactions were carried out in oven-dried glassware under an argon atmosphere 
unless otherwise noted. The Arthur
TM





was used for experimental procedure planning. All calculations were conducted using the 
SPARTAN 2010 Quantum Mechanics Program: (PC/x86) Release 1.0.1v4.  
Reagents and solvents 
HPLC grade tetrahydrofuran, methylene chloride, diethyl ether and hexanes were 
purchased from Fisher and VWR and were purified and dried by passing through a PURE 
SOLV
®
 solvent purification system (Innovative Technology, Inc.). Methanol was 
purchased from Fisher, distilled over magnesium iodide, and stored over 3 Ǻ molecular 
sieves. Sodium hydride was purchased from Fisher as a 60 % dispersion in mineral oil. 
All alkyllithium solutions were used after being freshly titrated using diphenylacetic acid 
as indicator. All other reagents were used as purchased from Aldrich, Acros, Alfa Aesar, 
and Strem Chemicals. Photochemistry experiments were performed using a 450 W 
medium pressure lamp housed in a quartz immersion cooled with a Thermo Neslab-ULT 
80 system circulator. Pyrex or quartz tubes were clamped approximately 5.0 cm from the 
immersion well lamp while stirring.  
Oxanthrone Ester 41: To a flask equipped with a stir bar 
was added tin dichloride (226 mg, 1.18 mmol, 3 equiv.), 
followed by concentrated HCl (0.9 mL). The reaction was 
stirred at rt until the SnCl2 was solubilized. Chrysophanol 45 (100mg) was dissolved in 
acetic acid (10 mL) and added slowly to the reaction flask at rt. The reaction was heated 
for 5 h at 80 ºC, was cooled to rt, diluted with water, and extracted with CH2Cl2. The 






vacuo to a yellow solid. This crude solid was then dissolved in acetic acid (5 mL) and 
placed in a reaction flask. DDQ (169 mg, 0.743 mmol, 2.1 equiv.) was added to the 
reaction which was heated at 60 ºC. Upon completion by TLC analysis (~1h), the 
reaction was cooled to rt and the DDQH was filtered off. Sodium bicarbonate solution 
was added to quench with acetic acid and the reaction mixture was extracted with CH2Cl2 
and washed with brine. The organic layer was dried over sodium sulfate, concentrated to 
a crude orange solid, and purified by column chromatography (4:1 hexanes:ethyl acetate) 
to provide 41 as an orange solid (85 mg, 80 %). Rf = 0.75 (4:1 hexanes: ethyl acetate); 
m.p.= (>220 ºC);  IR (thin film): max   3047.7, 2965.1, 2924.8, 2844.7, 1734.8, 1638.5, 
1617.1, 1601.7, 1489.4, 1453.1, 1371.7, 1292.7, 1220.5, 1194.8, 1163.0, 1086.5, 1014.9, 




H NMR (500 MHz, Chloroform-d) δ 12.12 (s, 1H), 12.01 (s, 
1H), 7.49 (dd, J = 8.4, 7.5 Hz, 1H), 6.99 (s, 1H), 6.98 – 6.94 (m, 2H), 6.79 – 6.77 (m, 
1H), 2.36 (s, 3H), 2.14 (s, 3H)..;
 13
C NMR (101 MHz, cdcl3) δ 192.39, 170.67, 162.91, 
162.74, 149.08, 139.57, 139.40, 136.80, 121.10, 119.74, 118.77, 118.62, 114.82, 112.62, 
66.67, 22.35, 21.44.; HRMSESI (m/z): [M-H]+ calcd for C17H14O5, 297.0763; found 
[M-H]
 +
, 297.0768, 1.6831 ppm).  
Dimethylhydrazone lactone biaryl 58: To a dry flask equipped with a stir bar 
was added 2-carboxymethylbenzoquinone 53 (16.0 
mg, 0.951 mmol, 1 equiv.) in MeCN (0.5 mL) and 
the reaction was cooled to 0 ºC. Lanthanum triflate 






reaction, which resulted in a color change. A solution of benzaldhydrazone 57 (20mg, 
0.951 mmol, 1 equiv.) in MeCN (0.5 mL) was added slowly at 0 ºC and the reaction was 
warmed to rt. The reaction was then heated at 60 ºC for 3 h to achieve full conversion. 
Upon completion by TLC analysis, the reaction was cooled to rt, filtered through a layer 
of Celite, and concentrated in vacuo. The crude product was purified by column 
chromatography (1:1 hexanes: ethyl acetate) to afford lactone 58 as an orange solid (20 
mg, 61 %). Rf = 0.55 (1:1 hexanes: ethyl acetate); m.p. = (>220 ºC); IR (thin film): max   
3057.1, 2962.1, 2925.2, 2852.8, 2254.3, 1745.8. 1660.6, 1595.1, 1563.9, 1388.8, 1338.9, 




H NMR (400 
MHz, DMSO-d6) δ 13.09 (s, 1H), 7.89 (s, 1H), 7.64 (s, 1H), 6.98 (d, J = 10.2 Hz, 1H), 
6.78 (s, 1H), 6.22 (d, J = 10.2 Hz, 1H), 5.21 (dd, J = 16.3, 1.4 Hz, 1H), 4.87 (d, J = 16.0 
Hz, 1H).; 
13C NMR (126 MHz, dmso) δ 179.90, 162.60, 154.89, 154.43, 152.37, 142.76, 
135.80, 129.49, 126.99, 108.96, 107.45, 105.86, 103.59, 85.84, 60.10, 42.15.; 
HRMSESI (m/z): [M]+ calcd for C17H16N2O6, 344.1008; found [M-H]
 +
, 343.0948 
2.5574 ppm).  
2-Bromo-3,6-bis(methoxymethoxy)benzaldehyde 63: 2-Bromo-3,6-
dihydroxybenzaldehyde was dissolved (2.31 g, 10.6 mmol) in CH2Cl2 
(90 mL) in an oven-dried flask with a stir bar. The reaction was cooled 
to 0 ˚C with an ice bath and N,N-diisopropylethylamine (6.46 mL, 37.1 
mmol, 3.50 equiv.) was added via a syringe and stirred for 10 min. Chloromethyl methyl 






of 10 min. This solution was allowed to warm to room temperature and stirred for 12 h. 
Upon completion by TLC, water (50 mL) was added and then the organic layer was 
washed with brine, dried over sodium sulfate, filtered, and concentrated in vacuo. 
Purification by column chromatography (4:1 hexanes: ethyl acetate) afforded 
bromobenzaldehyde 63 as a white solid (2.65 g, 82 %). NOTE: this compound was stored 
in a -20 ˚C freezer to prevent partial deprotection over time. Rf = 0.40 (4:1 hexanes: ethyl 
acetate); m.p. 48-50 ˚C (EtOAc); IR (thin film): max  2960.3, 2905.6, 2828.6, 1697.1, 





NMR (CDCl3, 400 MHz): s, 1H),  7.27 (d, J=10Hz, 1H),  7.13 (d, J=10Hz, 
1H),  5.18 (s, 4H),  3.51 (s, 3H),  3.48 (s, 3H); 13C NMR (CDCl3, 100 MHz) :  190.2, 
153.7, 149.1, 125.8, 121.5, 115.9, 114.8, 95.8, 95.7, 55.4, 55.3; HRMSESI (m/z): 
[2M+Na]
+
 calcd for C11H13BrO5, 630.9791; found [2M+Na]
 +
, 630.9787 (- 0.6339 ppm). 
Benzaldehyde 73: ((3,5-Bis(methoxymethoxy)benzyl)oxy)(tert-butyl)dimethylsilane 
62 (1.00 g, 2.92 mmol) was dissolved in THF (23 mL) in a dry 
round bottom flask equipped with a stir bar. The reaction was 
stirred and cooled to 0˚C with an ice bath. N-Butyllithium (1.40 
mL, 2.3 M in hexanes, 1.1 equiv.) was added via a syringe to this solution slowly and the 
reaction was allowed to slowly warm to rt over 1.5 h. The brownish solution was then 
cooled back to 0 ˚C with an ice bath. DMF (0.450 mL, 5.84 mmol, 2.0 equiv.) was added 
via a syringe and the yellow solution was allowed to warm to room temperature. Upon 






solution, extracted with ethyl acetate, washed with brine, dried over sodium sulfate, 
filtered, and concentrated in vacuo to afford a crude oil. This crude oil was purified by 
column chromatography (3:1 hexanes: ethyl acetate) to afford benzaldehyde 73 (840 mg, 
78 %) as a clear oil. Rf = 0.76 (3:2 hexanes: ethyl acetate); IR (thin film): max 2955.6, 
2931.1, 2857.4, 1688.3, 1609.6, 1575.0, 1471.8, 1392.4, 1265.0, 1154.6, 1101.3, 1004.4, 




H NMR (CDCl3, 400 MHz):  10.4 (s, 1H),  6.78 (s, 2H),  
5.19 (s, 4H),  4.66 (s, 2H),  3.43 (s, 6H),  0.89 (s, 9H),  0.05 (s, 6H); 13C NMR 




 calcd for C18H30O6Si, 393.1709; found [M+Na]
 +
, 393.1716 (+1.7804 ppm). 
Bromobenzyl Alcohol 64: ((3,5-Bis(methoxymethoxy)benzyl)oxy)(tert-
butyl)dimethylsilane 62  (2.02 g, 5.90 mmol, 1.2 equiv.) was 
dissolved in dry THF (65 mL) in a round bottom flask 
equipped with a stir bar. The reaction was cooled to 0 ˚C 
with an ice bath. N-Butyllithium (2.57 mL, 2.3 M in hexanes, 1.2 equiv.) was added via 
syringe to this solution slowly and the reaction was allowed to slowly warm to room 
temperature over 1.5 h. The brownish solution was then cooled to 0˚C with an ice bath. A 
separate solution of bromobenzaldehyde 63 (1.50 g, 4.92 mmol) in THF (20 mL) was 
slowly syringed into the aryl lithium solution over a period of 5 min, maintaining the 
reaction temperature at 0˚C. After addition, the solution was allowed to slowly warm to 






addition of saturated NH4Cl solution and then extracted with ethyl acetate. The combined 
organic phases were washed with water, then brine, then dried over sodium sulfate, 
filtered, and concentrated in vacuo to afford bromobenzyl alcohol 64 as a crude yellow 
oil. Purification by column chromatography (gradient, 4:1 hexanes: ethyl acetate to 1:1 
hexanes: ethyl acetate) afforded compound 64 (1.77 g, 56 %) as a light yellow oil. Rf = 
0.43 (3:1 hexanes: ethyl acetate); IR (thin film): max   3525.3, 2955., 2900.4, 2856.2, 
2826.2, 1735.5, 1611.6, 1585.5, 1471.9, 1437.3, 1397.0, 1253.9, 1204.1, 1152.7, 1083.9, 




H NMR (CDCl3, 400 MHz):  6.93, 
(dd, J= 9.0, 9.0 Hz, 2H),  6.73 (s, 2H),  6.66 (d, J= 9.8, 1H),  5.72 (d, J=9.8 Hz, 1H), 
 5.12 (d(ovlp), J=6.67 Hz, 2H)  5.12 (m, 2H),  5.06 (d, J=6.67 Hz, 2H),  4.99 (d, J= 
6.9 Hz, 1H),  4.83 (d, J=6.9 Hz, 1H),  4.62 (s, 2H),  3.48 (s, 3H),  3.28 (s, 6H),  
3.15 (s, 3H),  0.89 (s, 9H),  0.04 (s, 6H); 13C NMR (CDCl3, 100 MHz) 

; HRMSESI (m/z): [M+Na]+ calcd for 
C28H43BrO10Si, 669.1707; found [M+Na]
 +
, 669.1700 (- 1.0461 ppm). 
Bromobenzophenone 65: Bromobenzyl alcohol 64 (1.50 g, 2.32 mmol) was 
dissolved in CH2Cl2 (30 mL) in a round bottom flask 
equipped with a stir bar. A separate solution of IBX (973 
mg, 3.47 mmol, 1.50 equiv.) in DMSO (4.0 mL) in a vial 
was prepared and then added to the alcohol via a syringe 






h and monitored by 
1
H NMR. Upon completion, a saturated solution of sodium 
thiosulfate (10 mL) was added, followed by water (20 mL). The reaction mixture was 
extracted with CH2Cl2 and then washed with water, brine, dried over sodium sulfate, 
filtered, and concentrated in vacuo to afford a crude reddish oil. Purification by column 
chromatography (2:1 hexanes: ethyl acetate) gave bromobenzophenone 65 (1.13 g, 76 %) 
as a light orange oil. Rf = 0.43 (3:1 hexanes: ethyl acetate); IR (thin film): max  2954.5, 
2929.6, 2856.0, 2827.2, 1680.7, 1608.6, 1580.5, 1464.3, 1395.6, 1259.8, 1203.7, 1152.3, 




H NMR (CDCl3, 400 MHz):  7.02 (d, J= 9.0 
hz, 1H),  6.96 (d, J= 9.0 hz, 1H),  6.75 (s, 2H),  5.14 (s, 2H),  5.01 (s, 4H),  4.87 (s, 
2H),  4.66 (s, 2H),  3.48 (s, 3H),  3.27 (s, 6H),  3.20 (s, 3H),  0.90 (s, 9H),  0.05 (s, 
6H); 
13
C NMR (CDCl3, 100 MHz):  
; HRMSESI (m/z): [M+Na]+ calcd for C28H41BrO10Si, 
667.1550; found [M+Na]
 +
, 667.1542 (-1.1991 ppm). 
Cyanobenzophenone 59: Bromobenzophenone 65 (200 mg, 0.301 mmol) was 
dissolved in N,N-dimethylacetamide (DMA) (3.20 mL) in 
a microwave tube (10 mL) equipped with a stir bar. This 
solution was thoroughly degassed by bubbling with argon 
for 10 min. Zn(CN)2 (31 mg, 0.263 mmol, 0.85 equiv.) 
and Pd(PPh3)4 (71.6 mg, 0.062 mmol, 0.20 equiv.) were added sequentially to the 
microwave tube and then the tube was sealed with a cap. This solution was heated in a 






water (5 mL) and 1 M HCl (1 mL) and then extracted with ethyl acetate (2x). The 
combined organic phase was washed with water, brine, dried over sodium sulfate, 
filtered, and concentrated in vacuo to provide a dark crude oil. Purification by column 
chromatography (gradient: 5:1 hexanes: ethyl acetate to 2:1 hexanes: ethyl acetate) 
afforded cyanobenzophenone 59 (110.0 mg, 60 %) as a white solid. m.p. (EtOAc) = 74-
76 ˚C; Rf = 0.65 (1:1 hexanes: ethyl acetate) ; IR (thin film): max  3057.1, 2956.4, 2856.8, 





H NMR (CDCl3, 400 MHz): dd J= 9.2, 9.2 Hz, 2H),  6.73, 
(s, 2H),  5.20, (s, 2H),  5.02 (s, 4H),  4.80 (s, 2H),  4.65 (s, 2H),  3.47 (s, 3H),  
3.27 (s, 6H),  3.14 (s, 3H),  0.88 (s, 9H),  0.05 (s, 6H); 13C NMR (CDCl3, 100 MHz): 
 
; HRMSESI (m/z): [M+Na]+ calcd for 
C29H41NO10Si, 614.2397; found [M+Na]
 +
, 614.2425 (+ 4.5585 ppm). 
Cyanobenzophenone 67: Cyanobenzophenone 59 (550 mg, 0.930 mmol) was 
dissolved in MeOH (10.0 mL) in a round bottom flask 
equipped with a stir bar. para-Toluenesulfonic acid 
monohydrate (355 mg, 1.86 mmol, 2.0 equiv.) was added in 
one batch and the reaction was heated to 50 ˚C in an oil bath. The reaction solution turned 
bright red upon addition of the acid. The reaction was monitored by TLC and upon 
completion (5 h) water (10 mL) was added. The reaction was extracted with ethyl acetate 






filtered, and concentrated in vacuo to provide a dark red residue. Purification by column 
chromatography (5% MeOH in CH2Cl2) provided cyanobenzophenone 67 (156 mg, 55 
%) as an orange solid. m.p.= (MeOH): 180 ˚C (decomposed); Rf = 0.17 (7 % MeOH in 
CH2Cl2); IR (thin film): max : 3210.8, 2923.8, 2841.6, 2227.5, 1632.3, 1584.0, 1495.2, 




H NMR (d6-DMSO, 
500 MHz):  11.36 (s, 2H),  10.38 (s, 1H),  9.49 (s, 1H),  6.97 (d, J= 9.0 Hz, 1H),  
6.86 (d, J= 9.0 Hz, 1H),  6.31 (s, 2H),  5.30 (t, J= 5.6 Hz, 1H),  4.39 (d, J= 5.5 Hz, 
1H); 
13
C NMR (d6-DMSO, 100 MHz) : 

; HRMSESI (m/z): [M+H]+ calcd for C15H11NO6, 302.0665; found [M+H]
 +
, 
302.0653 (+ 3.9726 ppm).
 Cyanoxanthone 68: Cyanobenzophenone 67 (40 mg, 0.133 mmol) was placed in an 
oven-dried microwave tube equipped with a stir bar. 
ZnCl2 (36 mg, 0.266 mmol, 2 equiv.) was added to the 
tube followed by water (1 mL) and the vessel was 
sealed with a cap. This was heated at 120 ˚C for 7 min. in a microwave reactor with 
stirring. Upon completion by TLC analysis, the reaction mixture was extracted with ethyl 
acetate and washed with 1M aqueous HCl, brine, dried over sodium sulfate and 
concentrated in vacuo to provide a crude orange solid. Purification by column 
chromatography (5% MeOH in CH2Cl2) provided cyanoxanthone 68 (21.0 mg, 56 %) as 











H NMR (d6-DMSO, 400 MHz): 12.2 (s, 1H),  7.80 (d, J= 9.3 hz, 1H),  
7.57 (d, J= 9.3 hz, 1H),  6.97 (s, 1H),  6.75 (s, 1H),  5.52 (bs, 1H),  4.57 (s, 2H); 13C 
NMR (d6-DMSO, 100 MHz): 





Benzaldehyde 63 (2.00 g, 6.55 mmol) was dissolved in methanol (40 
mL) in a dry round bottom flask equipped with a stir bar. This was 
cooled to 0˚C in an ice bath while stirring and sodium borohydride 
(372 mg, 1.50 equiv.) was added. The reaction was monitored by 
TLC analysis. Upon completion of the reaction (20 min), a solution of saturated NH4Cl 
was added (10 mL) followed by addition of 1M HCl (5 mL). The resultant solution was 
extracted with CH2Cl2, washed with water, brine, dried over sodium sulfate, filtered, and 
concentrated in vacuo to provide the corresponding alcohol as a clear oil. This oil was 
taken up in DMF (40 mL) and cooled to 0 ˚C in an ice bath.  Sodium hydride (525 mg, 
(60% dispersion in mineral oil) 13.1 mmol, 2.00 equiv.) was added and the solution and 
stirred for 10 min. Benzyl bromide (1.17 mL, 9.83 mmol, 1.50 equiv.) was added 
dropwise to the reaction and the reaction was warmed to room temperature. Upon 
completion by TLC analysis (3 h), the reaction was quenched with a solution of saturated 






with water (2x), brine, dried over sodium sulfate, filtered, and concentrated in vacuo to a 
crude oil. Purification by column chromatography (8:1 hexanes: ethyl acetate) provided 
benzyl ether 72 (2.10 g, 81%) as a clear oil. Rf = 0.45 (4:1 hexanes:ethyl acetate); IR 





H NMR (CDCl3, 400 MHz):  7.40 (d, J=8.4 Hz, 2H),  7.33 (dd, J= 
7.6, 7.1 Hz, 2H),  7.26 (m, 1H),  7.06 (dd, J= 11.7, 9.1, Hz, 2H),  5.17 (s, 2H),  5.12 
(s, 2H),  4.79 (s, 2H),  4.62 (s, 2H),  3.51 (s, 3H),  3.45 (s, 3H); 13C NMR (CDCl3, 
100 MHz): 

; HRMSESI (m/z): [M+Na]+ calcd for C18H21BrO5, 419.0470; found, 
419.0461 (- 2.1477 ppm).  
Benzyl Alcohol 74: Note: both substrates 73 and 72 were azeotropically dried with 
toluene prior to use. 2-((benzyloxy)methyl)-3-bromo-1,4-
bis(methoxymethoxy)benzene 72 (500 mg, 1.30 mmol) 
was dissolved in ether (15 mL) in a round bottom flask 
equipped with a stir bar under an atmosphere of argon. 
This solution was cooled to -78˚C and t-BuLi (1.7 M solution in pentane, 1.61 mL, 2.10 
equiv.) was added dropwise and the reaction stirred for 5 min. A solution of 
benzaldehyde 73 (531 mg, 1.44 mmol, 1.10 equiv.) in ether (10 mL) was added slowly 
via a syringe. The resulting yellow solution was slowly warmed to room temperature. 






solution of NH4Cl and extracted with ether. The organic phase was washed with brine, 
dried over sodium sulfate, filtered, and concentrated in vacuo. The crude oil was purified 
by column chromatography (2:1 hexanes: ethyl acetate) to afford benzyl alcohol 74 (550 
mg, 61% yield) as a clear oil. Rf = 0.85 (1:1 hexanes: ethyl acetate); IR (thin film): max  
3522.4, 3055.7, 2955.6, 2900.0, 2856.5, 1586.2, 1473.3, 1265.2, 1152.0, 1087.4, 1044.3, 




H NMR (CDCl3, 400 MHz):  7.31-7.18 (m, 5H),  
6.91 (d, J=10Hz, 1H),  6.85 (d, J=10Hz, 1H),  6.88 (s, 2H),  6.61 (d, J=7.7Hz, 1H),  
5.36 (d, J=7.7Hz, 1H),  5.01 (s, 2H),  4.95-4.93 (m, 5H),  4.82 (dd, J=12.5, 6.8Hz, 
2H),  4.78 (d, J=10.2Hz, 1H),  4.57(s, 2H),  4.52 (dd, J=11.8, 6.8),  3.37(s, 3H),  
3.17(s, 6H),  3.12(s, 3H),  0.85(s, 9H),  0.00(s, 6H); 13C NMR (CDCl3, 100 MHz) : 

; 
HRMSESI (m/z): [M+Na]+ calcd for C36H52O11Si, 711.3177; found [M+Na]
 +
, 711.3197 
(+ 2.2493 ppm). 
Benzophenone 75: Benzyl alcohol 74 (500 mg, 0.726 
mmol) was dissolved in CH2Cl2 (7.5 mL) in a round 
bottom flask equipped with a stir bar. Separately, a 
solution of IBX (265 mg, 0.944 mmol, 1.30 equiv.) in 
DMSO (1.24 mL) in a vial was prepared and then added to the alcohol via a syringe at 
room temperature. The resulting orange solution was stirred at room temperature for 3 h 
and monitored by 
1






sodium thiosulfate (5 mL) was added, followed by water (10 mL). This was extracted 
with CH2Cl2 and washed with water (2 x 10 mL) and then brine, dried over sodium 
sulfate, filtered, and concentrated in vacuo to give a crude orange oil. Purification of the 
crude oil by column chromatography (2:1 hexanes: ethyl acetate) afforded benzophenone 
75 (390 mg, 78 %) as a light orange oil. Rf = 0.89 (1:1 hexanes: ethyl acetate); IR (thin 
film): max  2965.6, 2954.2, 2856.5, 1674.8, 1608.5, 1472.5, 1435.1, 1253.9, 1151.9, 




H NMR (CDCl3, 400 MHz): 
m, 5H), d, J=9Hz, 1H),  6.91 (d, J=9Hz, 1H),  6.68 (s, 2H),  5.04 
(s, 2H),  4.88 (s, 4H),  4.78 (s, 2H), 4.58 (s, 2H),  4.50 (s, 2H),  4.41 (s, 2H),  3.37 
(s, 3H),  3.16 (s, 6H),  3.13 (s, 3H),  0.85 (s, 9H),  0.00 (s, 6H); 13C NMR (CDCl3, 
100 MHz) :  

; HRMSESI (m/z): [M+Na]+ calcd for C36H50O11Si, 709.3020; found [M+Na]
 +
, 
709.3030 (+ 1.4098 ppm).  
Dihydroisobenzofuran 76: Benzophenone 75 (150 mg, 0.218 mmol) was dissolved 
in methanol (9.0 mL) in a flame-dried flask equipped 
with a stir bar. The solution was degassed by bubbling 
with argon for 10 min. Pd(OH)2/C (20%) (40.9 mg, 
0.0437 mmol, 0.2 equiv.) was added at room temperature and then the flask was purged 






analysis. The reaction initially converted to a lower spot by TLC (benzyl alcohol 77: Rf = 
0.54 (1:1 hexanes: ethyl acetate)) and was ultimately converted to a higher spot (product 
76: Rf = 0.81 (1:1 hexanes: ethyl acetate)). Upon completion by TLC analysis (1 h), the 
reaction was filtered through a pad of celite and concentrated in vacuo to afford a crude 
oil. Purification by column chromatography (3:1 hexanes: ethyl acetate) afforded a clear 
oil 76 (90.0 mg, 92%). Rf = 0.81 (1:1 hexanes: ethyl acetate) ;IR (thin film): max  2954.0, 
2901.1, 2825.7, 1610.3, 1587.6, 1492.4, 1397.6, 1356.7, 1240.9, 1205.5, 1151.0, 1109.6, 




H NMR (CDCl3, 400 MHz):  
7.43 (d, J= 3.0Hz, 1H),  6.87 (d, J= 8.7Hz, 1H),  6.79 (d, J= 8.7Hz, 1H),  6.66 (bs, 
2H),  5.66 (dd, J= 11.8, 3.5Hz, 1H),  5.50 (d, J= 11.8Hz, 1H),  4.96 (bs, 2H),  4.88 
(d, J= 6.6Hz, 1H),  4.85 (d, J= 6.6Hz, 1H),bs, 2H),  4.72 (d, J= 6.6Hz, 1H),  
4.58 (d, J= 6.6Hz, 1H),  3.26 (bs, 3H),  3.17 (s, 3H),  2.93 (s, bs (ovlp), 6H),  2.04 
(s, 3H); 
13
C NMR (CDCl3, 100 MHz): 

; We observed peak broadening for the aryl ( 6.66, bs)  and MOM ether 
hydrogens ( 4.96 (bs, 2H),  2.93 (s, bs (ovlp), 3H)) due to presumed slow rotation of 
the 2,6-disubstituted aryl ring of the dihydroisobenzofuran moiety. HRMSESI (m/z): 
[M+Na]
+
 calcd for C23H30O9, 473.1788; found [M+Na]
 +






Benzophenone alcohol 77: Benzophenone 75 
(250 mg, 0.364 mmol) was dissolved in THF (30 mL) 
in a dry round bottom flask equipped with a stir bar. 
This was degassed with a stream of argon for 10 min. 
20% wt. Pd(OH)2/Carbon (20 mg, 0.03 mmol, 0.08 equiv.) was added in one batch and 
the reaction flask was purged 3x with a balloon of hydrogen. The reaction was stirred at 
room temperature and was monitored closely by TLC analysis. Upon completion by TLC 
analysis (1.5 h), the reaction solution was filtered through a pad of Celite and 
concentrated in vacuo to a crude oil. Purification by column chromatography (2:1 
hexanes: ethyl acetate) provided benzyl alcohol 77 (163 mg, 75 %) as a clear oil. Rf = 
0.54 (1:1 hexanes: ethyl acetate) ;IR (thin film): max 3512.9, 2968.4, 2955.3, 2857.3, 
1660.3, 1609.2, 1471.0, 1435.0, 1395.2, 1263.4, 1152.3, 1086.6, 1036.8, 1004.1, 922.6, 
837.2, 734.4 cm-1; 1H NMR (CDCl3, 400 MHz):  7.13 (d, J= 9.1 hz, 1H),  6.93 (d, 1H, 
J= 9.1 hz),  6.77 (s, 2H), 5.19 (s, 2H),  5.01 (s, 4H),  4.74 (s, 2H),  4.68 (s, 2H),  
4.66 (s, 2H),  3.51 (s, 3H),  3.25 (s, 6H),  3.09 (s, 3H),  0.93 (s, 9H),  0.08 (s, 6H); 
13
C NMR (CDCl3, 100 MHz): 

; HRMSESI (m/z): [M+H]+ calcd for 
C29H44O11Si, 619.2551; found [M+Na]
 +







 Benzophenone Methyl Ester 66: Benzyl alcohol 77 (200 mg, 0.335 mmol) was 
dissolved in CH2Cl2 (4.00 mL) in a round bottom flask 
equipped with a stir bar. Dess-Martin periodinane (213 
mg, 0.503 mmol, 1.5 equiv.) was added in one batch at 
room temperature. The resulting cloudy solution became bright yellow over 1 h. Upon 
completion by TLC analysis (1 h), a saturated solution of sodium thiosulfate (1 mL) was 
added, followed by a saturated solution of sodium bicarbonate (1 mL). The reaction 
mixture was extracted with CH2Cl2 and the organic phase was washed with brine, dried 
over sodium sulfate, filtered, and concentrated in vacuo to afford a crude oil. The crude 
oil was purified by column chromatography (2:1 hexanes: ethyl acetate) to provide the 
benzaldehyde (170 mg, 85.3%) as a clear oil. Rf = 0.60 (1:1 hexanes: ethyl acetate); IR 
(thin film): max  2955.2, 2929.3, 2855.8, 1688.6, 1608.7, 1580.2, 1472.0, 1434.3, 1393.7, 





(CDCl3, 400 MHz): s, 1H),  7.21 (d, J=9Hz, 1H),  7.13 (d, J=9Hz, 1H),  5.19 
(s, 2H),  5.00 (s, 4H),  4.88 (s, 2H),  4.66 (s, 2H),  3.47 (s, 3H),  3.28 (s, 6H),  3.23 
(s, 3H),  0.90 (s, 9H),  0.06 (s, 6H); 13C NMR (CDCl3, 100 MHz) 
: 
;HRMSESI(m/z): [M+Na]+ calcd 
for C29H42O11Si, 617.2394; found [M+Na]
 +
, 617.2409 (+ 2.4302 ppm). The pure 
benzaldehyde (200 mg, 0.336 mmol) was dissolved in a 1/2/5 mixture of water (4.2 






The reaction was cooled to 0 ˚C with an ice bath and sodium phosphate monobasic 
monohydrate (NaH2PO4-H2O) (140 mg, 1.01 mmol, 3 equiv.) was added, followed by 2-
methyl-2-butene (1.07 mL, 10.1 mmol, 30 equiv.) via a syringe. Sodium chlorite 
(NaClO2) (166 mg, 1.84 mmol, 5.5 equiv.) was added to the solution in one batch. This 
solution turned cloudy as it was slowly warmed to room temperature. Upon completion 
by TLC analysis, the reaction was quenched with a saturated solution of NH4Cl (NOTE: 
A 1M HCl quench resulted in formation of chlorinated byproducts) and extracted with 
ethyl acetate (2x). The organic layers were washed with brine, dried over sodium sulfate, 
filtered, and concentrated in vacuo to a provide a clear residue. This was dried under high 
vacuum and was used directly for the next step. A stir bar was added to the flask and the 
residue was taken up in a 1/1 mixture of methanol (5 mL) and ether (5 mL), which was 
followed by addition via a syringe of TMSCHN2 (2.00 M solution in hexanes, 1.68 mL, 
10 equiv.). The reaction visibly produced bubbles upon addition and turned bright 
yellow. Upon completion by TLC analysis (20 min), the reaction was concentrated in 
vacuo to provide a yellow residue which was purified by column chromatography (3:1 
hexanes: ethyl acetate) to afford methyl ester 66 (150 mg, 71 %, 2 steps) as an orange oil. 
Rf = 0.75 (1:1 hexanes: ethyl acetate); IR (thin film): max  2954.8, 2930.1, 2902.3, 
2856.7, 1735.7, 1668.4, 1609.5, 1584.2, 1475.0, 1436.3, 1394.8, 1265.2, 1203.8, 1153.5, 




H NMR (CDCl3, 400 MHz):  
7.14 (d, J=9.1 Hz, 1H),  7.03 (d, J=9.1 Hz, 1H),  6.72 (s, 2H),  5.07 (s, 2H),  4.98 (s, 
4H),  4.72 (s, 2H),  4.64 (s, 2H),  3.74 (s, 3H),  3.42 (s, 3H),  3.26 (s, 6H),  3.15 (s, 






; HRMSESI (m/z):  
[M+Na]
+
 calcd for C30H44O12Si, 647.2500; found [M+Na]
 +
, 647.2488 (- 1.8540 ppm). 
Graphisin A 42: Benzophenone methyl ester 66 (115 mg, 
0.184 mmol) was dissolved in methanol (2.50 mL) in a round 
bottom flask equipped with a stir bar. para-Toluenesulfonic 
acid monohydrate (70 mg, 0.368 mmol, 2.0 equiv.) was added 
in one portion and the reaction was heated to 45˚C in an oil bath. The reaction solution 
turned light orange as the reaction proceeded. The reaction was monitored by TLC 
analysis and upon completion (3 h), water (5 mL) was added. The reaction mixture was 
extracted with ethyl acetate (2x) and the combined organic layer was washed with brine, 
dried over sodium sulfate, filtered, and concentrated in vacuo to provide an orange oil. 
Purification by column chromatography (5% MeOH in CH2Cl2) provided graphisin A 42 
(48 mg, 77 %) as a yellow solid. The solid was found to be soluble in methanol, ethyl 
acetate, DMSO, but not in CHCl3 or CH2Cl2. m.p.(ethyl acetate)= 94-97˚C; Rf = 0.47 (7% 
methanol in CH2Cl2); IR (thin film): max  3344.0, 2954.0, 2844.8, 1637.1, 1577.1, 1461.6, 
1434.3, 1258.6, 1202.4, 1152.5, 1015.3 cm
-1
; See Table 2.5 for NMR comparison data to 
the literature: HRMSESI (m/z): [M+23]+ calcd for C16H14O8, 357.0586; found [M+23]
+
, 











C NMR Comparison of Graphisin A (42) to the Literature
28 
 Literature Reported- d6-DMSO  Observed- d6-DMSO 
1
 H 13 C 1 H 13 C 
11.38 (2H, br s) 199.9 11.35 (2H, br s) 199.9 
9.70 (1H, s) 168.5 9.68 (1H, s) 168.5 
9.23 (1H, br s) 162.0 9.16 (1H, br s) 162.1 
6.94 (1H, d, J 8.9) 152.7 6.93 (1H, d, J 8.9) 152.8 
6.81 (1H, d, J 8.9) 151.6 6.80 (1H, d, J 8.9) 151.7 
6.24 (2H, s) 146.2 6.24 (2H, s) 146.2 
5.27 (1H, t, J 5.8) 131.7 5.23 (1H, t, J 5.8) 131.7 
4.36 (2H, d, J 5.8) 122.7 4.35 (1H, d, J 5.9) 122.8 









    
Sydowinin B 60: Method 1: Nitrile xanthone 68 (21 mg, 0.074 mmol) was placed in 
a flask with stir bar. Methanol (0.8 mL) was added 
followed by aqueous 3M H2SO4 (0.8 mL). The flask 
was sealed and heated at 60 ˚C for 2 h, cooled to room 
temperature, and diluted with water. Ethyl acetate was added to extract and then the 






in vacuo to a crude orange solid. Purification by column chromatography (5 % MeOH in 
CH2Cl2) provided sydowinin B 60(12.0 mg, 51%) as a white solid. Method 2: Graphisin 
A 42 (22.0 mg, 0.066 mmol) was placed in a microwave tube equipped with a stir bar. 
Anhydrous ZnCl2 (17.9 mg, 0.132 mmol) was added and water (1 mL) was added and 
then the tube was sealed with a cap. This was heated at 120˚C for 10 min. with stirring in 
a microwave reactor. Upon completion by TLC analysis, the mixture was extracted with 
ethyl acetate and washed with 1M aqueous HCl, brine, dried over sodium sulfate and 
concentrated in vacuo to give a crude yellow solid. Purification by column 
chromatography (5% MeOH in CH2Cl2) provided sydowinin B 60 as a white solid (12.0 
mg, 58%). m.p. (ethyl acetate)= 220˚C (decomposes); Rf = 0.29 (1:1 hexanes: ethyl 
acetate); IR (thin film): max 3423.5, 2924.2, 2852.3, 1703.6, 1650.8, 1610.2, 1493.8, 




H NMR (CDCl3, 
400 MHz):  s),  10.4 (1H, br s),  7.64 (1H, d, J 9.1 ),  7.48 (1H, d, J 9.1 ),  
7.00 (1H, d, J 1),6.75 (1H, d, J 1),  5.51 (1H, t, J 5.9),  4.60 (1H, d, J 5.9), 3.85 
(3H, s);
13
C NMR (d6-DMSO, 100 MHz); 

See Table 2.6HRMSESI (m/z): [M-H]+ calcd for C16H12O6, 
315.0505; found [M+Na]
 +












C NMR Comparison of Sydowinin B (60) to the Literature
70 







12.2 (1H, s) 12.2 (1H, s) 180.3 
10.4 (1H, br, s) 10.4 (1H, s) 166.8 
7.62 (1H, d, J 8) 7.64 (1H, d, J 9.1 ) 160.4 
7.46 (1H, d, J 8) 7.48 (1H, d, J 9.1 ) 155.5 
6.98 (1H, d, J 1) 7.00 (1H, d, J 1) 154.1 
6.74 (1H, d, J 1) 6.75 (1H, d, J 1) 150.7 
5.50 (1H, br, s) 5.51 (1H, t, J 5.9) 148.9 
4.60 (2H, br, s) 4.60 (1H, d, J 5.9) 125.3 

















PIDA Oxidation of Graphisin A 42 to Spiro-Dieneone 89: Graphisin A 42 
(50.0 mg, 0.150 mmol) was placed in round bottom flask with 
a stir bar. THF (1.40 mL) was added followed by phenyliodide 
diacetate (PIDA) (53.0 mg, 0.164 mmol, 1.1 equiv.) and the 
reaction was stirred at room temperature for 20 min. during 
which time the solution turned bright orange. Upon completion by TLC analysis, the 
solution was evaporated in vacuo and purified by column chromatography (4:1 
CH2Cl2:ethyl acetate) to afford 89 as a yellowish oil (36.0 mg, 72 %). This material was 
not stable in methanol or water and degraded rapidly in these solvents.  Rf =0.53 (7% 
methanol in CH2Cl2); IR (thin film): max 3453.2, 3380.7, 3069.7, 2959.4, 1706.0, 1663.5, 





H NMR (CDCl3, 400 MHz): bs,),  7.10 (1H, d, J= 10.2 
hz),  6.68, (s, 1H),  6.53 (s, 1H),  6.43 (d, 1H, J= 10.2 hz),  4.73 (s, 2H),  3.55 (s, 
3H) ;
13
C NMR (CDCl3, 100 MHz);  
HRMSESI (m/z): [M+H]+ 
calcd for C16H12O6, 333.0610, found [M+Na]
 +
, 333.0623 (+ 3.9032 ppm).  
Pd/C Oxidation to Spiro-Dieneone 89 from Graphisin A 42: Graphisin A 
42 (25.0 mg, 0.075 mmol) was placed in a round bottom flask equipped with a stir bar. 
This flask was purged thoroughly with an oxygen balloon. Ethyl acetate (1.0 mL) was 
added followed by 10% Pd/C (3.0 mg, 1 equiv.) and the reaction was stirred at room 






was filtered through Celite and the solvent was evaporated to afford spiro-dieneone 89 
(22.0 mg, 88.5%) as an unstable yellow oil. 
Acid-Promoted Rearrangement of Spiro-dieneone 89 to Acid 90 and 
Depsidone 91: Spiro-dieneone 89 (50.0 mg, 0.150 mmol) was placed in a round 
bottom flask with a stir bar. 
THF (1.50 mL) was added 
and the reaction mixture was 
cooled to 0°C. 3.0 M aq. 
H2SO4 (0.50 mL, 10 equiv.) 
was added and the reaction was stirred as it warmed to room temperature. Upon 
conversion of the starting material by TLC analysis, the reaction was diluted with water 
and extracted with ethyl acetate, washed with brine, dried over sodium sulfate, and 
concentrated in vacuo to provide a crude yellow oil. Purification by column 
chromatography (5 % MeOH in CH2Cl2) afforded carboxylic acid 90 as a yellow solid 
(30 mg, 57%) and depsidone 91 as a white solid (6.0 mg, 12%). Acid 90: m.p. (acetone): 
decomposes >200˚C: Rf =0.133 (5% MeOH in CH2Cl2); IR (thin film): max 3414.4, 
3004.0, 2953.8, 1707.7, 1668.1, 1578.9, 1433.8, 1364.2, 1293.2, 1195.5, 1111.9, 1055.9, 
977.8, 826.8, 710.9 cm-1; 1H NMR (CDCl3, 400 MHz): 12.3 (s, 1H), d 9.41 (s, 1H), d 
6.68 (d, 1H, J= 8.8 hz), d 6.57 (d, 1H, J= 8.8 hz), d 6.41 (d, 1H, J= 1.5 hz), d 6.36 (d, 
1H, J= 1.5 hz), d 5.08 (t, 1H, J= 5.9 hz), d 4.25 (d, 2H, J= 5.9 hz), d 3.73 (s, 3H);
13
C 






HRMSESI (m/z): [M-H]+ calcd for 
C16H14O9, 373.0536, found [M+Na]
+
, 373.0548 (+ 3.2167 ppm). Depsidone 91: m.p. 
(CH2Cl2): 149-151˚C : Rf =0.86 (5% MeOH in CH2Cl2); IR (thin film): max 3346.9, 
3117.2, 2954.5, 2919.1, 2851.1, 1671.9, 1622.7, 1568.1, 1468.7, 1438.6, 1357.8, 1328.7, 




H NMR (CDCl3, 400 MHz): s, 1H), 
 11.0 (s, 1H),  7.39 (d, 1H, J= 9.2hz),  6.93 (bs, 1H),  6.86 (ovlp, d, 1H, J=9.2hz),  
6.85 (ovlp, bs, 1H),  4.72 (d, 2H, J= 5.8hz),  4.13 (s, 3H),  1.78 (t, 1H, J= 5.8hz); 13C 
NMR (CDCl3, 100 MHz);  
HRMSESI (m/z): [M+H]+ calcd for 
C16H12O8, 333.0430, found [M+H]
+
, 333.0646  
TFAA-Promoted Conversion of Acid 90 to Depsidone 91: Acid 90 (17.0 
mg, 0.049 mmol) was placed in a vial equipped with stir bar. Toluene (0.5 mL) was 
added to the vial, followed by trifluoroacetic anhydride (0.015 mL, 2.1 equiv.). This was 
heated to 60˚C and monitored by TLC. Upon completion by TLC analysis, this was 
cooled to room temperature and methanol (1 mL) was added and the reaction stirred for 
10 min. The solvent was then removed in vacuo and the product purified by column 







Benzophenone 81: Note: both substrates 80 and 72 
were azeotropically dried with toluene prior to use. Aryl 
bromide 72 (1.86 gram, 4.853 mmol) was dissolved in 
ether (40 mL) in a round bottom flask equipped with a 
stir bar under an atmosphere of argon. This solution was cooled to -78˚C and t-BuLi (1.7 
M solution in pentane, 6.00 mL, 2.10 equiv.) was added dropwise and the reaction stirred 
for 5 min. A solution of benzaldehyde 80 (1.283 g, 5.34 mmol, 1.10 equiv.) in ether (20 
mL) was added slowly via a syringe. The resulting yellow solution was slowly warmed to 
room temperature. Upon completion by TLC analysis (2 h), this solution was quenched 
with a saturated solution of NH4Cl and extracted with ether. The organic phase was 
washed with brine, dried over sodium sulfate, filtered, and concentrated in vacuo. The 
crude oil was purified by column chromatography (2:1 hexanes: ethyl acetate) to afford 
the benzyl alcohol (1.90g, 70% yield) as a clear oil. Rf =0.65  (1:1 hexanes: ethyl 
acetate); IR (thin film): max  3525.4, 3053.4, 2950.9, 2900.4, 1611.2, 1580.2, 1479.1, 




H NMR (CDCl3, 500 MHz):  7.37-
7.28 (m, 5H),  6.98 (d, J=8.8Hz, 1H),  6.92 (d, J=8.8Hz, 1H), 6.68 (d, J=7.7Hz, 1H), 
 6.57 (s, 2H),  5.41 (d, J=7.7Hz, 1H),  5.07 (s, 2H),  5.05-4.97 (m, 5H),  4.90 (s, 
2H),  4.85 (d, J=10.2Hz, 1H),  4.59(m, 2H),  3.43 (s, 3H),  3.24(s, 6H),  3.22(s, 
3H), s 13C NMR (CDCl3, 100 MHz) : 155.57, 151.02, 150.57, 138.67, 138.39, 
134.71, 128.13, 127.76, 127.32, 126.85, 118.68, 115.81, 114.62, 109.43, 95.86, 94.88, 






HRMSESI (m/z): [M]+ calcd for C30H38O10, 558.2465; found [M+Na]
 +
, 581.2352 (+ 
1.8925 ppm). The benzyl alcohol (1.90 gram, 3.4 mmol) was dissolved in CH2Cl2 (30 
mL) and DMSO (10 mL) in a round bottom flask equipped with a stir bar. IBX (1.43 
gram, 5.10 mmol, 1.50 equiv.) was added to the reaction at room temperature. The 
resulting yellowish solution was stirred at room temperature for 3 h and monitored by 
1
H 
NMR. Upon completion of the reaction (2 h), a saturated solution of sodium thiosulfate 
(20 mL) was added, followed by water (20 mL). This was extracted with CH2Cl2 and 
washed with water (2 x 10 mL) and then brine, dried over sodium sulfate, filtered, and 
concentrated in vacuo to give a crude orange oil. Purification of the crude oil by column 
chromatography (6:1 DCM: ethyl acetate) afforded benzophenone 81 (1.20, 63%) as a 
light orange oil. Rf = 0.65 (1:1 hexanes: ethyl acetate); IR (thin film): max  3054.4, 





H NMR (CDCl3, 500 MHz): m, 5H), d, J=9Hz, 
1H),  6.91 (d, J=9Hz, 1H),  6.50 (s, 2H),  5.03 (s, 2H),  4.88 (s, 4H),  4.80 (s, 2H),  
4.50 (s, 2H),  4.38 (s, 2H),  3.37 (s, 3H),  3.16 (s, 9H),  2.19 (s, 3H; 13C NMR 
(CDCl3, 100 MHz) : 194.17, 156.38, 151.27, 149.47, 142.95, 138.91, 135.76, 128.03, 
127.70, 127.17, 126.93, 119.73, 117.37, 116.18, 109.31, 95.78, 95.21, 94.48, 72.63, 
64.37, 56.00, 55.93, 55.67, 22.19; HRMSESI (m/z): [M]+ calcd for C30H36O10, 
556.2308; found [M+Na]
 +






Benzaldehyde 82: Benzophenone 81 (1.20 g, 2.16 mmol) was dissolved in THF (20 
mL) in a dry round bottom flask equipped with a stir bar. 
This was degassed by a stream of argon for 10 min. 20% 
wt. Pd(OH)2 (121 mg, 0.175 mmol, 0.08 equiv.) was 
added in one batch and the reaction flask was purged 3x with a balloon of hydrogen gas. 
The reaction was stirred at room temperature and was monitored closely by TLC 
analysis. Upon completion by TLC analysis (1.5 h), the reaction solution was filtered 
through a pad of Celite and concentrated in vacuo to a crude oil. This oil was used 
directly in the next reaction without any purification Rf = 0.35 (1:1 hexanes: ethyl 
acetate). The benzyl alcohol was dissolved in CH2Cl2 (15 mL) and DMSO (5 mL) in a 
round bottom flask equipped with a stir bar. IBX (905 mg, 3.2 mmol, 1.50 equiv.) was 
added to the reaction at room temperature. The resulting solution became bright yellow 
over 1 h. Upon completion by TLC analysis (2 h), a saturated solution of sodium 
thiosulfate (1 mL) was added, followed by a saturated solution of sodium bicarbonate (1 
mL). The reaction mixture was extracted with CH2Cl2 and the organic phase was washed 
with brine, dried over sodium sulfate, filtered, and concentrated in vacuo to afford a 
crude oil. The crude oil was purified by column chromatography (6:1 CH2Cl2: ethyl 
acetate) to provide the benzaldehyde 82 (800 mg, 79 %) as a clear oil. Rf = 0.65 (6:1 
methylene chloride: ethyl acetate); IR (thin film): max  3055.9, 2959.3, 2905.4, 28297, 
1692.6, 1670.2, 1607.7, 1579.9, 1474.5, 1391.6, 1264.9, 1152.7, 1113.9, 1048.7, 948.9, 










1H),  7.13 (d, J=9Hz, 1H),  6.57 (s, 2H), 5.19 (s, 2H 5.00 (s, 4H),  4.88 (s, 2H),  
3.47 (s, 3H),  3.28 (s, 6H),  3.23 (s, 3H),  2.27 (s, 3H) ; 13C NMR (CDCl3, 100 MHz) 
: 192.05, 189.45, 157.01, 153.20, 149.09, 143.66, 136.16, 125.55, 122.08, 117.95, 
117.45, 109.56, 95.69, 95.40, 94.64, 56.39, 56.05, 55.92, 22.25; HRMSESI(m/z): [M]+ 
calcd for C23H28O10, 464.1682; found [M+H]
 +
, 487.1567 (+ 2.6685 ppm). 
Benzophenone Methyl Ester 83: Benzaldehyde 82 (800 mg, 1.72 mmol) was 
dissolved in a 1/2/5 mixture of water (4.5 mL)/THF (9 
mL)/t-BuOH (14 mL) in a round bottom flask equipped 
with a stir bar. The reaction was cooled to 0 ˚C with an 
ice bath and sodium phosphate monobasic monohydrate 
(NaH2PO4-H2O) (713 mg, 5.2 mmol, 3 equiv.) was added, followed by 2-methyl-2-
butene (3.67 mL, 34 mmol, 20 equiv.) via a syringe. Sodium chlorite (NaClO2) (850 mg, 
9.4 mmol, 5.46 equiv.) was added to the solution in one batch. This solution turned 
cloudy as it was slowly warmed to room temperature. Upon completion by TLC analysis, 
the reaction was quenched with a saturated solution of NH4Cl (NOTE: A 1M HCl quench 
resulted in formation of chlorinated byproducts) and extracted with ethyl acetate (2x). 
The organic layers were washed with brine, dried over sodium sulfate, filtered, and 
concentrated in vacuo to a provide a clear residue. This was dried under high vacuum and 
was used directly for the next step. A stir bar was added to the flask and the residue was 
taken up in a 1/1 mixture of methanol (8 mL) and ether (8 mL), which was followed by 






reaction visibly produced bubbles upon addition and turned bright yellow. Upon 
completion by TLC analysis (20 min), the reaction was quenched with acetic acid (1mL, 
enough to change color from bright yellow to clear) concentrated in vacuo to provide a 
yellow residue which was purified by column chromatography (1:1 hexanes: ethyl 
acetate) to afford methyl ester 83 (550 mg, 64b%, 2 steps) as an orange oil. Rf = 0.70 (1:1 
hexanes: ethyl acetate); IR (thin film): max  3056.5, 2954.7, 2894.7, 2829.9, 1735.2, 
1668.7, 1608.2, 1583.7, 1476.9, 1439.1, 1391.5, 1266.2, 1232.2, 1152.9, 1084.8, 1047.6, 




H NMR (CDCl3, 500 MHz):  7.14 (d, J=9.1 
Hz, 1H),  7.03 (d, J=9.1 Hz, 1H),  6.56 (s, 2H),  5.07 (s, 2H),  4.98 (s, 4H),  4.72 (s, 
2H),  3.74 (s, 3H),  3.42 (s, 3H),  3.26 (s, 6H),  3.15 (s, 3H),  2.28 (s, 3H); 13C 
NMR (CDCl3, 100 MHz: 191.75, 167.33, 155.83, 150.84, 148.72, 142.31, 130.75, 
125.99, 119.86, 119.79, 118.05, 109.21, 95.68, 95.47, 94.61, 77.41, 77.16, 76.90, 56.17, 
56.05, 55.85, 52.40, 22.21; HRMSESI (m/z): [M]+ calcd for C24H30O11, 494.1788; 
found [M+Na]
 +
, 517.1698 (+ 2.3203 ppm). 
Acremonidin E 78: Benzophenone methyl ester 83 (420 mg, 0.85 mmol) was 
dissolved in methanol (8.0 mL) in a round bottom flask 
equipped with a stir bar. para-Toluenesulfonic acid 
monohydrate (242 mg, 1.27 mmol, 1.5 equiv.) was added 
in one portion and the reaction was heated to 45˚C in an oil bath. The reaction solution 
turned light orange as the reaction proceeded. The reaction was monitored by TLC 






extracted with ethyl acetate (2x) and the combined organic layer was washed with brine, 
dried over sodium sulfate, filtered, and concentrated in vacuo to provide an orange oil. 
Purification by column chromatography (5% MeOH in CH2Cl2) provided acremonidin E 
78 (250 mg, 93 %) as a brownish solid.; m.p.(CH2Cl2)= 94-97˚C; Rf = 0.70 (7% methanol 
in CH2Cl2); IR (thin film): max  3358.4, 2955.5, 2923.5, 2851.0, 1680.1,  1635.4, 1582.1, 




H NMR (CDCl3, 500 MHz: 
δ 10.52 (s, 1H), 9.50 (s, 2H), 6.81 (d, J = 9.0 Hz, 1H), 6.69 (d, J = 9.0 Hz, 1H), 6.10 (s, 
2H), 3.55 (s, 3H), 2.14 (s, 3H). ;
13
C NMR (CDCl3, 100 MHz); δ 199.21, 169.54, 160.65, 
155.29, 149.59, 144.36, 129.94, 125.29, 119.22, 109.20, 109.01, 77.41, 77.16, 76.91, 
52.49, 22.12; HRMSESI (m/z): [M]+ calcd for C16H14O7, 318.0740; found [M+H]
 +
, 
319.0805 (+ 4.0742 ppm). 
Pinselin 79: Acremonidin E 78 (31.0 mg, 0.097 mmol) was placed in a microwave 
tube equipped with a stir bar. ZnCl2 (27 mg, .200 mmol) was 
added and water (1.3 mL) was added and then the tube was 
sealed with a cap. This was heated at 120˚C for 7 min. with 
stirring in a microwave reactor. Upon completion by TLC analysis, the mixture was 
extracted with ethyl acetate and washed with 1M aqueous HCl, brine, dried over sodium 
sulfate and concentrated in vacuo to give a crude yellow solid. Purification by column 
chromatography (5% MeOH in CH2Cl2) provided pinselin 79 as a yellow solid (20 mg, 
68%). m.p. (ethyl acetate)= 220˚C (decomposes); Rf = 0.40 (1:1 hexanes: ethyl acetate); 










H NMR (400 MHz, 
Acetone-d6) δ 12.29 (s, 1H), 9.20 (s, 1H), 7.58 – 7.47 (m, 2H), 6.80 (d, J = 0.6 Hz, 0H), 
6.60 (d, J = 0.7 Hz, 0H), 3.92 (s, 3H), 2.42 (s, 1H).; 
13
C NMR (126 MHz, acetone) δ 
181.72, 167.50, 162.36, 156.92, 151.46, 150.73, 150.35, 126.04, 120.90, 119.18, 118.77, 
111.78, 108.13, 107.30, 52.67, 22.54.HRMSESI (m/z): [M-H]+ calcd for C16H12O6, 
301.0712; found [M+H]
 +
, 301.0714 (+ 0.6643 ppm).  
PIDA Oxidation of Acremonidin E 78 to Spiro-Dieneone 97: Acremonidin 
E 78 (35.0 mg, 0.110 mmol) was placed in round bottom 
flask with a stir bar. Ethyl acetate (1.3 mL) was added 
followed by 10% wt palladium on carbon (2.20 mg, 0.055 
mmol, 0.50 equiv.) and then vacuum flushed with an oxygen 
balloon. The reaction was stirred at room temperature for 24 hr during which time the 
solution turned bright yellow. Upon completion by TLC analysis, the solution was 
filtered through celite and evaporated in vacuo to afford 97 as a yellowish oil (34.0 mg, 
97 %). This material was not stable in methanol or water and degraded rapidly in these 
solvents. Rf =0.25 (CH2Cl2); IR (thin film): max  3429.7, 3062.5, 2958.9, 2919.7, 2841.6, 
1704.7, 1664.2, 1623.7, 1593.8, 1443.9, 1405.9, 1340.2, 1260.3, 1224.4, 1182.5, 1078.5, 




H NMR (500 MHz, Chloroform-d) δ 12.55 (s, 1H), 7.09 (d, J 
= 10.2 Hz, 1H), 6.48 (s, 1H), 6.42 (d, J = 10.2 Hz, 1H), 6.36 (s, 1H), 3.55 (s, 3H), 2.39 (s, 
3H).
13






153.62, 140.91, 131.68, 109.69, 106.14, 104.81, 100.05, 88.11, 52.57, 23.21; HRMSESI 
(m/z): [M+H]
+
 calcd for C16H12O7, 317.0661, found [M+H]
 +
, 317.0668 (+ 2.2077 ppm).  
Model Benzyl Alcohol: Note: both substrates 95 and 
72 were azeotropically dried with toluene prior to use. 
Aryl bromide 72 (500 mg, 1.31 mmol) was dissolved in 
ether (20 mL) in a round bottom flask equipped with a stir bar under an atmosphere of 
argon. This solution was cooled to -78˚C and t-BuLi (1.7 M solution in pentane, 1.61 mL, 
2.10 equiv.) was added dropwise and the reaction stirred for 5 min. A solution of MOM-
protected salicylic aldehyde 95 (238 mg, 1.44 mmol, 1.10 equiv.) in ether (5 mL) was 
added slowly via a syringe. The resulting yellow solution was slowly warmed to room 
temperature. Upon completion by TLC analysis (2 h), this solution was quenched with a 
saturated solution of NH4Cl and extracted with ether. The organic phase was washed with 
brine, dried over sodium sulfate, filtered, and concentrated in vacuo. The crude oil was 
purified by column chromatography (2:1 hexanes: ethyl acetate) to afford the benzyl 
alcohol (450 mg, 71% yield) as a clear oil. Rf =0.75 (1:1 hexanes: ethyl acetate); IR (thin 
film): max  3463.0, 3031.8, 2954.4, 2902.0, 2862.2, 1477.5, 1456.3, 1360.2, 1231.5, 




H NMR (500 MHz, Chloroform-d) δ 
7.60 (ddd, J = 7.6, 2.0, 1.0 Hz, 1H), 7.36 – 7.24 (m, 5H), 7.24 – 7.17 (m, 1H), 7.12 (d, J = 
9.1 Hz, 1H), 7.02 (dd, J = 8.5, 5.1 Hz, 3H), 6.60 (d, J = 9.4 Hz, 1H), 5.12 (d, J = 6.8 Hz, 
1H), 5.10 – 5.03 (m, 4H), 4.88 (d, J = 6.8 Hz, 1H), 4.80 (d, J = 10.8 Hz, 1H), 4.56 – 4.46 






151.00, 150.77, 137.93, 134.19, 132.66, 128.31, 127.92, 127.85, 127.62, 127.36, 126.47, 
121.03, 116.33, 115.05, 113.70, 95.70, 95.36, 93.58, 77.41, 77.16, 76.90, 72.27, 66.52, 
62.69, 56.01, 55.98, 55.50.; HRMSESI (m/z): [M+Na]+ calcd for C27H32O8, 484.2097; 
found [M+Na]
 +
, 507.2001 (+ 1.1830 ppm). 
Model Benzophenone: Model benzyl alcohol (1.27 g, 2.62 mmol) was dissolved in 
CH2Cl2 (24 mL) and DMSO (6 mL) in a round bottom flask 
equipped with a stir bar. IBX (1.01 g, 3.93 mmol, 1.50 
equiv.) was added to the reaction at room temperature. The 
resulting yellowish solution was stirred at room temperature 
for 3 h and monitored by 
1
H NMR. Upon completion of the reaction (2 h), a saturated 
solution of sodium thiosulfate (20 mL) was added, followed by water (50 mL). This was 
extracted with CH2Cl2 and washed with water (2 x 10 mL) and then brine, dried over 
sodium sulfate, filtered, and concentrated in vacuo to give a crude orange oil. Purification 
of the crude oil by column chromatography (2:1 hexanes: ethyl acetate) afforded the 
model benzophenone (1.05 gram, 79%) as a light orange oil. Rf = 0.75 (1:1 hexanes: 
ethyl acetate); IR (thin film): max  3060.2, 2954.1, 2906.2, 2826.5, 1663.3, 1596.6, 




H NMR (500 
MHz, Chloroform-d) δ 7.79 (dd, J = 7.8, 1.8 Hz, 1H), 7.40 (ddd, J = 8.3, 7.3, 1.8 Hz, 
1H), 7.22 – 7.13 (m, 2H), 7.11 – 7.01 (m, 5H), 6.99 (ddd, J = 7.8, 7.3, 1.1 Hz, 1H), 5.13 
(s, 2H), 4.93 (s, 2H), 4.91 (s, 2H), 4.56 (s, 2H), 4.33 (s, 2H), 3.45 (s, 3H), 3.26 (s, 3H), 
3.24 (s, 3H).; 
13






134.88, 133.84, 131.75, 128.96, 128.01, 127.62, 127.21, 125.87, 121.46, 116.33, 115.87, 
115.51, 95.65, 95.11, 94.87, 72.78, 63.82, 56.06, 56.03, 55.86. ; HRMSESI (m/z): [M]+ 
calcd for C27H30O8, 482.1941; found [M+Na]
 +
, 505.1823 (- 2.9692 ppm).  
Model Benzaldehyde: The model benzophenone (500 mg, 1.04 mmol) was dissolved 
in THF (10 mL) in a dry round bottom flask equipped with 
a stir bar. This was degassed by a stream of argon for 10 
min. 20% wt. Pd(OH)2 (72 mg, 0.104 mmol, 0.1 equiv.) 
was added in one batch and the reaction flask was purged 3x with a balloon of hydrogen 
gas. The reaction was stirred at room temperature and was monitored closely by TLC 
analysis. Upon completion by TLC analysis (1.5 h), the reaction solution was filtered 
through a pad of Celite and concentrated in vacuo to a crude oil. This oil was used 
directly in the next reaction without any purification Rf = 0.54 (1:1 hexanes: ethyl 
acetate). The benzyl alcohol was dissolved in CH2Cl2 (10 mL) and DMSO (3 mL) in a 
round bottom flask equipped with a stir bar. IBX (435 mg, 1.55 mmol, 1.50 equiv.) was 
added to the reaction at room temperature. The resulting solution became bright yellow 
over 1 h. Upon completion by TLC analysis (2 h), a saturated solution of sodium 
thiosulfate (5 mL) was added, followed by water (20mL). The reaction mixture was 
extracted with CH2Cl2 and the organic phase was washed with brine, dried over sodium 
sulfate, filtered, and concentrated in vacuo to afford a crude oil. The crude oil was 
purified by column chromatography (6:1 CH2Cl2: ethyl acetate) to provide the model 






(thin film): max  2927.5, 2827.1, 1683.6, 1661.8, 1596.1, 1477.7, 1454.8, 1296.1, 1252.9, 




H NMR (500 MHz, Chloroform-d) δ 10.39 
(s, 1H), 7.96 (dd, J = 8.2, 1.8 Hz, 1H), 7.45 – 7.40 (m, 1H), 7.33 (d, J = 9.1 Hz, 1H), 7.19 
(d, J = 9.2 Hz, 1H), 7.10 – 7.01 (m, 2H), 5.26 (s, 2H), 4.96 (s, 2H), 4.91 (s, 2H), 3.51 (s, 
3H), 3.27 (s, 3H), 3.23 (s, 3H).; 13C NMR (126 MHz, cdcl3) δ 193.56, 188.93, 157.12, 
154.71, 148.23, 135.56, 134.28, 131.36, 127.30, 124.08, 122.96, 121.75, 116.12, 115.38, 
95.44, 95.42, 94.46, 56.59, 56.56, 56.19, 56.16.; HRMSESI(m/z): [M]+ calcd for 
C20H22O8, 390.1315; found [M+Na]
 +
, 413.1218 (+ 1.4524 ppm). 
Model Benzophenone Methyl Ester: The model benzaldehyde (200 mg, 0.512 
mmol) was dissolved in a 1/2/5 mixture of water (6 
mL)/THF (12 mL)/t-BuOH (30 mL) in a round bottom 
flask equipped with a stir bar. The reaction was cooled 
to 0 ˚C with an ice bath and sodium phosphate monobasic monohydrate (NaH2PO4-H2O) 
(212 mg, 1.54 mmol, 3 equiv.) was added, followed by 2-methyl-2-butene (1.1 mL, 10.1 
mmol, 25 equiv.) via a syringe. Sodium chlorite (NaClO2) (253 mg, 2.80 mmol, 5.5 
equiv.) was added to the solution in one batch. This solution turned cloudy as it was 
slowly warmed to room temperature. Upon completion by TLC analysis, the reaction was 
quenched with a saturated solution of NH4Cl (NOTE: A 1M HCl quench resulted in 
formation of chlorinated byproducts) and extracted with ethyl acetate (2x). The organic 
layers were washed with brine, dried over sodium sulfate, filtered, and concentrated in 






directly for the next step. A stir bar was added to the flask and the residue was taken up in 
a 1/1 mixture of methanol (7.5 mL) and ether (7.5 mL), which was followed by addition 
via a syringe of TMSCHN2 (2.00 M solution in hexanes, 1.30 mL, 5 equiv.). The reaction 
visibly produced bubbles upon addition and turned bright yellow. Upon completion by 
TLC analysis (20 min), the reaction was concentrated in vacuo to provide a yellow 
residue which was purified by column chromatography (1:1 hexanes: ethyl acetate) to 
afford the model benzophenone methyl ester (150 mg, 69%, 2 steps) as an orange oil. Rf 
= 0.70 (1:1 hexanes: ethyl acetate); IR (thin film): max  3076.0, 2953.4, 2907.2, 2827.1, 





H NMR (500 MHz, Chloroform-d) δ 7.77 (dd, J = 7.7, 1.8 Hz, 1H), 
7.46 (ddd, J = 8.3, 7.3, 1.9 Hz, 1H), 7.23 – 7.17 (m, 2H), 7.16 – 7.12 (m, 1H), 7.08 (td, J 
= 7.5, 1.0 Hz, 1H), 5.18 (s, 2H), 4.99 (s, 2H), 4.95 (s, 2H), 3.66 (s, 3H), 3.52 (s, 3H), 3.32 
(s, 3H), 3.27 (s, 3H).; 
13
C NMR (126 MHz, cdcl3) δ 193.25, 166.21, 156.76, 149.54, 
149.20, 133.92, 133.51, 130.99, 128.85, 123.42, 121.59, 118.63, 118.40, 115.47, 95.96, 
95.33, 94.82, 56.24, 56.10, 56.01, 52.21.; HRMSESI (m/z): [M]+ calcd for C21H24O9, 
420.1420; found [M+Na]
 +
, 443.1307 ( -2.4823 ppm). 
Model Deprotected Benzophenone 94: The model 
benzophenone methyl ester (77 mg, 0.184 mmol) was 
dissolved in methanol (2.0 mL) in a round bottom flask 
equipped with a stir bar. para-Toluenesulfonic acid 






was heated to 45˚C in an oil bath. The reaction solution turned light orange as the 
reaction proceeded. The reaction was monitored by TLC analysis and upon completion (1 
h), water (2.0 mL) was added. The reaction mixture was extracted with ethyl acetate (2x) 
and the combined organic layer was washed with brine, dried over sodium sulfate, 
filtered, and concentrated in vacuo to provide an orange oil. Purification by column 
chromatography (5% MeOH in CH2Cl2) provided benzophenone 94 (45.0 mg, 84 %) as a 
brownish solid. m.p.(CH2Cl2)= >220˚C; Rf = 0.60 (7% methanol in CH2Cl2); IR (thin 





H NMR (500 MHz, Chloroform-d) δ 11.57 (s, 1H), 10.34 (s, 1H), 
7.47 (ddd, J = 8.4, 7.2, 1.7 Hz, 1H), 7.18 (ddd, J = 8.0, 1.7, 0.5 Hz, 1H), 7.15 (d, J = 9.1 
Hz, 1H), 7.08 (d, J = 9.1 Hz, 1H), 7.05 (ddd, J = 8.4, 1.1, 0.5 Hz, 1H), 6.14 (s, 1H), 3.48 
(s, 3H).;
 13
C NMR (126 MHz, cdcl3) δ 201.42, 169.16, 161.93, 155.72, 146.80, 136.60, 
131.48, 125.67, 123.41, 121.71, 121.28, 119.58, 118.35, 110.49, 52.39.; HRMSESI 
(m/z): [M]
+
 calcd for C15H12O6, 288.0634; found [M-17]
 +
, 271.0606 
Pd/C Oxidation to Spiro-dieneone 96: Triphenol benzophenone 94 (20.0 mg, 
0.069 mmol) was placed in a round bottom flask equipped with a 
stir bar. This flask was purged thoroughly with an oxygen balloon. 
Ethyl acetate (1.5 mL) was added followed by 10% Pd/C (3.0 mg, 
1 equiv.) and the reaction was stirred at room temperature (48 h). 
Upon completion of the reaction by TLC analysis (48 h), the reaction was filtered 






75%) as an unstable yellow oil. This material was not stable in methanol or water and 
degraded rapidly in these solvents.  Rf =0.53 (7% methanol in CH2Cl2); 
1
H NMR (500 
MHz, Benzene-d6) δ 12.81 (s, 1H), 7.52 (ddd, J = 7.7, 1.5, 0.7 Hz, 1H), 7.02 (ddd, J = 
8.6, 7.2, 1.5 Hz, 1H), 6.89 (dt, J = 8.4, 0.8 Hz, 1H), 6.57 (ddd, J = 7.9, 7.2, 0.8 Hz, 1H), 
6.19 (d, J = 10.2 Hz, 1H), 5.64 (d, J = 10.2 Hz, 1H), 2.81 (s, 3H).;
 13
C NMR (126 MHz, 
c6d6) δ 195.22, 189.98, 173.80, 170.24, 166.95, 140.01, 137.93, 131.75, 125.57, 122.45, 
121.04, 113.51, 100.91, 88.33, 51.92.; HRMSESI (m/z): [M286.0477]+ calcd for 
C15H10O6, 286.2390, found [M+h]
 +
, 287.0550 (+ 2.0902 ppm).  
Diphenylphosphoxanthone 109: To a dry flask was added xanthone 100 (50 mg, 
0.206 mmol) and CH2Cl2 (2.5 mL). DMAP (8 mg, 
0.66 mmol, 0.3 equiv.) and pyridine (32 uL, 0.397 
mmol, 1.31 equiv.) were added and then the reaction 
was cooled to 0ºC with an ice bath. Diphenyl chlorophosphate (56 uL, 0.271 mmol, 1.31 
equiv.) was added dropwise to the reaction and it was warmed to rt over an hour. Upon 
completion by TLC analysis, the reaction was quenched with water and extracted with 
CH2Cl2. The organic layer was washed with water and brine, dried over sodium sulfate, 
and concentrated in vacuo. The crude solid was purified by column chromatography (4:1 
hexanes: ethyl acetate to 1:1) to provide a yellowish solid (60 mg, 61%).; m.p.= >220ºC; 
Rf = 0.35 (1:1 hexanes: ethyl acetate); IR (thin film): max  2926.6, 2905.4, 2895.5 2850.7, 
2765.4, 1651.6, 1622.2, 1577.4, 1484.3, 1432.8, 1392.6, 1291.3, 1261.4, 1238.5, 1186.1, 










Chloroform-d) δ 12.60 (s, 1H), 8.23 (dd, J = 8.0, 1.7 Hz, 1H), 7.73 (ddd, J = 8.6, 7.2, 1.7 
Hz, 1H), 7.43 (dd, J = 8.6, 1.0 Hz, 1H), 7.37 (ddd, J = 8.1, 7.1, 1.1 Hz, 1H), 7.35 – 7.31 
(m, 3H), 7.25 – 7.22 (m, 3H), 7.18 (td, J = 7.4, 1.1 Hz, 2H), 6.89 – 6.85 (m, 1H), 6.70 (d, 
J = 1.1 Hz, 1H), 5.27 (d, J = 8.4 Hz, 2H);
 13
C NMR (126 MHz, cdcl3) δ 181.97, 162.10, 
156.34, 156.20, 150.46, 150.41, 144.90, 135.81, 129.95, 126.02, 125.65, 125.64, 124.35, 
120.61, 120.17, 120.14, 120.13, 117.96, 108.65, 108.59, 105.38, 69.28, 69.23. 
HRMSESI (m/z): [M+H]+ calcd for C26H19O7P, 475.0947; found [M+H]
 +
, 475.0955 
1.6839 ppm).  
Methoxyxanthone 102: Diphenylphosphoxanthone 109 (50 mg) was placed in a dry 
borosilicate test tube equipped with a stir bar. Degassed 
methanol (2.0 mL) was added to the tube and this was 
photolyzed in a photobox with a Hanovia lamp with no 
filter for 10 h at rt. This was then concentrated and 
purified by column chromatography (3:1 hexanes : ethyl acetate) to afford a white solid 
102 (5 mg, 18%). Rf = 0.60 (3:1 hexanes: ethyl acetate); IR (thin film): max  2924.6, 
2850.7, 1654.6, 1622.2, 1567.4, 1484.3, 1432.8, 1390.6, 1289.3, 1261.4, 1228.5, 1189.1, 




H NMR (400 MHz, 
Chloroform-d) δ 12.63 (s, 1H), 8.28 (d, J = 8.0 Hz, 1H), 7.76 (ddd, J = 8.7, 7.1, 1.7 Hz, 
2H), 7.48 (d, J = 8.5 Hz, 1H), 7.43 – 7.36 (m, 1H), 6.96 (s, 0H), 6.77 (s, 0H), 4.53 (s, 
1H), 3.45 (s, 2H);
 13






124.24, 120.82, 118.04, 108.78, 105.26, 73.99, 58.77.; HRMSESI (m/z): [M+H]+ calcd 
for C15H12O4, 257.0814; found [M+H]
 +
, 257.0812, 0.7780 ppm).  
Graphisin diphenylphosphate 110: To a 
dry flask was added graphisin A 42 (43 mg, 
0.129 mmol) and CH2Cl2 (1.5 mL). DMAP (5.0 
mg, 0.041 mmol, 0.3 equiv.) and pyridine (20 uL, 0.247 mmol, 1.92 equiv.) were added 
and then the reaction was cooled to 0ºC with an ice bath. Diphenyl chlorophosphate (35 
uL, 0.170 mmol, 1.31 equiv.) was added dropwise to the reaction and this was warmed to 
rt over an hour. Upon completion by TLC analysis, the reaction was quenched with water 
and extracted with CH2Cl2. The organic layer was washed with water and brine, dried 
over sodium sulfate, and concentrated in vacuo. This was purified by column 
chromatography (5% MeOH in CH2Cl2) to afford 110 as a yellowish solid (30 mg, 41%). 
Rf = 0.50 (5% MeOH in CH2Cl2); IR (thin film): max  3238.5, 3059.2, 2982.1, 2957.2, 





H NMR (500 MHz, Chloroform-d) δ 12.37 (s, 0H), 10.83 (s, 0H), 10.41 (s, 
1H), 7.32 – 7.25 (m, 5H), 7.19 – 7.11 (m, 4H), 7.08 (dd, J = 7.6, 1.1 Hz, 3H), 6.85 (d, J = 
9.1 Hz, 1H), 6.75 (d, J = 9.0 Hz, 1H), 6.26 (s, 2H), 4.94 (d, J = 9.2 Hz, 2H), 3.53 (s, 3H).;
 
13
C NMR (126 MHz, cdcl3) δ 199.72, 169.53, 155.35, 150.16, 150.10, 145.16, 130.07, 
130.07, 129.28, 125.96, 125.95, 125.92, 124.93, 120.14, 120.11, 120.10, 120.08, 120.06, 
119.37, 111.05, 109.28, 106.63, 69.77, 69.73, 52.29.; HRMSESI (m/z): [M+H]+ calcd 
for C28H23O11P, 567.1056; found [M+H]
 +





































































































































 Studies Toward the Bicyclo [3.2.2] Core of Anthraquinone-Xanthone 
Natural Products 
3.1 Proposed Dearomative Cyclization of an Anthraquinone-Xanthone Hybrid 
 In the previous chapter, we described our initial proposal for the synthesis of 
anthraquinone-xanthone heterodimeric natural products through cycloaddition between 
two photoactivated substrates: an anthraquinone and a hydroxymethyl substituted 
benzophenone (Scheme 2.1). However, we determined that the two substrates did not 
react in the proposed manner. Although we determined that the oxanthrone ester readily 
underwent ESIPT, we did not observe reactions originating from the dienone tautomer 
form (Scheme 2.24). We also determined that although the benzophenone natural product 
graphisin A contains a m-hydroxymethyl phenol moiety, it did not form the zwitter-ionic 
m-quinomethane intermediate upon photochemical irradiation reported for simiar 
systems.
54
 To overcome these findings, we elected to revise our synthetic plan by 
building the bicyclo [3.2.2] core structure of the heterodimeric family of natural products 
in a stepwise fashion. In devising our approach, we wanted to take advantage of the 
propensity of anthraquinones to tautomerize under certain conditions to discover new 
reactivity for this family of molecules. Scheme 3.1 outlines our revised strategy toward 
anthraquinone-xanthone model system 1.  We planned to construct the bicyclo [3.2.2] 
core structure via a novel dearomative cyclization process from anthraquinone-xanthone 





arising from cross-coupling of the known iodoxanthone 3
43 
and the prefunctionalized 
anthraquinone moiety 4. The known model iodoxanthone 3 may be derived from a 
Friedel-Crafts/dehydative cyclization process of orcinol 5 and salicylic acid 6 followed 
by benzylic oxidation and ortho-iodination.  
Scheme 3.1: Revised Retrosynthesis of Bicyclo [3.2.2] Core Model System 1. 
 Tautomers of anthraquinones can be obtained under certain conditions. Likewise, 
tautomerism of their reduced hydroquinone congeners have also been reported.
12
 Scheme 
3.2 highlights two such examples where a hydroxyhydroquinone tautomerizes to the 
dearomatized keto form. Muller and coworkers reported that upon reduction of 
hydroxyanthraquinone 7 with sodium dithionate, the compound fully converted to 
hydroquinone 8 as observed by 
1
H NMR analysis (Scheme 3.2A). Interestingly, 
intermediate 8 has undergone dearomatization to the keto form shown, where a new 
methylene signal is clearly observed. The authors reported that the fully aromatic 





anthraquinone 7 in the presence of air. Subsequently, compound 8 was further reduced 
under enzymatic conditions to afford alcohol 9 in 22 % yield.
12
 Additionally, Morreal and 
coworkers reported zinc (0) metal reduction of hydroxyanthraquinone 10 to afford tetra-
phenol 11 (Scheme 3.2B).
101
 Heating 11 in ethanol at 60 ºC converted it to its para-  
Scheme 3.2: Literature Precedent for Tautomerism of Hydroxyhydroquinones 8, 11, and 
14 
 
quinone form 12, which then reacted with an amine and subsequently oxidized to afford 





observed for the related leucoquinzarin 14 in ethanol (Scheme 3.2C), a compound used 
as an analyte for determining magnesium ion concentration through formation of metal 
complex 16.
102 
 With this literature precedent in hand, we proposed that the anthraquinone-
xanthone biaryl 2 may be reduced to tetra-phenol 17 which may undergo a similar 
tautomerism to several dearomatized intermediates.  A productive tautomer would be the 
keto-phenolate form 18 as it converts the sp
2
 hybridized carbon of the biaryl linkage to a 
sp
3
 hybridized carbon. This creates a potentially more favorable conformation wherein 
the enolate of the neighboring hydroquinone could attack the benzylic position. This 
bond formation would complete the formation of the bicyclo [3.2.2] ring system found in 
the anthraquinone-xanthone heterodimeric natural products. 







 We further examined the potential benzylic bromide similar to 18 by obtaining a 
ground state conformer followed by DFT (B3LYP/6-31G*) optimization using Spartan 
(Figure 3.1). The xanthone and hydroquinone ring systems are bisected, but the benzylic 
bromide of the xanthone appears to be in proximity of the desired hydroquinone carbon 
for the proposed alkylation. The DFT-optimized conformation of biaryl 2 also places the 
xanthone and anthraquinone moieties in a bisected arrangement. However, the benzyl 
bromide is not near the central anthraquinone ring. This 3-D model analysis supports the 
proposed requirement for the anthraquinone moiety to undergo tautomerization in order 
to access a conformer that could participate in the desired dearomative transformation.  
Figure 3.1: DFT Minimized 3D-Models of Tautomer 18 (left) and Biaryl 2 (right). 
  
3.2 Initial Synthetic Route Toward Anthraquinone-Xanthone Biaryl 2 
 We began our studies by preparing the known, model iodoxanthone 3 (Scheme 
3.4). Preheating salicylic acid 6, neutral alumina, and methanesulfonic acid in a flask at 
150 ºC for five minutes followed by addition of orcinol 5 and heating for 30 minutes 






added before the preheating, the isolated yield of xanthone 19 is much lower (20 %). In 
the literature preparation of xanthone 21, Snider and coworkers report using an acetate to 
protect the phenol prior to benzylic oxidation.
43 
In our hands, the acetate proved to be too 
labile during the subsequent oxidation step, as we recovered undesired, over-bromination 
products. Accordingly, for the current studies we relied on the bulkier pivalate group. 
Benzylic oxidation with AIBN in the presence of NBS, followed by acetate displacement 
and basic hydrolysis, provided xanthone 21 (50 % yield, 4 steps). We were able to 
recover unreacted pivalate-protected 20 from the oxidation step and resubmit the 
compound to obtain more material. Selective ortho iodination afforded iodoxanthone 3 in 
good yield (80 %).  
Scheme 3.4: Synthesis of Model Xanthone 3 
 
To prepare an anthraquinone synthon for cross-couple with xanthone 3, we began 
with commercially available 1,8-dihydroxyanthraquinone 22 (Scheme 3.5). Heating 





was selectively iodinated to give iodoanthraquinone 23 in excellent yield (95%).
103
 We 
then MOM protected 23 under standard conditions, but were surprised to obtain the 
protected iodoanthraquinone 24 in only 30 % isolated yield. We found the major product 
to be the product derived from protodehalogenation of phenol 23. This transformation has 
been precedented in the literature for ortho-iodo-phenols under basic conditions.
104
 
Analogous bromination conditions of 22 were unselective and attempts to protect 
anthraquinone 23 with other groups under non-basic conditions occurred in negligible or 
low yields. Employing stannylation conditions reported by Nicolaou and coworkers for a  
Scheme 3.5: Attempted Stannylation of Protected Iodoanthraquinone 24 
 
similarly protected anthraquinone using palladium (0) tetrakistriphenylphosphine and 







 Attempted lithium halogen exchange with t-BuLi of 24 also did not 
afford stannane 25 and resulted in protodehalogenation products.  
After failed attempts to functionalize the anthraquinone moiety with a handle for 
cross-coupling, we turned our attention to preparing a protected hydroquinone equivalent. 
Sequential MOM and methyl ether protections of anthraquinone 22 occurred in 90 % 
yield over two steps to afford the protected anthraquinone 27 (Scheme 3.6). Reduction of 
27 with phase transfer catalyst tetra-butylammonium bromide and sodium dithionate in a 
degassed 3:1 mixture of THF and water provided a hydroquinone intermediate which was 
readily methylated upon addition of potassium hydroxide solution and methyl iodide to 
afford trimethyl protected hydroquinone 28 (70 %). We initially attempted to use the 
MOM ether of 28 for a directed lithiation (i.e. nBuLi, tBuLi, Mg) followed by quenching 
with either a stannyl chloride or trialkylborate to install a handle for cross-coupling. 
However, these conditions did not furnish the desired products. A closely related reaction 
was reported on the protected anthraquinone 30 using the Lochmann-Schlosser base to 
deprotonate followed by trapping with trimethylstannyl chloride to afford aryl stannane 
31 (Scheme 3.6).
106
 The authors also reported difficulty with other basic conditions 
wherein they observed products derived from addition of butyl side chains into the 
hydroquinone when n-butyllithium was employed. We also attempted the reported 
Lochmann-Schlosser conditions on 28 whereby quenching with tributylstannane chloride 
to afforded aryl stannane 29 in 20 % isolated yield. A major byproduct of this reaction 





Scheme 3.6: Formation of the Protected Hydroquinone Stannane 29 from 22  
 
demethylation by the bases employed. Alternative bases, temperatures, solvents, or 
electrophiles did not improve this reaction. Only trimethyl or tributyltin chloride were 
found to be competent electrophiles for this transformation.  
 Fortunately, were able to accumulate enough stannane 29 to attempt Stille 
coupling conditions with iodoxanthone 3 to prepare the protected biaryl compound 33 
(Scheme 3.7). Cross-coupling conditions known for xanthone 3 (Pd(OAc)2, (S)-Phos) did 
not afford 33, but instead produced protodehalogenated and destannylated byproducts.
43 
Other standard Stille coupling conditions (e.g. Pd(PPh3)4, CuI) also resulted in similar 





not afford biaryl 33. Preparing the diacetylated xanthone 32 and attempting similar 
conditions already mentioned also did not afford biaryl 34. At this point, we believed that 
the protected aryl stannane 29 was a poor cross-coupling partner, likely due to its electron 
rich nature. Thus, combined with the fact that xanthone 3 was a sterically demanding 
coupling partner, we sought an alternative method to form the key biaryl bond.  
Scheme 3.7: Attempted Stille Cross-Coupling of Aryl Stannane 29 and Xanthone 3 
 
3.3 Attempted Biaryl Formation via Benzylic Ether Formation 
 As we were experiencing difficulty with intermolecular cross-coupling reactions 
between xanthone 3 and various anthraquinone derivatives, we considered that tethering 
the two components may offer a reasonable solution. We considered that benzylic ether 
36 could arise from nucleophilic displacement of a phenol and an activated benzyl 
xanthone (Scheme 3.8). Ether 36 could then undergo either intramolecular 
dehydrogenative coupling
107
 or transition metal mediated arylation
108
 to form 
benzochromene 35 and the desired biaryl linkage. An example of such an intramolecular 






Scheme 3.8: Proposed Intramolecular Dehydrogenative Coupling of Benzylic Ether 36 
 
We were able to readily convert the benzyl acetate of xanthone 39 to the mesylate 
40 in 85 % yield (Scheme 3.9). The MOM ether of 28 was readily hydrolyzed to afford 
free phenol 41 (80 %). Combining 40 and 41 under basic conditions furnished benzyl 
ether 42 in good yield and set the stage for the proposed dehydrogenative coupling.  






Subjecting benzyl ether 42 to conditions reported for intramolecular 
dehydrogenative couplings resulted in the formation of anthraquinone ether 43, a product 
of oxidative demethylation (Scheme 3.10).
107 
Formation of this product was not 
surprising considering the propensity for hydroquinones to convert to anthraquinones 
under oxidative conditions. However, we viewed anthraquinone ether 43 or its free 
phenol 44 as suitable substrates for further study. Conversion of 42 to anthraquinone 44 
was achieved through a two-step basic hydrolysis-oxidation sequence in 70 % yield.  
Scheme 3.10: Oxidation of Protected Hydroquinone 42 to Anthraquinones 43 and 44  
 
 Table 3.1 summarizes attempted conditions for intramolecular oxidative coupling 
on anthraquinone ether 44. Various metal and ligand combinations reported for similar 
reactions were tested in catalytic or stoichiometric amounts. However, we did not observe 
formation of any new products under the conditions investigated. Slow decomposition 





examples of simple tethered aromatic rings undergoing oxidative coupling, we were not 
able to find any examples reported for anthraquinone or xanthone ring systems.
108, 109 
This may be due to the high stability of both anthraquinones and xanthones. Due to this 
inherent stability, we elected to functionalize one of the ring systems to investigate a 
potential palladium-catalyzed arylation.  
Table 3.1: Attempted Dehydrogenative Coupling of Anthraquinone Ether 44 to Form 
Benzochromene 45 
 
 We began this investigation using the simple anthraquinone ether 47 prepared 
from alkylation of anthraquinone 22 with mesylate
110





conditions reported by Fagnou and coworkers,
111
 we were able to form the aryl-aryl bond 
to provide anthraquinone-benzochromene 48 (50 %). We found that use of 0.5 
equivalents of silver (I) carbonate was necessary for the product to be formed above trace 
amounts due to poisoning of the palladium catalyst by the iodine formed during the 
reaction.  
Scheme 3.11: Model Study Arylation of Anthraquinone Ether 47 
 
Ortho-selective iodination of anthraquinone ether 44 provided phenolic ether 49 
(85 %) (Scheme 3.12). We then subjected compound 49 to conditions previously 
described by Fagnou and coworkers. However, surprisingly, we recovered anthraquinone 
50 and xanthone benzaldehyde 51 as the major products. These byproducts formed as a 
result of an oxidative cleavage at the benzylic position followed by protodehalogenation 
of the xanthone iodide. We thought that protection of the phenol may hinder the observed 
side reactivity, which was achieved under standard methylation conditions to provide 
anthraquinone methyl ether 52. However, we observed similar byproducts 50 and 
benzaldehyde 53 as the major isolated products. Employing other palladium-catalyzed 
conditions resulted in similar byproducts or protodehalogenation in the absence of base. 





anthraquinone mediated by irradiation with light.
112
 Repeating the reaction conditions in 
the absence of any light source still resulted in the formation of byproducts derived from 
oxidative cleavage. 
Scheme 3.12: Attempted Arylation of Iodo-Anthraquinone Ethers 49 and 52 
 
We concluded that the anthraquinone moiety was causing the cleavage at the 
benzylic position, possibly through a hydrogen abstraction mechanism.
112 
Reducing 
anthraquinone iodide 52 with borane led to the corresponding hydroquinone 54 in modest 
yield (35 %) (Scheme 3.13). Treatment of hydroquinone 54 under arylation conditions 
resulted in the formation of protodehalogenation product 55. However, in this case 





Scheme 3.13: Formation of Hydroquinone 54 and Attempted Arylation 
 
At this juncture, we abandoned this route to install the biaryl linkage due to the 
observed side reactivity of various anthraquinone aryl ether intermediates. Accordingly, 
we sought to design a route that would allow flexibility for the construction of the 
anthraquinone ring and allow for direct installation of the biaryl bond via an 
intermolecular cross-coupling reaction.  
3.4 Anthraquinone-Xanthone Biaryl Formation  
3.4.1 Suzuki Coupling of Protected Naphthol and Xanthone Fragments 
 Diels-Alder cycloadditions between juglones and dienes to form intermediates 
that readily undergo oxidation to polyphenolic derivatives has been widely used in the 
literature, with an early example reported by Kelly and coworkers in 1977.
113
 A recent 
example by Schmidt reported heating silyldienyl ether 56 and juglone 57 in toluene, 
followed by treatment with HCl in methanol to afford the anthraquinone chrysophanol 58 
(90 %) (Scheme 3.14).
114





coworkers in their synthesis of bisanthraquinone antibiotics utilizing juglone 
derivatives.
115
 They found that the internal hydrogen bond of juglone 57 partially 
activates C3 through resonance form 59. This resonance of juglone 57 governs the 
regioselectivity of Diels-Alder reactions with electronically biased dienes to provide 
adducts akin to 58.  
Scheme 3.14: a) A Diels-Alder Reaction of Silyldienyl Ether 56 and Juglone 57 b) 
Internal Hydrogen Bond of Juglone 57 Governs Regioselectivity 
 
We reasoned that the related substituted naphthoquinones would be suitable 
precursors to a substituted anthraquinones. We planned to construct anthraquinone-
xanthone biaryl 60 through a Suzuki coupling between boronic acid 61 and iodoxanthone 
3 (Scheme 3.15). Xanthone 3 was in hand from a previous route (Scheme 3.4); boronic 








Scheme 3.15: Revised Retrosynthesis of Anthraquinone-Xanthone Biaryl 60 via Suzuki 
Coupling of Xanthone 3 and Boronic Acid 61  
 
 Xanthone 3 was reported as a substrate in a Suzuki coupling toward the synthesis 
of an advanced model system of the tetrahydroxanthone parnafungin.
43 
In this report, 
Snider and coworkers detailed optimal conditions for cross-coupling. Using their reported 
conditions, we recovered less than 10 % yield of the desired Suzuki product 62, 50 % 
yield of the boronic acid homodimer product 63, and protodeiodinated xanthone products 
constituted the remaining mass balance (Scheme 3.16). While this was a low isolated 
yield, it established the desired biaryl bond could be forged between the xanthone and 
protected anthraquinone precursor.   






 Table 3.2 summarizes our efforts to optimize the Suzuki reaction of 61 and 3. We 
quickly found that lowering the catalyst loading to 15 % and the equivalents of 61 to 1.2 
with respect to 3 reduced the formation of byproduct 63 and increased the formation of 
product 62 (entry 2). We changed the solvent from a 3:1 mixture of THF:H2O to toluene 
for easier degassing and heating at 70 ºC for 24 hours. Altering the palladium source 
from Pd(OAc)2 to Pd2(dba)3 did not change the reactivity significantly (entry 3), however 
changing to PdCl2(PPh3)2 or Pd(PPh3)4 drastically lowered the formation of 62 (entires 4 
and 5). We also found (S)-Phos to be the optimal phosphine ligand, as other ligands either 
lowered the conversion or completely shut down reactivity (entries 6-8). This was not 
surprising because (S)-Phos was engineered for cross-couplings of hindered 2,6-
disubstituted substrates such as iodoxanthone 3.
117
 We did attempt other bases besides 
potassium phosphate; however this base was optimal in our hands. After initial reaction 
optimization, we found that 15 % Pd(OAc)2, 15 % (S)-Phos, 2 equiv. K3PO4, in toluene at 
80 ºC (entry 2) provided the highest conversion to naphthyl xanthone 62 which was 









Table 3.2: Optimization of the Suzuki Reaction of 61 and 3 to Provide 62 
Entry
b 
Catalyst (mol %) Ligand (mol %) Base:Solvent
b 
Result (% conv.) 
1 30 % Pd(OAc)2 30 % (S)-Phos 
2 equiv. K3PO4; 
THF/H2O (3/1) 
<10% 62, 50% 63 
2 15 % Pd(OAc)2 15 % (S)-Phos 
2 equiv. K3PO4; 
PhMe 
63% 62, 20% 63 
3 15 % Pd(dba)2 15 % (S)-Phos 
2 equiv. K3PO4; 
PhMe 




15 % (S)-Phos 
2 equiv. K3PO4; 
PhMe 
16% 62, 35% 63 
5 15 % Pd(PPh3)4 15 % (S)-Phos 
2 equiv. K3PO4; 
PhMe 
0% 62, 25% 63 
6 15 % Pd(OAc)2 15 % P(tBu)3 
2 equiv. K3PO4; 
PhMe 
47% 62, 20% 63 
7 15 %Pd(OAc)2 
15 % P(tBu)2-
(biPhen) 
2 equiv. K3PO4; 
PhMe 
19% 62, 30% 63 
8 15 % Pd(OAc)2 
15 % PCy3 - 
HBF4 
2 equiv. K3PO4; 
PhMe 
0% 62, 0% 63 
a 
Entries 2-8 were run with 1.2 equiv. of 61 and 1.0 equiv. of 3.
b
All reactions were run at 0.1M with respect 





Upon scaling the optimized conditions to larger than 100 mg of 3, we observed 
some reproducibility issues and lower yields of the desired biaryl product 62. We found it 
necessary to thoroughly degas the toluene by freeze-pump-thaw technique immediately 
prior to use to reduce formation of homodimer 63. We also found it necessary to increase 
the Pd(OAc)2 and (S)-Phos loading to 25 % when running the reaction on a 500 mg scale 
to ensure complete conversion of the starting materials and still observe 62 in similar 
yield. The main issue was the homodimerization of 61 to form 63, thus syphoning away 
substrate necessary for the Suzuki reaction.  
We found a literature report for facile conversion of aryl boronic acids to their 
homodimers in the presence of Pd(OAc)2 (5 mol %) under air in methanol (Scheme 
3.17a).
118
 Employing those conditions on 61 resulted in full conversion in less than an 
hour, with the major product being homodimer 63. The mass balance of this reaction was 
the protodeborylation product and other unidentified oxidative products. In an attempt to 
circumvent this side reactivity, the aryl trifluoroborate potassium salt 64 was prepared 






Scheme 3.17: a) Homodimerization of Boronic Acid 61 b) Suzuki Coupling with Aryl 
BF3K salt 64 and 3 c) Attempted Suzuki Coupling with MIDA-Boronate 65 and 3 
 
Biaryl product 62 was recovered as the major product, but in a slightly lower 
isolated yield than the previous condition. In the same line of thinking, we prepared 
MIDA-protected boronate 65 based on a literature precedent that reported a slow 
dissociation of the diacid to unmask the boronic acid in small concentrations.
119
 Upon 
attempting the Suzuki reaction, we observed xanthone 21 as the only new product 
(Scheme 3.17c). Xanthone 21 formed as a result of protodehalogenation of 3 which 





3.4.2 Diels-Alder Cycloadditions of Silyldienyl Ether 56 and Naphthoquinone-
Xanthone Biaryls 
 With the protected naphthol-xanthone biaryl 62 in hand, we sought to oxidatively 
deprotect this compound to access the free naphthoquinone and investigate Diels-Alder 
conditions with silyldienyl ether 56.  Reported oxidative deprotection of methyl-protected 
hydroquinones with NBS in the presence of catalytic amount of sulfuric acid did afford 
the desired naphthoquinone, but also brominated the electron rich aryl ring of the 
xanthone to afford 66 in 85 % yield (Scheme 3.18).
120
 Alternatively, oxidative 
demethylation of 62 was achieved with excess silver (I) oxide in the presence of 40 % 
aqueous nitric acid to provide 67 (60 %). Initially, we were unable to remove the 
methoxy group with boron trichloride or boron tribromide due to formation of 
halogenated byproducts, presumably by nucleophilic addition into the reactive 
naphthoquinone. However, treatment of 62 with 3.3 equivalents of boron tribromide 
resulted in full deprotection to provide naphthoquinone-xanthone biaryl 68. We initially 
thought the oxidation occurred spontaneously in the presence of air when working on 
smaller scale, but observed lower yields when scaling up material. When purifying the 
reaction on a silica gel column, we observed isolation of 68 after flushing the column 
with ethyl acetate to identify polar material. We discovered that the product of the boron 
tribromide reaction is actually the hydroquinone which oxidizes to 68 slowly in air but 
readily in the presence of air and silica gel. We then optimized the procedure by adding 
an oxidation step after deprotection with BBr3 to afford naphthoquinone-xanthone biaryl 





Scheme 3.18: Oxidative Deprotection of 62 to Provide Naphthoquinone 68 
 
 With both naphthoquinone-biaryls 67 and 68 in hand, we investigated conditions 
for Diels-Alder cycloaddition with diene 56 (Scheme 3.19). Treating 68 with three 
equivalents of 56 in toluene at 80 ºC for 3 h followed by acid hydrolysis in methanol 
resulted in a 30 % yield of the anthraquinone-xanthone biaryl 60. We observed three 
downfield shifts in the 
1
H NMR spectrum (11.8-13 ppm), indicative of the hydrogen-
bonding phenols in 60. We believe the regioselectivity of the Diels-Alder reaction is as 
shown based on comparison to the literature for similar systems and 2D NMR data 







Scheme 3.19: Diels-Alder Reactions of Silyldienyl Ether 56 and Naphthoquinones 68 
and 67 
 
We also performed this reaction sequence with diene 56 and protected-naphthoquinone 
67 to afford an analogous protected anthraquinone-xanthone derivative 70 as a single 
regioisomer. Subsequent deprotection of the methoxy group provided a new similar 
product to 60 with three downfield signals in the 
1
H NMR spectrum, which we assigned 
to the structure 71. This assignment was supported by 2-D NMR experiments conducted 





3.6.2). The regioselectivity of the Diels-Alder reaction was reversed in the case of 67, 
possibly due to electron donation of the peri methoxy group into the neighboring 
carbonyl, thus reversing the polarity of the double bond.
113 
This hypothesis is supported 
by comparing the orbital coefficients of the dienophile carbons of naphthoquinoes 67 and 
68 in Spartan 2010. Similar to that reported for hydroxyjuglone,
121 
the calculations show 
a larger coefficient at the -position for 68 due to the internal hydrogen bonding. 
Methoxynaphthoquinone 67 lacks this hydrogen bond, thus corresponding to a larger 
orbital coefficient in the -position. Boeckman and coworkers reported a similar trend in 
regioselectivity of Diels-Alder cycloadditions of juglones and highly polarized dienes.
122 
However, the authors reported that the regioselectivity fails when non-polarized dienes 
are utilized. Interestingly, we never isolated a mixture of regioisomers in either case, 
indicating complete substrate control. It is also worth noting that compounds 60,70, and 
71 are the only anthraquinone-xanthone biaryls prepared synthetically we could find 
reported in the literature, other than the previously discussed example of (-)-euxanmodin 
(Section 1.6.2).
22
 Further studies are needed in order to determine if the trisubstituted 
biaryls (60, 70, or 71) maintain axial chirality.
123
 
3.5 Attempted Dearomative Cyclization of Anthraquinone-Xanthone Biaryls 
 After preparing the anthraquinone-xanthone biaryl 60, we wished to test our 
proposal of a possible dearomative cyclization to the bicyclo [3.2.2] core outlined 
previously (Scheme 3.3). We planned to use the benzyl alcohol as a handle to install a 





recent literature reports of intermolecular Friedel-Crafts reactions of aryl rings and benzyl 
alcohols catalyzed by Lewis acids (Scheme 3.20).
124
  





H NMR experiments were conducted in CD3CN to determine if we could 
observe any tautomerization of the reduced anthraquinone (Scheme 3.21). Due to poor 
solubility of both 60 and sodium dithionate, we conducted the reduction in a biphasic 
system with tetra-butylammonium bromide as a catalyst. After five minutes, the solution 
had changed from bright orange to yellow, possibly indicating of formation of the 
hydroquinone species. The 
1
H NMR of the organic phase presumably revealed 
conversion of 60 to hydroquinone 75 due to shifting of the aromatic peaks and 
disappearance of two downfield (12-13 ppm OH signals). However, we were unable to  
Scheme 3.21: 
1






observe dearomatized forms derived from 75 as reported for related systems (Scheme 
3.2). This could be due to the high dilution required for 75 to be soluble or the inability of 
75 to undergo tautomerization to dearomatized forms under these conditions. We 
observed recovery of 60 after several hours, presumably due to air oxidation to the highly 
stable anthraquinone.  
Despite not observing dearomatized tautomers by 
1
H NMR, we tested our 
proposal in the conditions shown in Scheme 3.22. Reducing anthraquinone-xanthone 
biaryl 60 with excess sodium dithionate in a 3:1 mixture of degassed THF/H2O in the 
presence of tetra-butylammonium bromide provided intermediate 75. A variety of Lewis 
acids were then added to the reaction and heated for 12 h.
124 
Unfortunately, the only  






product isolated was the starting material 60. We thought changing to protic conditions 
may assist with proton transfer and therefore promote tautomerization of 75. Reduction 
of 60 with zinc metal under Bronsted acidic conditions presumably resulted in initial 
formation of hydroquinone 75, but no new product formation occurred. We concluded 
that the benzyl alcohol may not be ionizing or may not be a good enough leaving group 
under the attempted conditions. Attempted selective mesylation or tosylation of the 
benzyl alcohol 60 with triethylamine in methylene chloride resulted in over 
mesylation/tosylation of both the benzylic alcohol and phenols (Scheme 3.23). Switching 
the base to pyridine in the presence of DMAP resulted in the formation of a new product  







in low yield (30 %) which was determined to be benzyl chloride 76. Subjection of benzyl 
chloride 76 to similar reducing and Bronsted acidic conditions (Zn (0) or Na2S2O4) led to 
decomposition or recovery of benzyl alcohol 60. We observed conversion of 76 to a new 
product by TLC using BH3-Me2S in THF which was then acidified with HFIP to induce 
tautomerization. However, we observed benzyl alcohol 60 as the major product of this 
reaction. Future plans will study treatment of 76 under reductive conditions, followed by 
protonation and heating to attempt to induce cyclization. At this stage, we have 
developed a method to construct the advanced intermediate anthraquinone-xanthone 
biaryl 60 which has thus far not been advanced to the desired bicyclo [3.2.2] ring system. 
3.6 Investigation of Potential Photochemical-Mediated Cyclization of an 
Anthraquinone-Xanthone Biaryl 
3.6.1 Literature Background 
 At the same time we were developing the route to anthraquinone-xanthone biaryl 
60 to test the proposed dearomative cyclization (Scheme 3.3), we were also considering a 
potential photochemical mediated process of an anthraquinone-xanthone biaryl to deliver 
the desired bicyclo [3.2.2] ring system.  
While searching for any literature precedent for a proposed photomediated 
rearrangement of an anthraquinone-xanthone biaryl, we found several related examples. 
Wan and coworkers recently reported that ortho-substituted biphenyl phenol 77 
underwent proton transfer from the phenol to the neighboring aromatic ring at the 6’ 
position upon photochemical irradiation (Scheme 3.24a).
125





readily in the absence of water or polar solvent, leading the authors to believe it is an 
intramolecular protonation of the aromatic carbon by the phenol hydrogen. The dihedral 
angle between the planes of the two aromatic rings of 77 was calculated to be 54º,
125 
which allows for proper orbital overlap between the phenolic hydrogen and the -system 
of the neighboring aromatic ring. Quinone methide 78a or its mesomer 78b is thought to 
be the intermediate of ESIPT, which then forms 79 after aromatization.  
Another example involved a novel photomediated rearrangement of a substituted 
ortho-hydroxyanthraquinone initiated by a facile hydrogen atom abstraction. Quinones in 
the excited state are known to efficiently abstract hydrogen atoms and act as electron 
acceptors.
126
 Jones and coworkers reported the rearrangement of prenyl-substituted 
anthraquinone 80 to ketal 81 by irradiating at 366 nm in a thoroughly degassed 3:2 
mixture of acetic acid and water (Scheme 3.24b). The reaction mechanism began by 
excitation of the anthraquinone followed by hydrogen atom abstraction to diradical 82. 
The diradical underwent a single electron transfer (SET) and protonation to stabilized 
cation 83. Under aqueous conditions, cation 83 was thought to be in equilibrium with 
ketal 84. This hydrolyzed slowly in the hydroquinone oxidation state but readily 
hydrolyzed in the quinone oxidation state when run in the presence of air. Alternatively, 
the cation 83 can be trapped intramolecularly by the aryl ring to form the 5-membered 
enol ring 85. This can be opened to under the acidic medium and recyclize to form a 
2:2:1 mixture of diastereomers of ketal 81 in 50 % overall yield. The structure of 81 was 





Scheme 3.24: a) Wan’s Reported ESIPT of Phenolic-Biaryl 77 b) Jone’s Reported Novel 
Photorearrangement of Antrhaquinone 80 c) Kraus’ Reported Yang Cyclization to 
Paulownin 90  
 
In a related process, Kraus and coworkers reported the synthesis of (+/-)-
paulownin 90 from a key Norrish-Yang type cyclization of ketone 88 (Scheme 3.24c).
127
 





carbonyl to the diradical and hydrogen abstraction at the benzyl position. Recombination 
of the radicals provided the tertiary alcohol of (+/-)-paulownin 90.  
Based on the literature examples illustrated above, we propose that the methyl-
substituted anthraquinone-xanthone biaryl 91 may undergo ESIPT similar to Wan’s 
system (Scheme 3.25). Biaryl 91 was calculated to have a dihedral angle of 65º between 
the planes of the anthraquinone and xanthone ring systems (Figure 3.2). The methyl 
substitution of the xanthone moiety of 91 forces the biaryl linkage into a more bisected 
conformer (Wan’s system 77 has a dihedral angle of 54º). This bisection may allow for 
protonation to occur at the position ortho to the carbonyl to provide cation 92 which  
Figure 3.2: DFT Optimized Low Energy Conformer of Anthraquinone-Xanthone Biaryl 
91 
 
could readily convert to ketone 93 by proton transfer. We feel the solvent for this 
proposed proton transfer is important because the intramolecular hydrogen-bonding of 





carbonyl of the anthraquinone in 93 may be excited under photoirradiation to the 
diradical intermediate 94. The oxygen radical of the diradical intermediate could then 
potentially abstract a hydrogen atom of the xanthone methyl group to form 95, similar to 
the Yang cyclization examples previously described. Figure 3.3 displays a DFT 
optimized conformer of proposed intermediate 93, wherein the new sp
3
 center potentially  
Scheme 3.25: Proposed Photochemical-Mediated Rearrangement of Biaryl 91 
 
allows for abstraction of the xanthone methyl group. The benzylic radical 95 could then 
add into the doubly conjugated position to form intermediate 96. Intermediate 96 could 
then undergo respective hydrogen atom transfers to form the semiquinone 97 containing 





Figure 3.3: DFT Optimized Conformer of Proposed Intermediate 93 
 
Scheme 3.26: Proposed Photochemical-Mediated Rearrangement of Biaryl 91 
 
Analogously, we envisioned that photolysis of biaryl 91 in the presence of a 
reducing agent may produce the radical anion intermediate 98 via 93 (Scheme 3.26). The 
carbon-centered radical of 98 may abstract the methyl hydrogen, establishing the anti 





intermediate 99. This intermediate may then undergo a Michael additionto form radical 
anion 100 which may oxidize to regenerate the reducing reagent and form the desired 
bicyclo [3.2.2] ring system 101. 
3.6.2 Synthesis of Anthraquinone-Xanthone Biaryl 91 
 To test this proposed rearrangement, we prepared the anthraquinone-xanthone 
biaryl 91 analogously to 60 shown below (Scheme 3.27). We performed a Suzuki 
coupling between boronic acid 61 and known iodoxanthone 102 using similar conditions 
as reported above (Table 3.2). We changed the solvent to DCE for this reaction due to 
increased solubility of xanthone 102. Deprotection and oxidation of the naphthol ring 
occurred similarly to above by treatment with BBr3 followed by manganese dioxide to 
afford naphthoquinone 104 (60 %). Naphthoquinone biaryl 104 was then combined with 
silyldienyl ether 56 and heated neat at 60 ºC. This was followed by acidic hydrolysis to 
afford the anthraquinone-xanthone 91 (50 %). Protected naphthol biaryl 103 could also 
be oxidized to protected naphthoquinone-xanthone biaryl 105 with silver (I) oxide and 
nitric acid. This was subjected to similar Diels-Alder conditions to afford the 





Scheme 3.27: Synthesis of Anthraquinone-Xanthone Biaryl 91 
 
The regioselectivity for the cycloadditions was ultimately confirmed by 2D NMR 
experiments of biaryls 91 and 106. We observed HMBC correlations of biaryl 91 
between the upfield carbonyl of the anthraquinone moiety
128
 and two nearby aryl 
hydrogens. Analogously, we observed one HMBC correlation for each carbonyl of the  






anthraquinone moiety for biaryl 106 (Figure 3.4). These HMBC correlations confirmed 
the regioisomeric Diels-Alder cycloadditions of silyldienyl ether 56 and naphthoquinones 
104 and 105.   
3.6.3: UV-Vis Absorption Spectra for Biaryls 60 and 91 
 With anthraquinone-xanthone biaryls 60 and 91 in hand, we obtained UV-Vis 
spectra to characterize their UV absorbance spectra (Figures 3.5 and 3.6). Biaryl 60 has 
two overlapping broad absorption bands (437 nm and 376 nm). The absorption observed 
at lower wavelengths was due to the chloroform that has a reported absorption cutoff at 
260 nm. Based on comparison to the related anthraquinone chrysophanol, the absorbance 
band centered at 437nm is likely due to a * electron transition.129 Similarly, the 































 The UV-Vis spectrum of biaryl 91 shows two overlapping broad absorption bands 
with peaks of 433 nm and 375 nm, similar to the spectrum of 60. This data confirms that 
both birayls 60 and 91 readily absorb light in the visible and near UV region.  
Figure 3.6: UV-Vis Absorption Spectra for Biaryl 91 in Chloroform 
 
3.6.4: Photochemistry of Biaryls 60 and 91 
We tested our proposed rearrangement of biaryl 91 under photochemical 
conditions (Table 3.3). We initially irradiated (280 nm) 91 in an NMR tube in CDCl3 to 
determine if we could observe reactivity (entry 1). However, we only observed starting 
material after prolonged reaction time. Running similar reactions in the presence of 
DMSO or in mixed polar protic solvents to promote ESIPT
58
 also resulted in recovery of 
starting material (entries 2-5). In a similar manner, conducting the reaction under acidic 
conditions to try and promote proton transfer also resulted in recovered starting material 

























resulted in full recovery of starting material. Other previously attempted reducing 
conditions of biaryl 60 also had no effect on biaryl 91 (entires 9 and 10). Photolysis of 91 
in benzene and 0.1M NEt3, which was reported to be an electron donor to anthraquinones 
upon irradiation,
131
 resulted in trace amount of new products. However these new 
products were determined to be adducts with triethylamine. Adding organic electron 
donors 107 or 108 to biaryl 91 in the presence of light or under reported thermal 
conditions (entries 11-12) also resulted in recovered starting material.
132 







 We also examined whether hydroxymethyl biaryl 60 could be activated under 
photochemical conditions (Table 3.4). Wan and coworkers reported the formation of m-
quinonemethane intermediates of hydroxymethyl-substituted phenolic biaryls upon 
irradiation with UV light (Scheme 2.3).
56 
Photolysis (280 nm) of biaryl 60 in a variety of 
solvents resulted in no conversion (enries 1-4). Photolysis (> 200 nm, quart glass) of 60 
at shorter wavelengths (entry 6) or in the presence of acid (entry 7) also resulted in no 
conversion.  
Table 3.4: Photolysis of Biaryl 60 
 
 Based on our initial proposal (Scheme 3.2-3.3) to reduce the anthraquinone 
moiety of 60 to hydroquinone 109 to promote potential conversion to various 
dearomatized tautomers 110, we wanted to determine if these proposed intermediates 
could be converted to the desired product 97 under photochemical irradiation (Scheme 





irradiating with UV light resulted in no conversion of the 60. Similarly, sodium 
dithionate reduction of 60 followed by irradiation with UV light resulted in recovered 
starting material. Reduction of 60 in the presence of Pd/C in an atmosphere of hydrogen 
initially showed conversion to a new product by TLC. The mixture was filtered and then 
photolyzed in a quartz tube in a 1:1 mixture of CHCl3/TFE. However, this reaction  






resulted in full decomposition of the starting material. Other reducing conditions, such as 
borane, sodium dithionate, or ascorbate, followed by prortonation and photolysis are 
currently being evaulated in order to determine if this proposed reaction pathway is 
viable.   
3.7: Proposal for Completion of the Synthesis 
Figure 3.7: Anthraquinone-Xanthone Natural Products Acremonidin A (111) and 
Acremoxanthone (112). 
 
If we are able to successfully convert anthraquinone-xanthone biaryl model 
substrate 60 or 91 to the bicyclo [3.2.2] ring system, we propose to apply this to the total 
synthesis of natural products acremonidin A (111) and acremoxanthone (112) (Figure 
3.7). We would plan to prepare substituted benzophenone 1113 from aldehyde synthons 
114 and 115 using a similar route developed for the synthesis of acremonidin E (Scheme 
2.13). Selective ortho-iodination of bis-phenol 113 to afford aryl iodide 116 should be  






possible based on successful ortho-selective iodination of acremonidin E using the 
conditions shown. We we would attempt our developed Suzuki cross-coupling conditions 
with boronic acid 61 to afford biaryl 117 (Scheme 3.29).  
At this juncture, we would investigate whether there is free rotation about the 
trisubstituted biaryl bond of 117 to determine if there are atropisomers present. This 
would be determined by screening various chiral HPLC conditions. If we discovered that 
biaryl 117 exists as a mixture of stable atropisomers, we would investigate potential 
methods to construct this bond asymmetrically. Buchwald and coworkers developed a 
pioneering example a catalytic asymmetric Suzuki coupling of aryl boronic acids with 
ortho-phosphonate substituted naphthyl halides in moderate to excellent 
enantioselectivity employing Kenphos 118 as the source of chirality (Figure 3.8).
123 
Since this initial report, the Buchwald group and many others have contributed to this 




Deprotection of the methyl ethers of 117 with BBr3 followed by air oxidation in 
the presence of silica gel could provide naphthoquinone-benzophenone biaryl 120. A 
Diels-Alder reaction of naphthoquinone-biaryl 120 with silyldienyl ether 56 and further 





Scheme 3.29: Proposed Synthesis of Bicyclic Compound 122 
 
conditions to rearrange the model anthraquinone-xanthone biaryl 91 to the desired 
bicyclo [3.2.2] ring system, we would apply them to biaryl 121 to afford bicyclic 





asymmetrically, it could be possible for an axial to point chirality transfer upon formation 
of the quaternary center in product 122.  
Scheme 3.30: Proposed Late-Stage Synthesis toward Acremonidin A (111) and 






Finally, to install the secondary acetate moiety we plan to use a bulky hydride 
source (such as L-selectride or Super-Hydride) to reduce semiquinone 122 (Scheme 
3.30). This carbonyl should more reactive than the vinylogous acid, sterically hindered 
benzophenone, or methyl ester moieties also within the molecule. The multiple phenols 
of compound 122 may need to be protected to avoid deprotonation under the reducing 
conditions. We could potentially globally protect the phenols as MOM ethers under 
standard conditions to provide 123. When considering the diastereochemical outcome of 
the reduction, we believe the bicyclic ring system will block the hydride’s approach from 
the alpha face due to unfavorable steric interactions (Scheme 3.30). Thus, the reduction 
may occur under substrate control to afford alcohol 124, where the hydrogen is anti to the 
benzophenone ring system. A subsequent Mitsunobu reaction of the secondary alcohol 
124 in the presence of sodium acetate could afford 125 by installing the acetate moiety 
with the correct relative configuration of the natural products. Subjecting 124 to our 
previously developed microwave conditions could be implemented to convert the 
benzophenone to the corresponding xanthone but also may deprotect the MOM ethers 
under the acidic reaction conditions to afford acremoxanthone A (112). Alternatively, we 
could attempt mild acidic conditions to remove the labile phenolic MOM ethers to 
provide acremonidin A (111). This could also be converted to acremoxanthone A (112) 






3.8: Alternative Proposed Retrosynthetic Analysis for the Anthraquinone-Xanthone 
Heterodimeric Natural Products  
This family of natural products has been biosynthetically proposed to arise from 
some dimerization event of distinct anthraquinone-derived monomers. While the 
synthetic strategies described above aim to mimic this approach synthetically, it is not yet 
clear how to accomplish the dimerization or how to incorporate the unique bicyclo [3.2.2] 
ring system. A different strategy could be implemented where the core ring system is 
initially constructed, followed by a late-stage reduction and acetate installation. A 
proposed alternative retrosynthesis for acremonidin A (111) is shown in Scheme 3.31. 
The secondary acetate moiety could be installed at a late stage similar to the strategy 
outlined above (Scheme 3.30), Alternatively, we could investigate a chiral reduction of 




 for the 
enantioselective reduction of -disubstituted aryl ketones may be applied to this 
system. We imagine constructing the bicyclo [3.2.2] ring system of intermediate 127 via 
an intramolecular Heck cyclization of the aryl bromide and alkene moieties of 
intermediate 128. This strategy could construct the desired C-C bond and transpose the 





Scheme 3.31: Alternative Proposed Retrosynthesis for Acremonidin A (111) 
 
 
A similar literature precedent has been reported by Mann and coworkers in their 
synthetic efforts toward huperazine A (Scheme 3.32).
136
 They reported aryl bromide 129 
undergoing an intramolecular Heck reaction via either a 7-endo-trig or 6-exo-trig 
cyclization to products 130 or 131 and 132 respectively. Mechanistically, a palladium(0) 
insertion into the aryl bromide 129 afforded 133 followed by a 7-endo-trig olefin 
insertion to form intermediate 134 (path a). The only available syn-H for elimination 





attack by an unidentified hydride source displaced the Pd(II) intermediate to afford the 
130 as the major isolated product. Alternatively, a 6-exo-trig olefin insertion cyclization 
Scheme 3.32: Mann and Coworkers Intramolecular Heck Reaction toward Huperazine A 
 
of 133 afforded intermediate 135 (path b). This underwent syn--elmination with Hb to 
afford product 131 as the minor product. Minor byproduct 132 was thought to be formed 
from an olefin migration of 131 under the reaction conditions. Mann went on to reduce 
the ketone moiety prior to Heck cyclization to achieve favor the 6-exo-trig cyclization 
and achieve the total synthesis of huperazine A.
137
  
In our proposed route, palladium (0) insertion to into aryl bromide 128 would 





via a 6-exo-trig cyclization to 137, however there is no readily available syn hydrogen for 
-hydride elimination. The insertion would be reversible to reform intermediate 136. 
Alternatively, a 7-endo-trig cyclization would afford the bicyclic intermediate 138,  
Scheme 3.33: Proposed Intramolecular Heck Cyclization of Aryl Bromide 128 
 
which does have an available syn hydrogen for elimination to provide the desired ring 
system 126. We would attempt this reaction on the protected enone substrate 128 to avoid 
potential epimerization of the proposed palladium enol intermediate 137. This 
transformation would effectively form the bicyclo [3.2.2] ring system of the natural 
products through an initial Heck cyclization followed by syn--H elimination to 





Scheme 3.34: Proposed Diels-Alder Reactions of a Substituted Napthoquinone and 
Related Literature Examples 
 
 
We propose the precursor of the Heck cyclizatization 128 to arise from an 
intermolecular Diels-Alder reaction of substituted naphthoquinone 139 and silyldienyl 
ether 140 (Scheme 3.34a). We propose this reaction could proceed thermally or by a 
Lewis acid binding to the free phenol of the naphthoquinone moiety. We believe the free 
phenol of the naphthoquinone moiety would control the regioselectivity of the 





the cycloaddition, we would treat the product under acidic conditions to hydrolyze the 
ketal and form a conjugated enone which could be protected as ketal 128 for the 
subsequent Heck cyclization.  
A similar strategy using a Diels-Alder reaction of a substituted naphthoquinones 
has been reported by Kraus and coworkers wherein they reported the reaction between an 
acyl naphthoquinone 141 and silyldienyl ether 142 to afford intermediate 143 (Scheme 
3.34b).
138
 This intermediate 143 was then treated with TBAF in situ to induce a retro-
Dieckmann and subsequent Michael addition to afford naphthalene 144 in 77 % yield. 
Additionally, Gmeiner and coworkers performed a Diels-Alder reaction with juglone 145 
and triene 146 catalyzed by BF3-OEt2 to afford cycloadduct 147 in 55 % yield as a single 
diastereomer (Scheme 3.34c).
139
 The authors determined the cycloaddition occurred 
through the endo transition state with the phenyl and the reacting alkene residing in a 
trans conformation.  
The authors went on to further elaborate these intial Diels-Alder products and 
create a large library of compounds derived from substituted juglones and cross-
conjugated trienes. This reaction type has also been rendered asymmetric with examples 
of enantioselective Diels-Alder reactions of acyl naphthoquinones catalyzed by 
bis(oxazoline)-metal complexes,
140
 benzoquinones catalyzed by a chiral 
oxazaborolidinium cation,
141
 and juglones catalyzed by chiral BINOLs in the presence of 
borane.
142
 We imagine our system could be amendable to asymmetric catalysis as well 





that would both activate the dienophile and control the regio- and enantioselectivity of 
the cycloaddition.  
We envisioned the benzyl-substituted naphthoquinone 139 being made by an aryl 
anion addition of protected naphthalene derivative 148 and benzylic mesylate 149. A 
similarly substituted naphthalene fragment has been reported to undergo aryl anion 
addition to benzaldehyde in good yield.
143
 Benzylic mesylate 149 would arise from 
synthetic intermediates from the total synthesis of graphisin A (Scheme 2.13).   
This proposed synthesis could potentially allow for an enantioselective synthesis 
of bicyclo [3.2.2] ring systems related to anthraquinone-xanthone heterodimeric natural 
products. Key steps would include an intermolecular aryl anion addition of a protected 
naphthalene and a benzylic mesylate of a functionalized benzophenone, a Lewis acid-
mediated Diels-Alder reaction of a substituted naphthoquinone and a silyldienyl ether, 
and an intramolecular 7-endo-trig Heck cyclization to construt the bicyclic ring system.  
3.9 Conclusion 
 In this chapter, we have described preparation an anthraquinone-xanthone 
biaryl intermediate for rearrangement studies to form the bicyclo [3.2.2] ring system 
found in heterodimeric natural products. We surmised this could occur from a reduction 
of the anthraquinone moiety and subsequent tautomerization to a dearomatized 
intermediate that could then undergo an alkylation to an activated benzyl position of the 
linked xanthone. This type of tautomerization has been reported for analogous 





synthesis. We depicted our intial efforts to construct the biaryl through an attempted 
cross-coupling of functionalized anthraquinone 24 and xanthone 3. We then attempted 
intramolecular cross-coupling strategies through an anthraquinone xanthone ether 44, 
however we did not observe the desired bond formation. Finally, we developed a method 
for constructing various anthraquinone-xanthone biaryls through Suzuki coupling of 
iodoxanthones 3 or 98 and naphthalene fragment 61. There are few reports of the 
synthesis of such complex biaryls in the literature, so we are able to contribute our 
method of preparing these molecules.  We were able to examine a variety of conditions 
on multiple substrates to determine if our proposal could occur as planned, however we 
did not observe the desired reactivity. Experiments aimed at identifying conditions to 
achieve the proposed rearrangement are currently ongoing. We have outlined future plans 
for the application of this complex model system to the synthesis of heterodimeric natural 
products acremonidin A (111) and acremoxanthone A (112). We also described an 
alternative retrosynthesis for this family of natural products with key steps including an 
intermolecular aryl anion addition of a protected naphthalene and a benzylic mesylate of 
a functionalized benzophenone, a Lewis acid-mediated Diels-Alder reaction of a 
substituted naphthoquinone and a silyldienyl ether, and an intramolecular 7-endo-trig 








3.10 Experimental Section 
Instrumentation and methods-
1
H NMR spectra were recorded at 500 MHz at ambient 
temperature with CDCl3 (Cambridge Isotope Laboratories, Inc.) as the solvent unless 
otherwise stated. 
13
C NMR spectra were recorded at 100.0 MHz at ambient temperature 
with CDCl3 as the solvent unless otherwise stated. Chemical shifts are reported in parts 
per million relative to CDCl3 (
1H, δ 7.26; 13C, δ 77.0). Data for 1H NMR are reported as 
follows: chemical shift, integration, multiplicity (app = apparent, br = broad, par obsc = 
partially obscure, ovrlp = overlapping, s = singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet) and coupling constants. All 
13
C NMR spectra were recorded with complete 
proton decoupling. Infrared spectra were recorded on a Nicolet Nexus 670 FT-IR 
spectrophotometer. Crude mass spectra were obtained using a Waters Acquity Ultra-
Performance Liquid Chromatography (UPLC) system with PDA, ELC, and SQ detectors. 
High-resolution mass spectra were obtained in the Boston University Chemical 
Instrumentation Center using a Waters Q-TOF mass spectrometer. Melting points were 
recorded on a Mel-temp (Laboratory Devices). Analytical thin layer chromatography was 
performed using 0.25 mm silica gel 60-F plates. Flash chromatography was performed 
using 200-400 mesh silica gel (Sorbent Technologies, Inc.). Yields refer to 
chromatographically and spectroscopically pure compounds, unless otherwise stated.  All 
other reactions were carried out in oven-dried glassware under an argon atmosphere 
unless otherwise noted. The Arthur
TM





was used for experimental procedure planning. All calculations were conducted using the 
SPARTAN 2010 Quantum Mechanics Program: (PC/x86) Release 1.0.1v4.  
Reagents and solvents 
HPLC grade tetrahydrofuran, methylene chloride, diethyl ether and hexanes were 
purchased from Fisher and VWR and were purified and dried by passing through a PURE 
SOLV
®
 solvent purification system (Innovative Technology, Inc.). Methanol was 
purchased from Fisher, distilled over magnesium iodide, and stored over 3 Ǻ molecular 
sieves. Sodium hydride was purchased from Fisher as a 60 % dispersion in mineral oil. 
All alkyllithium solutions were used after being freshly titrated using diphenylacetic acid 
as indicator. All other reagents were used as purchased from Aldrich, Acros, Alfa Aesar, 
and Strem Chemicals. Photochemistry experiments were performed using a 450 W 
medium pressure lamp housed in a quartz immersion cooled with a Thermo Neslab-ULT 
80 system circulator. Pyrex or quartz tubes were clamped approximately 5.0 cm from the 
immersion well lamp while stirring.  
Acetoxy Protected iodoanthraquinone 22: Prepared 
according to the procedure described in the literature.
103 
22 
matched all reported characterization data.  
 Iodoanthraquinone 24: Chloromethyl methyl ether (150 







anthraquinone (400 mg) 22 and DIEA (375 uL, 2.156 mmol, 2.2 equiv.) in CH2Cl2 (10 
mL) at 0 ºC. The reaction was allowed to warm to rt and monitored by TLC. Upon 
completion by TLC analysis, the reaction was diluted with water and extracted with 
CH2Cl2, washed with brine, dried over sodium sulfate, and concentrated in vacuo to 
afford a crude oil. The oil was purified by column chromatography (2:1 hexanes: ethyl 
acetate) to provide 24 as a yellow solid (150 mg, 34 %). M.p.= 165-167 ºC (ethyl acetate) 
Rf = 0.38 (2:1 hexanes: ethyl acetate); IR (thin film): max  2966/5. 2925.9, 2857.9, 





H NMR (500 MHz, Chloroform-d) δ 8.20 (d, J = 8.2 Hz, 1H), 
8.17 – 8.14 (m, 1H), 7.74 (t, J = 7.8 Hz, 2H), 7.40 (d, J = 8.0 Hz, 1H), 5.13 (s, 2H), 3.69 
(s, 3H), 2.44 (s, 4H).;
 13
C NMR (126 MHz, cdcl3) δ 181.94, 181.58, 169.62, 157.03, 
149.72, 144.81, 134.83, 134.65, 134.28, 130.18, 126.36, 126.13, 125.33, 124.37, 103.95, 
102.05, 58.85, 21.27. HRMS-ESI (m/z): [M]
+
 calcd for C18H13IO6, 451.9757; found 
[M+H]
 +
, 452.9837 0.4415 ppm).  
MOM Methoxyanthraquinone 27: : Chloromethyl 
methyl ether (7.12 mL, 93.7 mmol, 1.5 equiv.) was added to a 
solution of 1,8-dihydroxyanthraquinone (15 g, 62.4 mmol) and 
DIEA (16.3 mL, 93.7 mmol, 1.5 equiv.) in CH2Cl2 (300 mL) at 0 
ºC. The reaction was allowed to warm to rt and monitored by TLC analysis. Upon 
completion by TLC, the reaction was diluted with water and extracted with CH2Cl2, 






mono-MOM anthraquinone as a crude yellow solid (17 g, 95 %). The crude solid was 
dissolved in DMF (250 mL) in a new dry flask equipped with a stir bar and potassium 
carbonate (12.4 g, 89.7 mmol, 1.5 equiv.) was added to the solution at 0 ºC. Methyl 
iodide (7.45 mL, 120 mmol, 2 equiv.) was added and the reaction was warmed to rt and 
monitored by TLC. Upon completion, the reaction was quenched with water, acidified 
with 1 M HCl, and extracted with CH2Cl2. The organic layer was washed with water, 
brine, dried over sodium sulfate, and concentrated to a crude oil. The oil was purified by 
column chromatography (4:1 hexanes: ethyl acetate) to provide 27 as a yellow solid (16 
g, 90 %). M.p. = 180 ºC (CH2Cl2); Rf = 0.65 (2:1 hexanes: ethyl acetate); IR (thin film): 
max  3075.8, 3007.1, 2944.1, 2841.2, 1669.6, 1584.8, 1464.6, 1441.5, 1313.9, 1271.4, 





(400 MHz, Chloroform-d) δ 7.88 (dd, J = 7.5, 1.3 Hz, 1H), 7.82 (dd, J = 7.7, 1.1 Hz, 1H), 
7.60 (ddd, J = 12.3, 8.3, 7.6 Hz, 2H), 7.52 (dd, J = 8.3, 1.2 Hz, 1H), 7.30 (d, J = 0.7 Hz, 




C NMR (101 MHz, cdcl3) δ 183.86, 
182.75, 159.56, 157.05, 134.93, 134.75, 134.09, 133.76, 125.21, 123.96, 122.98, 120.57, 
119.09, 118.06, 95.45, 77.48, 77.16, 76.84, 56.63.. HRMS-ESI (m/z): [M+]
+
 calcd for 
C17H14O5, 298.0841; found [M+H]
 +
, 299.0919 (0.000 ppm).  
Trimethoxy Anthracene 28: Separate reaction flasks 
containing THF (15 mL) and water (15 mL) were degassed for 
10 minutes by a stream of argon. Sodium dithionate (875 mg, 






methoxyMOManthraquinone 27 (500 mg, 1.68 mmol) and tetra-N-butylammonium 
bromide (270 mg, 0.84 mmol, 0.5 equiv.) were added to the flask containing THF. The 
water solution was added to the THF solution and was stirred at rt for 1 hr, which resulted 
in a color change from yellow to orange. 3.0 M potassium hydroxide (5.6 mL, 10 equiv.) 
was added to the biphasic solution, resulting in a deep red color. Methyl iodide (1.25 mL, 
20.1 mmol, 12 equiv.) was added and the reaction was stirred for 2 h at rt. Upon 
completion by TLC analysis, the reaction was quenched with 1M HCl and extracted with 
ethyl acetate. The organic layer was washed with water and brine, dried over sodium 
sulfate, and concentrated in vacuo to a crude oil. This was purified by column 
chromatography (4:1 hexanes: ethyl acetate) to afford an orange oil (375 mg, 70 %). Rf = 
0.55 (4:1 hexanes: ethyl acetate); IR (thin film): max  3057.1, 3002.4, 2936.7, 2839.9, 
1631.0, 1565.6, 1544.2, 1484.9, 1455.4, 1439.0, 1377.1, 1242.5, 1202.7, 1083.7, 1054.5, 




H NMR (500 MHz, Chloroform-d) δ 7.97 (dd, 
J = 8.7, 1.1 Hz, 1H), 7.87 (dd, J = 8.7, 1.0 Hz, 1H), 7.38 (dd, J = 8.7, 7.5 Hz, 2H), 7.10 
(dd, J = 7.5, 1.1 Hz, 1H), 6.79 (dd, J = 7.6, 1.1 Hz, 1H), 5.39 (s, 2H), 4.06 (s, 3H), 4.05 
(s, 3H), 3.96 (s, 3H), 3.65 (s, 3H);
 13
C NMR (126 MHz, cdcl3) δ 157.33, 154.44, 150.48, 
147.80, 127.70, 127.49, 125.84, 125.83, 119.52, 119.23, 116.61, 114.75, 110.93, 104.08, 
96.63, 77.42, 77.16, 76.91, 63.84, 62.67, 56.56, 56.32; HRMS-ESI (m/z): [M]
+
 calcd for 
C19H20O5, 328.1311; found [M+H]
 +






Stannane 29: 1.0 M Potassium t-butoxide in THF (335 uL, 0.33, mmol, 2 equiv.) was 
added dropwise to a solution of 2.3 M n-butyllithium (163 
uL, 0.37 mmol, 2.2 equiv.) in THF (0.5 mL) at -78 ºC and 
the reaction was stirred for 10 minutes. A solution of 
protected hydroquinone 28 (55 mg, 0.167 mmol) in THF 
(0.5 mL) was added slowly to the reaction mixture at -78 ºC and stirred for 1 h. 
Tributyltin chloride (236 uL, 0.871 mmol, 5.2 equiv.) was added to the solution and the 
reaction was slowly warmed to rt. Upon reaching rt, the reaction was quenched with 
saturated ammonium chloride and then extracted with ethyl acetate. The organic layer 
was washed with water and brine, dried over sodium sulfate, and concentrated in vacuo to 
afford a crude oil. The oil was purified by column chromatography (8:1 hexanes: ethyl 
acetate) to provide stannane 29 (22 mg, 21 %) as a yellow oil. Rf = 0.75 (8:1 hexanes: 
ethyl acetate); IR (thin film): max  2953.8, 2924.6, 2870.4, 2854.0, 1619.3, 1555.1, 
1449.3, 1413.0, 1354.9, 1293.6, 1246.6, 1155.3, 1071.3, 1025.9, 958.9, 993.5, 958.6, 




H NMR (500 MHz, Chloroform-d) δ 8.03 (d, J = 8.4 Hz, 1H), 
7.86 (dd, J = 8.8, 1.0 Hz, 1H), 7.49 (d, J = 8.5 Hz, 1H), 7.37 (dd, J = 8.7, 7.5 Hz, 1H), 
6.79 (dd, J = 7.5, 1.0 Hz, 1H), 5.12 (bs, 2H), 4.07 (s, 3H), 4.06 (s, 3H), 3.90 (s, 3H), 3.46 
(s, 3H), 1.70 – 1.53 (m, 6H), 1.38 (h, J = 7.3 Hz, 6H), 1.33 – 1.25 (m, 6H), 0.95 – 0.86 
(m, 9H).;
 13
C NMR (126 MHz, cdcl3) δ 157.51, 157.26, 148.75, 148.17, 132.99, 132.29, 
128.57, 127.29, 125.65, 119.82, 119.16, 118.26, 114.87, 104.29, 101.17, 63.44, 62.80, 
57.98, 56.56, 29.43, 28.00, 27.65, 27.64, 27.00, 17.67, 13.91, 13.75, 10.77. HRMS-ESI 
(m/z): [M+]
+
 calcd for C31H46O5Sn, 624.2367; found [M+]
 +






Trimethoxy Anthracene 41:  3M HCl (10 mL) was added to 
trimethoxy anthracene 28 (1.75 g, 5.33 mmol) in THF (20 mL) at 0 
ºC and allowed to warm to rt. Upon completion by TLC analysis, 
the reaction was diluted with water and extracted with ethyl 
acetate. The organic layer was washed with water and brine, dried over sodium sulfate, 
and concentrated in vacuo to a crude solid. The crude product was purified by column 
chromatography (2:1 hexanes: ethyl acetate) to provide protected anthracene 41 (1.2 g, 
80%) as a brownish solid. M.p. = 102-105ºC (ethyl acetate); Rf = 0.70 (2:1 hexanes: ethyl 
acetate); IR (thin film): max  3289.3, 3057.1, 3000.9, 2936.7, 2837.9, 1631.0, 1562.6, 
1534.2, 1484.9, 1453.4, 1438.0, 1377.1, 1266.7, 1240.5, 1202.7, 1083.7, 1053.5, 1023.7, 




H NMR (500 MHz, Chloroform-d) δ 
10.33 (s, 1H), 7.89 (dd, J = 8.8, 0.9 Hz, 1H), 7.77 (dd, J = 8.7, 1.0 Hz, 1H), 7.39 (ddd, J = 
17.5, 8.7, 7.4 Hz, 2H), 6.89 (dd, J = 7.4, 1.0 Hz, 1H), 6.79 (dd, J = 7.5, 0.9 Hz, 1H), 4.07 




C NMR (126 MHz, cdcl3) δ 155.78, 154.57, 148.86, 
148.63, 127.25, 127.21, 127.02, 125.62, 116.70, 116.69, 115.15, 113.01, 108.59, 104.17, 
77.33, 77.07, 76.82, 64.75, 62.61, 56.11. HRMS-ESI (m/z): [M]
+
 calcd for C17H16O4, 
284.1049; found [M+H]
 +
, 285.1135 (+ 2.8059 ppm).  
Pivaloyl xanthone 20: To a dry flask equipped with a stir 
bar was added 2,2-dimethylpropanoyl chloride (7.07 mL, 57.5 
mmol, 1.3 equiv.) to a solution of xanthone 19 (10.0 g, 44.2 






triethylamine (6.78 mL, 48.6 mmol, 1.1 equiv.) in CH2Cl2 (150 mL) at rt. The reaction 
turned from yellow to clear and was stirred at rt for 30 min. The reaction was quenched 
with water and extracted with CH2Cl2 The organic layer was washed with brine, dried 
over sodium sulfate, and concentrated in vacuo to afford 20 as a pure white solid (13 g, 
95%). This was used without further purification. Rf = 0.80 (4:1 hexanes: ethyl acetate); 
IR (thin film): max  3047.7, 2977.2, 2932.8, 2872.8, 1753.8, 1660.9, 1609.8, 1560.2, 




NMR (500 MHz, Chloroform-d) δ 8.24 (dd, J = 8.0, 1.7 Hz, 1H), 7.66 (ddd, J = 8.6, 7.1, 
1.7 Hz, 1H), 7.41 (ddd, J = 8.4, 1.1, 0.5 Hz, 1H), 7.32 (ddd, J = 8.0, 7.1, 1.1 Hz, 1H), 
7.19 (dd, J = 1.6, 0.8 Hz, 1H), 6.76 (dd, J = 1.5, 0.6 Hz, 1H), 2.47 (s, 3H), 1.49 (s, 9H).;
 
13
C NMR (126 MHz, cdcl3) δ 177.09, 175.35, 157.23, 155.24, 150.35, 146.00, 134.43, 
126.72, 123.76, 122.35, 119.29, 117.45, 115.94, 113.34, 39.13, 27.32, 21.87. HRMS-ESI 
(m/z): [M]
+
 calcd for C19H18O4, 310.1205; found [M+H]
 +
, 311.1298 (4.8212 ppm).  
Pivaloyl acetoxyxanthone: Freshly recrystallized N-
bromosuccinimide (2.52 g, 14.2 mmol, 1.1 equiv.), AIBN 
(212 mg, 1.3 mmol, 0.1 equiv.) and pivaloyl xanthone 20 
were dissolved in benzene (115 mL) in a flask equipped 
with a stir bar and reflux condenser. The reaction was heated to 80 ºC under reflux and 
monitored by TLC. Upon consumption of the starting material, the reaction mixture was 
cooled to rt, filtered to remove the succinimide byproduct, and concentrated in vacuo to 






acetate (3.16 g, 32.2 mmol, 2.5 equiv.) was added. The reaction was then heated at 80 ºC 
under reflux for 20 h. Upon completion by TLC analysis, the reaction was cooled to rt 
and acidified with 1M HCl and diluted with water. The mixture was extracted with ethyl 
acetate, washed with brine, dried over sodium sulfate, and concentrated to a crude oil. 
The oil was purified by column chromatography (6:1 hexanes: ethyl acetate) to afford 
acetoxyxanthone as a white solid (2.55 g, 53 %). Unreacted pivalate xanthone 20 was 
also recovered and recycled using the same procedure. m.p. = 120ºC (CH2Cl2); Rf = 0.25 
(6:1 hexanes: ethyl acetate); IR (thin film): max  3041.7, 2979.2, 2933.8, 2872.8, 1753.8, 
1665.4, 1660.9,1611.2, 1609.8, 1562.2, 1484.3, 1419.4, 1354.7, 1309.4, 1274.9, 1140.7, 
1110.4, 1057.8, 922.2, 758.6  cm
-1;
 1
H NMR (500 MHz, Chloroform-d) δ 8.23 (dd, J = 
8.0, 1.7 Hz, 1H), 7.68 (ddd, J = 8.6, 7.1, 1.7 Hz, 1H), 7.42 (dd, J = 8.5, 1.1 Hz, 1H), 7.36 
(s, 1H), 7.33 (ddd, J = 8.1, 7.1, 1.1 Hz, 1H), 6.90 (d, J = 1.6 Hz, 1H), 5.19 (s, 2H), 2.18 
(s, 3H), 1.50 (s, 9H);
 13
C NMR (126 MHz, cdcl3) δ 177.06, 175.33, 170.62, 157.40, 
155.36, 150.99, 143.32, 134.87, 126.88, 124.18, 122.43, 117.63, 117.08, 115.09, 114.70, 
64.73, 39.31, 27.45, 21.02.HRMS-ESI (m/z): [M]
+
 calcd for C21H20O6, 368.1260; found 
[M+Na]
 +
, 391.1161 (+ 0.7670 ppm).  
Pivaloyl Mesylxanthone 40: Potassium carbonate 
(2.25 g, 16.3 mmol, 2 equiv.) was added to a solution of 
acetoxyxanthone (3.00 g, 8.14 mmol) in methanol (53 
mL) at rt. The reaction was stirred at rt until completion 






with water. The mixture was extracted with CH2Cl2, washed with water, dried over 
sodium sulfate, and concentrated in vacuo to afford a white solid. The solid was taken up 
in dry CH2Cl2 (50 mL) in a dry flask and triethylamine (1.7 mL, 12.2 mmol, 1.5 equiv. ) 
was added followed by methansulfonyl chloride (0.70 mL, 8.95 mmol, 1.1 equiv.). The 
reaction was monitored by TLC analysis at rt. Upon completion by TLC analysis, the 
reaction was diluted with water and extracted with CH2Cl2. The organic layer was 
washed with brine, dried over sodium sulfate, and concentrated to provide a clear oil. 
This was purified by column chromatography (1:1 hexanes: ethyl acetate) to afford mesyl 
xanthone 40 (2.8 g, 85 %).  Rf = 0.35 (1:1 hexanes: ethyl acetate); IR (thin film): max  
3057.1, 2977.1, 2939.5, 2872.9, 1751.5, 1661.9, 1610.9, 1633.0, 1564.0, 1480.5, 1434.4, 





NMR (500 MHz, Chloroform-d) δ 8.24 (dd, J = 8.0, 1.7 Hz, 1H), 7.70 (ddd, J = 8.6, 7.2, 
1.7 Hz, 1H), 7.46 – 7.43 (m, 2H), 7.36 (ddd, J = 8.0, 7.1, 1.1 Hz, 1H), 6.96 (d, J = 1.6 Hz, 
1H), 5.31 (s, 2H), 3.06 (s, 3H), 1.50 (d, J = 0.8 Hz, 9H).;
 13
C NMR (126 MHz, cdcl3) δ 
177.06, 175.21, 157.48, 155.37, 151.41, 140.55, 135.09, 126.94, 124.41, 122.47, 117.71, 
117.31, 115.83, 115.27, 69.04, 39.37, 38.53, 27.45.; HRMS-ESI (m/z): [M]
+
 calcd for 
C20H20O7S, 404.0930; found [M+Na]
 +
, 427.0836 (2.1073 ppm).  
Pivaloylxanthone ether 42: In a dry flask 
with stir bar was added tetra-N-butylammonium 
iodide (45 mg, 0.123 mmol, 0.1 equiv.), and 





mmol, 1.3 equiv.) to a solution of trimethoxy anthracene 41 (385 mg, 1.36 mmol, 1.1 
equiv.) in DMF (12.5 mL) at 0 ºC. This was stirred for 5 minutes, then mesyl xanthone 40 
(500 mg) in DMF (2 mL) was added dropwise at 0 ºC and then the reaction was allowed 
to warm to rt. The reaction was monitored by TLC over 3 h and heated if necessary. 
Upon conversion of the mesyl xanthone by TLC analysis, the reaction was quenched with 
water and diluted with water. This was extracted with diethyl ether several times and then 
washed with water. The combined organic layers were washed with brine, dried over 
sodium sulfate and concentrated in vacuo to a crude oil which was purified by column 
chromatography (1:1 hexanes: ethyl acetate) to afford aryl ether 42 (465 mg, 63 %) as a 
brownish solid. M.p.= >220 ºC; Rf = 0.40 (1:1 hexanes: ethyl acetate); IR (thin film): max  
3053.9, 2985.3, 2933.9, 2835.4, 1752.6, 1660.9, 1632.3, 1610.3, 1563.8, 1479.9, 1464.7, 





NMR (500 MHz, Chloroform-d) δ 8.17 (dd, J = 8.0, 1.7 Hz, 1H), 7.83 (dd, J = 8.7, 1.0 
Hz, 1H), 7.78 (dd, J = 8.8, 1.0 Hz, 1H), 7.61 – 7.54 (m, 2H), 7.35 – 7.30 (m, 2H), 7.28 (d, 
J = 9.9 Hz, 1H), 7.27 – 7.21 (m, 2H), 7.16 (d, J = 1.6 Hz, 1H), 6.72 (dd, J = 11.2, 7.4 Hz, 
2H), 5.26 (s, 2H), 3.97 (s, 3H), 3.96 (s, 3H), 3.81 (s, 3H), 1.45 (s, 9H).;
 13
C NMR (126 
MHz, cdcl3) δ 177.12, 175.51, 157.55, 157.32, 155.85, 155.43, 150.96, 150.88, 147.74, 
145.28, 134.74, 127.78, 127.65, 126.83, 126.06, 125.66, 124.04, 122.47, 119.32, 119.21, 
117.68, 116.63, 116.02, 114.85, 114.77, 113.99, 107.09, 104.24, 77.41, 77.16, 76.91, 
70.50, 64.19, 62.71, 56.33, 39.32, 27.49, 27.48. HRMS-ESI (m/z): [M+H]
+





C36H32O8, 593.2175; found [M-29]
 +
, (oxidized to anthraquinone during ionization) 
563.1738.  
Hydroxyxanthone Aryl ether: To a flask 
with stir bar was added a 3M sodium hydroxide 
solution (2.9 mL, 8.6 mmol, 10 equiv.) to a 
solution of aryl ether 42 (500 mg, 0.866 mmol) in ethanol (10 mL) at rt. This solution 
was heated at 80 ºC under reflux and was monitored by UPLC analysis. After several 
hours, the reaction was complete by UPLC analysis and was cooled to rt and quenched 
with 1M HCl and diluted with water. This was extracted with CH2Cl2 and washed with 
brine, dried over sodium sulfate and concentrated in vacuo to provide ether (370 mg, 85 
%) as a white solid. M.p. = >220 ºC; Rf = 0.40 (1:1 hexanes: ethyl acetate); IR (thin film): 
max  3060.2, 2954.0, 2928.9, 2850.8, 1651.8, 1619.2, 1608.8, 1563.7, 1479.9, 1466.5, 





H NMR (500 MHz, Chloroform-d) δ 12.69 (s, 1H), 8.29 (dd, J = 8.0, 1.7 Hz, 
1H), 7.91 (dd, J = 8.7, 1.0 Hz, 1H), 7.87 (dd, J = 8.7, 0.9 Hz, 1H), 7.75 (ddd, J = 8.7, 7.1, 
1.7 Hz, 1H), 7.51 – 7.44 (m, 1H), 7.42 – 7.37 (m, 2H), 7.34 (dd, J = 8.7, 7.4 Hz, 1H), 





(126 MHz, cdcl3) δ 182.16, 162.16, 157.40, 156.69, 156.40, 156.01, 150.95, 148.04, 
147.76, 135.67, 127.78, 127.72, 126.11, 126.05, 125.69, 124.24, 120.81, 119.34, 119.32, 






56.39. HRMS-ESI (m/z): [M+H]
+
 calcd for C31H24O7, 509.1600; found [M+H]
 +
, 
509.1606 (+ 1.1784 ppm).  
Hydroxyxanthone Anthraquinone Aryl 
ether 44: Ferric chloride (64 mg, 0.393 mmol, 2 
equiv.) was added to a solution of 
hydroxyxanthone aryl ether (100 mg, 0.197 
mmol) in CH2Cl2 (3 mL) in a dry flask while stirring at rt. The reaction was monitored by 
TLC. Upon complete conversion by TLC analysis, the reaction was quenched with water 
and methanol and stirred for 20 min to separate the organic and aqueous layers. The 
organic layer appeared red and was extracted with CH2Cl2 and washed with brine, dried 
over sodium sulfate, and concentrated in vacuo to afford a crude solid. This solid was 
purified by column chromatography (1:2 hexanes: ethyl acetate) to afford ether 44 as a 
yellow solid (60 mg, 64 %). M.p. > 220 ºC; Rf = 0.20 (1:1 hexanes: ethyl acetate); IR 
(thin film): max  3067.2, 2925.8, 2853.4, 1669.6, 1632.4, 1598.9, 1586.6, 1481.2, 1467.4, 




H NMR (500 
MHz, Chloroform-d) δ 12.69 (s, 1H), 8.28 (dd, J = 8.0, 1.7 Hz, 1H), 7.88 (d, J = 3.2 Hz, 
1H), 7.86 (d, J = 3.4 Hz, 1H), 7.75 (ddd, J = 8.6, 7.1, 1.7 Hz, 1H), 7.67 (t, J = 8.1 Hz, 
1H), 7.57 (t, J = 8.0 Hz, 1H), 7.48 (d, J = 8.5 Hz, 1H), 7.40 (td, J = 7.6, 1.0 Hz, 1H), 7.34 
(d, J = 8.4 Hz, 1H), 7.32 (s, 1H), 7.24 (s, 1H), 6.92 (s, 1H), 5.40 (s, 2H), 4.06 (s, 3H).;
 13
C 
NMR (126 MHz, cdcl3) δ 183.66, 182.46, 181.87, 161.97, 159.41, 157.61, 156.57, 






120.51, 119.73, 119.69, 118.94, 117.97, 117.83, 108.25, 107.81, 104.95, 70.09, 56.53.; 
HRMS-ESI (m/z): [M+H]
+
 calcd for C29H18O7, 479.1131; found [M+H]
 +
, 479.1150 (+ 
3.9657 ppm).  
Anthraquinone Iodobenzylether 47: To a dry flask 
equipped with a stir bar was added 1,8-
dihydroxyanthraquinone 22 (685 mg, 2.84 mmol, 0.97 
equiv.) and DMF (12 mL). Potassium carbonate (445 mg, 
3.22 mmol, 1.1 equiv.) was added and the reaction was 
stirred at rt. A separate solution of ortho-iodobenzyl mesylate
109
 46 (915 mg, 2.93 mmol, 
1 equiv.) in DMF (2 mL) was added to this solution slowly and the reaction was heated to 
60 ºC. Upon completion by TLC analysis, the reaction was cooled to rt, quenched with 
1M HCl, and extracted with ethyl acetate. The combined organic layers were washed 
with water, brine, dried over sodium sulfate, and concentrated in vacuo to afford a crude 
yellow solid which was purified by column chromatography (1:1 hexanes: ethyl acetate) 
to provide ether 47 (865 mg, 65 %) as an orange solid. M.p. = >220 ºC; Rf = 0.55 (1:1 
hexanes: ethyl acetate); IR (thin film): max  3347.4, 3065.5, 2909.3, 2847.9, 1671.3, 





H NMR (500 MHz, Chloroform-d) δ 13.07 (s, 1H), 8.03 – 8.01 (m, 
1H), 7.98 (d, J = 7.6 Hz, 1H), 7.88 – 7.85 (m, 1H), 7.78 – 7.76 (m, 1H), 7.73 (t, J = 8.0 
Hz, 1H), 7.62 (t, J = 7.9 Hz, 1H), 7.52 – 7.46 (m, 1H), 7.38 (d, J = 8.4 Hz, 1H), 7.30 (d, J 






182.75, 162.59, 159.33, 139.06, 138.08, 136.02, 135.96, 135.89, 132.76, 129.67, 128.94, 
128.49, 124.89, 121.19, 120.74, 119.78, 119.71, 119.01, 95.83, 75.32.; HRMS-ESI (m/z): 
[M+H]
+
 calcd for C21H13IO4, 456.9937; found [M+H]
 +
, 456.8753 (+ 0.8753 ppm). 
Anthraquinone Benzochromene 48: To a sealed 
tube containing a stir bar was added ether 47 (70 mg, 0.153 
mmol), palladium acetate (3.5 mg, 0.153 mmol, 0.1 equiv.), 
tricyclohexylphosphine (8.61 mg, 0.306 mmol, 0.2 equiv.), silver carbonate (21.2 mg, 
0.078 mmol, 0.5 equiv.), and potassium carbonate (42.4 mg, 0.307 mmol, 2.0 equiv.). 
Degassed DMA (2 mL) was added to the sealed tube which was sealed with a crimper. 
The reaction tube was heated at 120 ºC for 12 h. The reaction was cooled to rt and 
quenched by adding water. This was extracted with ethyl acetate and then washed with 
water, brine, and then concentrated to a crude oil. This was purified by column 
chromatography (1:1 CH2Cl2: hexanes to 10:1 CH2Cl2: ethyl acetate) to provide an 
orange solid 48 (25 mg, 50 %). This solid was found to be very insoluble except in dilute 
CH2Cl2. M.p.= >220 ºC; Rf = 0.60 (4:1 hexanes: ethyl acetate); IR (thin film): max   
2959.1, 2924.0, 2852.2, 1669.8, 1633.0, 1584.7, 1448.8, 1355.0, 1285.2, 1238.8, 1204.3, 




H NMR (500 MHz, Chloroform-d) δ 12.91 (s, 
1H), 8.12 (d, J = 8.1 Hz, 1H), 8.05 (d, J = 8.1 Hz, 1H), 7.79 (d, J = 7.7 Hz, 1H), 7.75 (d, 
J = 8.0 Hz, 1H), 7.61 (dt, J = 14.8, 7.6 Hz, 2H), 7.44 (dd, J = 7.9, 2.8 Hz, 2H), 7.29 (d, J 
= 8.3 Hz, 1H), 5.36 (s, 2H).;
 13
C NMR (126 MHz, cdcl3) δ 188.74, 182.22, 162.67, 






126.88, 124.94, 124.79, 123.10, 121.56, 119.08, 69.02.; HRMS-ESI (m/z): [M+H]+ calcd 
for C21H12O4, 329.0814; found [M+H]
 +
, 329.0806 (+ 2.4310 ppm).  
 Iodoxanthone Anthraquinone Aryl Ether 
49: To a flask equipped with a stir bar was added 
ether 44 (175 mg, 0.366 mmol) and THF (2 
mL)/ethanol (2 mL). Iodine (75 mg, 0.293 mmol, 0.8 
equiv.) and iodic acid (25 mg, 0.146 mmol, 0.4 equiv.) in water (1 mL) were added to the 
reaction flask and this was stirred at rt for 24 h. The reaction turned red upon addition of 
the iodine and gradually yellow over time as a precipitate formed. Upon reaction 
completion as indicated by UPLC analysis, the reaction was quenched with a 10 % 
solution of sodium dithionate until the reaction became clear in color and was finally 
extracted with ethyl acetate. The organic layer was washed with brine, dried over sodium 
sulfate, and concentrated in vacuo to afford 49 as a yellow solid which was used without 
further purification (188 mg, 85 %). M.p. >220 ºC; Rf = 0.25 (1:1 hexanes: ethyl acetate); 
IR (thin film): max  3067.2, 2921.4, 2851.2, 1672.5, 1647.5, 1607.2, 1586.6, 1467.2, 
1435.5, 1388.1, 1276.2, 1240.1, 1158.3, 1066.7, 986.1, 744.4 cm
-1;
 1
H NMR (500 MHz, 
Chloroform-d) δ 13.80 (d, J = 0.7 Hz, 1H), 8.30 (dd, J = 8.1, 1.3 Hz, 1H), 7.91 (d, J = 7.7 
Hz, 1H), 7.90 – 7.87 (m, 1H), 7.80 (s, 1H), 7.77 (ddd, J = 8.8, 7.3, 1.6 Hz, 2H), 7.69 (t, J 
= 8.1 Hz, 1H), 7.64 (t, J = 8.2 Hz, 1H), 7.52 (d, J = 8.5 Hz, 1H), 7.42 (dd, J = 8.1, 7.1 Hz, 
1H), 7.36 (d, J = 8.4 Hz, 1H), 7.28 (d, J = 8.4 Hz, 1H), 5.36 (s, 3H), 4.08 (s, 4H).;
 13
C 






156.38, 147.84, 136.09, 135.13, 134.96, 134.29, 134.20, 126.30, 124.54, 124.05, 120.32, 
120.09, 119.67, 119.30, 118.31, 118.28, 108.17, 107.89, 75.27, 56.88.; HRMS-ESI (m/z): 
[M]
+
 calcd for C29H17IO7, 604.0019; found [M+H]
 +
, 605.0117 (+ 3.3057 ppm).  
 Methyl Ether 52: To a dry flask equipped with a 
stir bar was added iodoxanthone 49 (100 mg, 0.16 
mmol) and DMF (2.50 mL). Potassium carbonate (35 
mg, 0.24 mmol, 1.5 equiv.) was added to the solution, 
which turned from a cloudy yellow to a dark homogeneous red. Methyl iodide (0.103 
mL, 1.65 mmol, 10 equiv.) was added to the solution at rt. The reaction was monitored by 
TLC analysis. Upon completion after several hours, the reaction was quenched with 
water and 1M HCl, and extracted with CH2Cl2. The combined organic layers were 
washed with brine, dried over sodium sulfate, and concentrated in vacuo to afford a crude 
solid which was purified by column chromatography (1:1 hexanes: ethyl acetate) to 
afford methyl ether 52 (90 mg, 88 %). M.p.= >220 ºC;  Rf = 0.15 (1:1 hexanes: ethyl 
acetate); IR (thin film): max  3184.6, 3067.2, 2929.3, 1633.3, 1586.6, 1466.1, 1405.5, 
1323.5, 1323.5, 1283.6, 1240.5, 1143.3, 1071.6, 988.0, 741.4 cm
-1;
 1
H NMR (500 MHz, 
Chloroform-d) δ 8.31 (dd, J = 8.0, 1.7 Hz, 1H), 8.07 (s, 1H), 7.92 (d, J = 7.7 Hz, 1H), 
7.88 (d, J = 7.7 Hz, 1H), 7.69 (d, J = 8.3 Hz, 1H), 7.67 – 7.62 (m, 1H), 7.47 (d, J = 8.4 
Hz, 1H), 7.40 – 7.34 (m, 2H), 7.31 (d, J = 8.4 Hz, 1H), 5.32 (s, 2H), 4.08 (s, 3H), 4.03 (s, 
3H).;
 13
C NMR (126 MHz, cdcl3) δ 183.89, 182.76, 175.12, 159.71, 159.44, 158.45, 






124.05, 122.58, 120.23, 119.88, 119.33, 118.34, 117.81, 116.07, 114.51, 88.59, 75.42, 
62.17, 56.89.; HRMS-ESI (m/z): [M]
+
 calcd for C30H19IO7, 618.0175; found [M+H]
 +
, 
619.0270 (2.5847 ppm).  
 Hydroquinone ether 54:  To a dry flask 
equipped with a stir bar was added methyl ether 52 (30 
mg, 0.0485 mmol) and THF (1 mL). A 1M solution of 
BH3 in THF (0.100 mL, 0.102 mmol, 2.1 equiv.) was 
added to the reaction and this was heated to 40ºC and monitored by TLC. After 1 h, this 
was cooled to rt and then the solvent was removed in vacuo to afford a crude solid. This 
was purified by column chromatography to provide hydroquinone 54 (11 mg, 36 %). This 
product was found to be unstable and readily oxidized to anthraquinone 49. Accordingly, 
hydroquinone 54 was used directly without full characterization. Rf = 0.40 (2:1 hexanes: 
ethyl acetate); 1H NMR (500 MHz, Chloroform-d) δ 9.44 (s, 1H), 8.37 (s, 1H), 8.31 (d, J 
= 8.2 Hz, 1H), 7.69 (s, 1H), 7.67 (dd, J = 7.3, 1.7 Hz, 1H), 7.65 – 7.59 (m, 2H), 7.45 – 
7.42 (m, 1H), 7.39 – 7.32 (m, 3H), 6.79 (d, J = 7.5 Hz, 2H), 6.70 (d, J = 7.4 Hz, 1H), 5.44 
(s, 2H), 4.15 (s, 3H), 4.06 (s, 3H); LRMS-ESI (UPLC) (m/z): [M]
+
 calcd for C30H21IO7, 
620.0332; found [M+H]
 +







Boronic acid 61: The boronic acid was prepared according 
to the literature procedure.
116
 The characterization data matched 
the literature values.  
Methylxanthone 102 and hydroxymethyl-
xanthone 3: These compounds were prepared according 
to the literature procedure.
43
 The characterization data 
agreed with the literature values.  
  
Naphthalene MIDA-Boronate 65: To a sealed tube 
with a stir bar was added boronic acid 61 (100 mg, 0.382 
mmol) and N-Methyliminodiacetic acid (62 mg, 0.412 mmol, 
1.1 equiv.) and DMF (3 mL). The tube was sealed and 
heated at 100 ºC for 18 h. The reaction was cooled to rt and 
the stir bar was removed. The solvent was evacuated in vacuo to dryness and resulting 
brownish solid was used without further purification (140 mg, 98 %). Rf = 0.10 (1:1 
hexanes: ethyl acetate); IR (thin film): max  2958.4, 1756.5, 1705.2, 1628.6, 1590.3, 





H NMR (500 MHz, Chloroform-d) δ 8.00 (d, J = 8.5 Hz, 1H), 7.69 (d, J = 
8.5 Hz, 1H), 6.76 – 6.64 (m, 2H), 3.90 (s, 3H), 3.90 (s, 3H), 3.73 (s, 3H), 2.91 (s, 2H), 
2.83 (s, 2H), 2.59 (s, 3H).
 









149.53, 130.78, 130.48, 120.16, 118.06, 105.70, 104.52, 77.42, 77.16, 76.91, 63.53, 
63.47, 56.49, 55.84, 47.82, 36.49, 31.41. HRMS-ESI (m/z): [M+H]
+
 calcd for 
C18H21BNO7, 374.1526; found [M+H]
 +
, 374.1524 (+ 0.5345 ppm).  
 Trifluoroborate 64: To a round bottom flask equipped with a stir bar was added a 
solution of potassium hydrogen fluoride (261 mg, 3.34 mmol, 3.5 
equiv.) in water (2 mL). To this solution was added boronic acid 
61 (250 mg, 0.954 mmol) in methanol (2.5 mL) at rt and stirred. 
A white precipitate formed as the reaction proceeded. After 
stirring for 1 h, the solvent was removed under vacuum and then dried under high 
vacuum to afford compound 64 as a white crystalline solid (250 mg, 81 % yield). The 
product was used without further purification. M.p.= >220 ºC; IR (thin film): max  
3438.8, 3400.4, 2958.4, 1705.2, 1626.6, 1595.4, 1445.7, 1409.7, 1409.3, 1339.1, 1260.1, 




H NMR (500 MHz, 
DMSO-d6) δ 6.86 (d, J = 8.3 Hz, 1H), 6.73 (d, J = 8.4 Hz, 1H), 5.85 (q, J = 8.3 Hz, 2H), 
3.01 (s, 3H), 2.97 (s, 3H), 2.81 (s, 3H).; 13C NMR (126 MHz, dmso) δ 158.92, 149.71, 
149.11, 132.29, 127.71, 120.79, 115.06, 105.67, 102.41, 
61.87, 56.88, 55.43.; Low Res-ESI (m/z): [M-K]
+
 calcd for 
C13H13BF3KO3, 285.0547; found [M-K]
 +
, 285.0912. 
 Xanthone Biaryl 62: To a dry round bottom flask 
equipped with a stir bar was added boronic acid 61 (256 







equiv.), potassium phosphate (432 mg, 2.04 mmol, 2.5 equiv.), palladium acetate (45 mg, 
0.0.204 mmol), and (S)-Phos (83 mg, 0.204 mmol). The flask was purged 3X with argon. 
Thoroughly degassed (3X F-P-T cycles) toluene (18.0 mL) was added to the flask and the 
solution was heated in an oil bath at 65 ºC for 24 h. Upon complete conversion of starting 
materials by TLC analysis, the reaction was cooled to rt and quenched with water (20 
mL). The organic layer was washed with 10 mL of 1M HCl, extracted with ethyl acetate 
3x, washed with brine, dried over sodium sulfate, and concentrated to afford a crude 
brownish solid. The crude solid was purified by column chromatography (4:1 hexanes: 
ethyl acetate to 1:1). The product 62 was recovered as an orange solid (180 mg, 48 % 
yield). M.p. = 125-127 ºC (ethyl acetate); Rf = 0.15 (1:1 hexanes: ethyl acetate); IR (thin 
film): max  3494.2, 3431.9, 3060.2, 2932.2, 2835.5, 1733.2,  1649.9, 1608.5, 1579.4, 
1477.5, 1466.1, 1436.1, 1411.5, 1378.6, 1348.4,  1287.6, 1258.3, 1224.2, 1195.9, 1076.9, 




H NMR (500 MHz, Chloroform-d) δ 12.92 (s, 1H), 
8.31 (dd, J = 8.0, 1.7 Hz, 2H), 8.17 (dd, J = 8.6, 0.7 Hz, 2H), 7.79 (ddd, J = 8.7, 7.1, 1.7 
Hz, 2H), 7.55 (d, J = 8.3 Hz, 2H), 7.42 (dd, J = 8.0, 7.1 Hz, 2H), 7.38 – 7.31 (m, 2H), 
7.29 (s, 2H), 6.84 (d, J = 8.5 Hz, 2H), 6.79 (d, J = 8.5 Hz, 2H), 4.50 (dd, J = 13.2, 4.1 Hz, 
2H), 4.37 (dd, J = 13.3, 8.6 Hz, 2H), 3.99 (s, 3H), 3.94 (s, 4H), 3.58 (s, 3H), 2.89 (ddd, J 
= 8.6, 4.1, 0.7 Hz, 2H) ; 
13
C NMR (100 MHz, cdcl3) δ 182.33, 159.33, 156.49, 156.04, 
153.78, 150.25, 150.14, 149.99, 135.72, 129.25, 129.14, 126.13, 126.07, 124.25, 121.55, 
120.84, 119.28, 118.95, 118.12, 108.13, 106.96, 106.54, 104.60, 77.41, 77.16, 76.91, 
63.84, 62.23, 57.15, 56.10. HRMS-ESI (m/z): [M+H]
+
 calcd for C27H22O7, 459.1444; 
found [M+H]
 +





 Xanthone Biaryl 103: To a dry round bottom flask 
equipped with a stir bar was added boronic acid 61 (420 
mg, 1.60 mmol, 1.2 equiv.), iodoxanthone 102 (470 mg, 
1.34 mmol, 1 equiv.), potassium phosphate (709 mg, 3.34 
mmol, 2.5 equiv.), palladium acetate (75 mg, 0.33 mmol), 
and (S)-Phos (137 mg, 0.33 mmol). The flask was purged 3X with argon. Thoroughly 
degassed (3X F-P-T cycles) 1,2-dichloroethane (18.0 mL) was added to the flask and the 
solution was heated in an oil bath at 65 ºC for 24 h. Upon complete conversion of starting 
materials by TLC analysis, the reaction was cooled to rt and quenched with water (20 
mL). This was washed with 10 mL 1M HCl and then extracted with CH2Cl2 3x and then 
washed with brine, dried over sodium sulfate, and concentrated to a crude brownish solid. 
The solid 103 was purified by column chromatography (10:1 hexanes: ethyl acetate to 4:1 
to 1:1). The product was recovered as an orange solid (310 mg, 52 % yield). M.p. = 134-
138 ºC (ethyl acetate); Rf = 75 (1:1 hexanes: ethyl acetate); IR (thin film): max  3000.8, 
2935.2, 2834.5, 1652.8, 1614.5, 1600.5, 1515.3, 1466.5, 1409.1, 1385.9, 1273.4, 1152.4, 




H NMR (500 MHz, Chloroform-d) δ 12.77 
(s, 1H), 8.19 (d, J = 8.0 Hz, 1H), 8.07 (d, J=10hz, 1H), 7.77 (d, J = 8.4 Hz, 1H), 7.65 (t, 
J= 5 Hz 1H), 7.40 (d, J = 8.5 Hz, 1H), 7.31 – 7.26 (m, 1H), 7.24 (d, J = 8.5 Hz, 1H), 6.84 
(s, 1H), 6.72 (d, J= 8.6hz, 1H), 6.68 (d, J = , 8.6 Hz, 1H), 3.89 (s, 6H), 3.52 (s, 3H), 2.14 
(s, 3H). ; 13C NMR (100 MHz, cdcl3) δ 180.87, 157.95, 155.13, 154.26, 153.03, 149.18, 






117.38, 116.78, 113.59, 106.71, 105.07, 103.05, 60.94, 55.80, 54.88, 20.66.. HRMS-ESI 
(m/z): [M+H]
+
 calcd for C27H22O6, 443.1495; found [M+H]
 +
, 443.1509 (+ 3.1592 ppm).  
Naphthoquinone Xanthone 68: Biaryl 62 (150 mg, 
0.327 mmol) was placed in a clean, dry flask equipped with 
a stir bar. CH2Cl2 (7.5 mL) was added to the flask and the 
reaction miture was cooled to -78 ºC. Boron tribromide (102 
uL, 1.08 mmol, 3.3 equiv.) was added to the flask slowly 
over 1 min. The reaction turned bright red color and was slowly warmed to 0ºC over a 
period of 3 h and monitored by TLC. Upon conversion of the starting material to a 
baseline spot, the reaction was quenched with methanol (5 mL) and then warmed to rt 
while stirring. Water was added to dilute the reaction mixture which was then extracted 
with ethyl acetate three times. The organic layer was washed with brine, dried over 
sodium sulfate, and concentrated to a dark crude solid. CH2Cl2 (10 mL) was added 
followed by activated MnO2 (200 mg, 7 equiv.) and the heterogeneous solution was 
stirred at rt. The reaction turned bright red and was monitored by TLC. Upon conversion 
to an orange spot by TLC, the reaction mixture was filtered through a layer of Celite, and 
washed with CH2Cl2, and concentrated to afford a red solid. Purification by column 
chromatography (5 % MeOH in CH2Cl2) afforded naphthoquinone 68 (85 mg, 63 %) as a 
red amorphous solid. Rf = 0.35 (5 % MeOH in CH2Cl2); IR (thin film): max  3457.7,  
3057.7, 2969.2, 2922.5, 2853.5, 1673.8, 1640.3, 1609.5, 1477.4, 1418.1, 1380.0, 1271.9, 










Chloroform-d) δ 13.01 (s, 1H), 12.38 (d, J = 1.0 Hz, 3H), 8.29 (d, J = 7.9 Hz, 1H), 7.82 – 
7.77 (m, 2H), 7.76 (dd, J = 7.7, 1.0 Hz, 2H), 7.67 (d, J = 7.7 Hz, 3H), 7.53 (d, J = 8.6 Hz, 
3H), 7.43 (t, J = 7.6 Hz, 2H), 7.32 (s, 1H), 7.00 (s, 2H), 4.62 (d, J = 14.1 Hz, 4H), 4.50 
(d, J = 14.1 Hz, 3H);
 13
C NMR (126 MHz, cdcl3) δ 190.75, 184.01, 182.04, 159.16, 
158.92, 156.16, 152.60, 146.82, 139.95, 139.83, 138.69, 136.43, 131.85, 130.53, 126.18, 
125.28, 125.14, 120.18, 119.23, 118.38, 115.41, 109.11, 102.17, 63.38;HRMS-ESI (m/z): 
[M+H]
+
 calcd for C24H14O7, 415.0818; found [M+H]
 +
, 415.0806 (+ 2.8910 ppm).  
 Naphthoquinone Xanthone 104: A similar procedure described above for 
napthoquinone 68 is used to prepare naphthoquinone 104 
from biaryl 103 (60 %) as a red amorphous solid. Rf = 0.40 
(1:1 hexanes: ethyl acetate); IR (thin film): max  3057.7,  
2969.2, 2922.5, 2853.5, 1673.8, 1640.3, 1609.5, 1477.4, 
1418.1, 1380.0, 1271.9, 1225.5, 1192.9, 1137.2, 1076.9,  




H NMR (500 MHz, Chloroform-d) δ 12.96 (s, 1H), 12.29 (s, 
1H), 8.28 – 8.26 (m, 1H), 7.75 (d, J = 7.6 Hz, 2H), 7.64 (d, J = 7.5 Hz, 1H), 7.49 (d, J = 
8.4 Hz, 1H), 7.40 (t, J = 7.5 Hz, 1H), 6.99 (s, 1H), 6.94 (s, 1H), 2.26 (s, 3H).; 13C NMR 
(126 MHz, cdcl3) δ 190.76, 184.34, 182.05, 159.61, 159.19, 156.30, 156.08, 147.97, 
139.82, 139.36, 138.84, 135.70, 132.07, 131.55, 126.16, 124.32, 120.77, 119.12, 118.03, 
117.72, 115.33, 108.33, 107.25, 77.41, 77.16, 76.90, 21.43. HRMS-ESI (m/z): [M+H]
+
 
calcd for C24H14O6, 399.0869; found [M+H]
 +






Methoxynaphthoquinone Biaryl 67: To a flask equipped with a stir bar was 
added biaryl 62 (50 mg, 0.109 mmol) and acetone (2.0 
mL). Silver (I) oxide (126 mg, 0.545 mmol, 5.00 equiv.) 
was added followed by a 40 % aq. HNO3 solution (1.0 
mL) at 0ºC which immediately dissolved the silver to 
provide a clear solution. The reaction was warmed to rt 
which turned bright red after 20 minutes. Upon completion by TLC analysis (30 min), the 
reaction was quenched with water (5 mL) and extracted with CH2Cl2. The organic layer 
was washed with water, brine, dried over sodium sulfate, and concentrated in vacuo to 
afford crude 67 (31 mg, 65 %). The crude solid was used without further purification. Rf 
= 0.25 (1:1 hexanes: ethyl acetate); IR (thin film): max  3444.1, 3064.1, 2954.6, 2929.7, 
2858.5, 1663.8, 1642.7, 1608.5, 1581.5, 1563.8, 1470.5, 1470.1, 1430.5, 1367.3, 1309.5, 





H NMR (500 MHz, Chloroform-d) δ 12.99 (s, 1H), 8.28 (dd, J = 7.9, 1.7 Hz, 
1H), 8.03 (d, J = 7.9 Hz, 1H), 7.80 (ddd, J = 8.7, 7.1, 1.7 Hz, 1H), 7.68 (d, J = 7.9 Hz, 
1H), 7.57 – 7.51 (m, 1H), 7.43 (ddd, J = 8.1, 7.1, 1.1 Hz, 1H), 7.30 (s, 1H), 6.96 (d, J = 
10.3 Hz, 1H), 6.92 (d, J = 10.4 Hz, 1H), 4.49 (d, J = 0.6 Hz, 1H), 4.41 – 4.34 (m, 1H), 
3.62 (s, 3H).; 13C NMR (126 MHz, cdcl3) δ 184.75, 184.36, 182.26, 158.90, 158.00, 
156.55, 156.43, 149.65, 140.55, 138.26, 137.18, 137.04, 136.02, 134.00, 126.13, 124.87, 






61.91. HRMS-ESI (m/z): [M+H]
+
 calcd for C25H16O7, 429.0974; found [M+H]
 +
, 
429.0961 (+ 3.0296 ppm).  
 Methoxynaphthoquinone Biaryl 105: To a flask equipped with a stir bar was 
added biaryl 103 (50 mg, 0.111 mmol) and acetone (2.0 
mL). Silver (I) oxide (130 mg, 0.565 mmol, 5.00 equiv.) 
was added followed by a 40% aq. HNO3 solution (1.0 mL) 
at 0ºC which immediately dissolved the silver to provide a 
clear solution. The reaction was warmed to rt and turned 
bright red after 20 minutes. Upon completion by TLC analysis (30 min), the reaction was 
quenched with water (5 mL) and extracted with CH2Cl2. The organic layer was washed 
with water, brine, dried over sodium sulfate, and concentrated in vacuo to afford crude 
105. The crude oil was purified by column chromatography to provide 105 as a bright 
orange solid (30 mg, 64 %). M.p.= >220ºC; Rf =0.40 2:1 hexanes: ethyl acetate); IR (thin 
film): max  3064.1, 2954.6, 2929.7, 2858.5, 1663.8, 1642.7, 1608.5, 1581.5, 1563.8, 
1470.5, 1470.1, 1430.5, 1367.3, 1309.5, 1268.9, 1223.9, 1150.7, 1135.9, 1111.2, 1057.9, 




H NMR (500 MHz, Chloroform-d) δ 
12.94 (s, 1H), 8.29 (ddd, J = 8.0, 1.7, 0.5 Hz, 1H), 8.03 (d, J = 7.9 Hz, 1H), 7.78 (ddd, J = 
8.7, 7.1, 1.7 Hz, 1H), 7.64 (d, J = 7.8 Hz, 1H), 7.51 (ddd, J = 8.5, 1.1, 0.5 Hz, 1H), 7.42 
(ddd, J = 8.1, 7.2, 1.1 Hz, 1H), 7.00 – 6.88 (m, 3H), 3.63 (s, 3H), 2.21 (d, J = 0.7 Hz, 
3H).;
 13
C NMR (126 MHz, cdcl3) δ 184.96, 184.54, 182.08, 158.88, 158.64, 156.34, 






123.05, 120.79, 118.92, 118.06, 108.35, 107.12, 61.80, 21.55. HRMS-ESI (m/z): [M+H]+ 
calcd for C25H16O6, 413.1025; found [M+H]
 +
, 413.1022 (+ 0.7262 ppm).  
 Silyldienyl ether 56: This was prepared according to 
literature precedent and matched the literature reported values.
114 
Anthraquinone Methylxanthone Biaryl 91: To a dry 
flask equipped with a stir bar was added a 
solution of naphthoquinone 104 (32 mg, 0.0803 
mmol) in minimal amount of CH2Cl2. 
Silyldienyl ether 56 (75 mg, 0.402 mmol, 5 
equiv.) was added to the reaction mixture and 
then the flask was closed with a septum with a 22-gauge needle open to the air. The 
reaction was heated to 60ºC in an oil bath to evaporate the CH2Cl2 leaving the reaction 
stirring neat for 3 h. Upon conversion of the starting naphthoquinone 104 by TLC 
analysis, the reaction was removed from the heat and cooled to rt. Methanol was added (1 
mL) followed by 1M aq. HCl (1 mL) and the reaction was stirred for 1 h at rt open to the 
air. Upon completion by TLC analysis, water (2 mL) was added to dilute the mixture and 
then extracted with CH2Cl2. The organic layer was washed with brine, dried over sodium 
sulfate, and concentrated to a crude oil. This was purified by column chromatography 
(1:1 hexanes: ethyl acetate) to provide 91 as an orange solid (20 mg, 51 %). M.p. = >220 
ºC  Rf = 0,70 (1:1 hexanes: ethyl acetate); IR (thin film): max  3474.6, 2925.2, 2854.5, 











H NMR (500 MHz, Chloroform-d) δ 12.97 (s, 1H), 12.53 (s, 1H), 
12.02 (s, 1H), 8.29 (dd, J = 7.9, 1.7 Hz, 1H), 7.96 (d, J = 7.7 Hz, 1H), 7.77 (ddd, J = 8.6, 
7.2, 1.8 Hz, 1H), 7.70 (s, 1H), 7.67 (d, J = 7.7 Hz, 1H), 7.51 (d, J = 8.2 Hz, 1H), 7.41 
(ddd, J = 8.0, 7.1, 1.1 Hz, 1H), 7.12 (s, 0H), 6.97 (d, J = 0.8 Hz, 1H), 2.49 (s, 2H), 2.29 
(s, 3H).; 
13
C NMR (126 MHz, cdcl3) δ 192.90, 182.01(2), 162.89, 160.49, 159.18, 
156.27, 156.03, 149.55, 147.98, 139.74, 135.66, 133.47, 131.99, 126.13, 124.53, 124.29, 
121.53, 120.76, 119.81, 118.01, 116.25, 113.93, 108.30, 107.24, 105.14, 103.22, 77.41, 
77.16, 76.91, 22.44, 21.44.. HRMS-ESI (m/z): [M+H]
+
 calcd for C29H18O7, 479.1131; 
found [M+H]
 +
, 479.1133 (+ 0.4174 ppm).
 
 Anthraquinone Hydroxymethylxanthone Biaryl 60: To a dry flask equipped 
with a stir bar was added a solution of 
naphthoquinone 68 (32 mg, 0.0803 mmol) in a 
minimal amount of CH2Cl2. Silyldienyl ether 56 
(75 mg, 0.402 mmol, 5 equiv.) was added to the 
reaction mixture and the flask was closed with a 
septum with a 22-gauge needle open to the air. The reaction was heated to 60 ºC in an oil 
bath to evaporate the CH2Cl2 and the reaction was stirred neat for 3 h. Upon conversion 
of the starting naphthoquinone 68 by TLC analysis, the reaction was cooled to rt. 
Methanol was added (1 mL) followed by 1M aq. HCl (1 mL) and the solution was stirred 
for 1 h at rt open to air. Upon completion by TLC analysis, water (2 mL) was added to 






with brine, dried over sodium sulfate, and concentrated to a crude oil. The crude product 
was purified by column chromatography (1:1 hexanes: ethyl acetate) to provide 60 as an 
orange solid (20 mg, 51 %). M.p. = >220 ºC; Rf = 0.25 (1:1 hexanes: ethyl acetate); IR 
(thin film): max  3438.8,  2952.2, 2850.5, 1718.1, 1658.8, 1610.5, 1435.5, 1382.6, 1268.9, 




H NMR and 
13
C NMR of 60 
were taken on the tetra-acetate due to poor solubility of 68 in all attempted NMR 
solvents.  
1
H NMR of tetra-acetate (500 MHz, Chloroform-d) δ 8.28 (d, J = 8.1 Hz, 1H), 
8.26 (dd, J = 8.1, 1.7 Hz, 1H), 8.06 (dd, J = 1.8, 0.9 Hz, 1H), 7.74 (ddd, J = 8.7, 7.2, 1.7 
Hz, 1H), 7.67 (d, J = 7.9 Hz, 1H), 7.57 (s, 1H), 7.49 (dd, J = 8.5, 1.0 Hz, 1H), 7.39 (t, J = 
7.7 Hz, 1H), 7.24 (d, J = 1.0 Hz, 1H), 4.94 (d, J = 18.8 Hz, 2H), 2.53 (s, 3H), 2.41 (s, 
3H), 2.18 (s, 3H), 2.14 (s, 3H).; 
13
C NMR (126 MHz, cdcl3) δ 189.05, 182.13, 181.78, 
177.02, 175.48, 173.34, 170.22, 169.62, 157.24, 156.26, 155.49, 150.37, 148.21, 147.84, 
146.67, 135.25, 134.81, 134.30, 131.00, 126.87, 126.13, 124.58, 123.48, 122.48, 117.79, 
63.08, 21.90, 21.22, 20.94.: HRMS-ESI (m/z): [M+H]
+
 calcd for C29H18O8, 495.1080; 
found [M+H]
 +
, 495.1060 (+ 4.0395 ppm). 
 Anthraquinone Methylxanthone Biaryl 
106: A similar procedure to that described above 
was used to prepare 60 from 
methoxynaphthoquinone 105 (30 mg) and 
silyldienyl ether 56 (68 mg) in 48 % yield. Rf = 






2924.6, 2852.3, 1717.3, 1639.3, 1608.9, 1477.5, 1434.1, 1381.4, 1340.9, 1264.3, 1223.1, 




H NMR (500 MHz, 
Chloroform-d) δ 13.42 (s, 1H), 12.94 (s, 1H), 8.28 (dd, J = 8.0, 1.3 Hz, 1H), 7.89 (d, J = 
7.7 Hz, 1H), 7.84 – 7.80 (m, 1H), 7.78 – 7.74 (m, 1H), 7.62 (dd, J = 7.7, 0.5 Hz, 1H), 
7.53 – 7.46 (m, 1H), 7.40 (ddd, J = 8.1, 7.2, 1.1 Hz, 1H), 7.17 (s, 0H), 6.95 (d, J = 0.7 
Hz, 1H), 4.06 (s, 3H), 2.54 (s, 1H), 2.28 (s, 2H).; 
13
C NMR (126 MHz, cdcl3) 
13
C NMR 
(126 MHz, cdcl3) δ 189.08, 183.03, 182.04, 161.20, 160.57, 159.14, 156.29, 155.96, 
148.24, 147.72, 138.48, 135.65, 135.59, 132.60, 131.94, 126.13, 124.22, 121.15, 120.79, 
118.78, 118.66, 118.55, 118.46, 118.00, 117.35, 108.27, 107.29, 56.76, 22.58, 21.42.; 
HRMS-ESI (m/z): [M+H]
+
 calcd for C30H20O7, 493.1287; found [M+H]
 +
, 493.1270 (+ 
3.4474ppm). 
 Methoxyanthraquinone Biaryl 70: A similar procedure to that described above 
was used to prepare 60 from 
methoxynaphthoquinone 67 (35 mg) and 
silyldienyl ether 56 (76 mg) in 30 % yield. Rf = 
0.30 (1:1 hexanes: ethyl acetate); IR (thin film): 
max  3497.9, 2956.2, 2925.7, 2854.5, 1722.2, 
1632.8, 1609.5, 1468.5, 1380.9, 1263.9, 1151.9, 1040.9, 1018.1, 843.4,  755.2 cm
-1
: We 




C signals in proximity of the biaryl bond due to 
the hindered rotation of 70. 
1
H NMR (500 MHz, Chloroform-d) δ 13.02 (s, 1H), 12.83 (s, 






(ddd, J = 8.8, 7.2, 1.7 Hz, 1H), 7.72 (dd, J = 7.9, 1.0 Hz, 1H), 7.63 (dd, J = 16.4, 1.6 Hz, 
1H), 7.56 (d, J = 8.6 Hz, 1H), 7.44 (t, J = 7.7 Hz, 1H), 7.33 (d, J = 3.2 Hz, 1H), 7.12 (dd, 
J = 13.7, 1.7 Hz, 1H), 4.55 (dd, J = 14.0, 8.3 Hz, 1H), 4.40 (dd, J = 13.9, 4.8 Hz, 1H), 
3.68 (d, J = 2.7 Hz, 3H), 2.47 (s, 3H).; 
13
C NMR (126 MHz, cdcl3) δ 188.10, 187.34, 
182.13, 162.83, 162.38, 158.80, 156.32, 149.50, 148.93, 148.17, 138.69, 138.17, 137.40, 
135.86, 134.40, 132.45, 126.01, 124.63, 124.38, 124.07, 123.39, 120.73, 120.61, 120.33, 
118.03, 107.92, 106.24, 63.05, 61.83, 22.38; HRMS-ESI (m/z): [M+H]
+
 calcd for 
C30H20O8, 509.1236; found [M+H]
 +
, 509.1236 (+ 0.000 ppm). 
Hydroxyanthraquinone 71: To a dry flask 
equipped with a stir bar was added biaryl 70 (15.o 
mg, 0.295 mmol) and CH2Cl2 (0.500 mL). The 
solution was cooled to 0ºC followed by addition of 
aluminum trichloride (15 mg, 0.118 mmol, 4 
equiv.). The reaction was stirred and allowed to warm to rt. After 6 h of stirring at rt, the 
reaction was quenched with 1M HCl (1 mL) and 5 % Rochelle’s salt solution (1 mL) and 
diluted with CH2Cl2. The mixture was stirred until a clear separation of organic and 
aqueous layers formed. The mixture was extracted with CH2Cl2, washed with brine, dried 
over sodium sulfate, and concentrated in vacuo to afford a crude orange solid. The solid 
was purified by column chromatography (1:1 hexanes: ethyl acetate) to provide 71 as an 
orange solid (6 mg, 41%). M.p.= > 220ºC;  Rf = 0.50 (1:1 hexanes: ethyl acetate); IR 










H NMR (500 MHz, 
Chloroform-d) δ 13.19 (s, 1H), 13.04 (s, 1H), 12.62 (s, 1H), 8.30 (dd, J = 7.9, 1.7 Hz, 
1H), 7.97 (d, J = 7.7 Hz, 1H), 7.80 (ddd, J = 8.7, 7.2, 1.7 Hz, 1H), 7.73 – 7.70 (m, 1H), 
7.70 – 7.68 (m, 1H), 7.54 (d, J = 8.5 Hz, 1H), 7.43 (ddd, J = 8.1, 7.1, 1.1 Hz, 2H), 7.34 
(s, 1H), 7.16 (dd, J = 1.7, 0.9 Hz, 1H), 4.80 (d, J = 5.6 Hz, 1H), 4.68 – 4.62 (m, 1H), 4.52 
(dd, J = 14.2, 7.0 Hz, 1H), 2.49 (s, 3H); HRMS-ESI (m/z): [M+H]
+
 calcd for C29H18O8, 
495.1080; found [M+H]
 +
, 495.1096 (+ 3.2316 
ppm). 
Anthraquinone Chloroxanthone Biaryl 
76: To a reaction flask equipped with a stir bar 
was added hydroxymethyl anthraquinone-xanthone biaryl 60 (10 mg, 0.02 mmol) in 
CH2Cl2 (1 mL). DMAP (~1 mg) followed by pyridine (3.3 L, 0.0404 mmol, 2 equiv.) 
was added to the solution at 0ºC. Methanesulfonyl chloride (30.4 uL of 1M solution in 
CH2Cl2 , 0.0303 mmol, 1.5 equiv.) was added dropwise at 0ºC and then the reaction was 
allowed to warm to rt. The reaction was stirred for 48 h at rt. The reaction was quenched 
with water and then extracted with CH2Cl2, washed with brine, dried over sodium sulfate, 
and concentrated in vacuo to a crude oil. The oil was purified by column chromatography 
(4:1 CH2Cl2: ethyl acetate) to afford chloride 76 as an amorphous solid (3 mg, 30%).. Rf 
= 0.40 (4:1 CH2Cl2: ethyl acetate). 
1
H NMR (500 MHz, Chloroform-d) δ 13.06 (s, 1H), 
12.55 (s, 1H), 11.98 (s, 1H), 8.30 (dd, J = 8.0, 1.7 Hz, 1H), 7.98 (d, J = 7.7 Hz, 1H), 7.81 






7.52 (m, 1H), 7.44 (ddd, J = 8.1, 7.2, 1.1 Hz, 1H), 7.28 (s, 1H), 7.13 (dd, J = 1.7, 0.9 Hz, 
1H), 4.56 (dd, J = 12.3, 0.6 Hz, 1H), 4.41 (d, J = 12.3 Hz, 1H). LRMS-ESI (UPLC) 
(m/z): [M]
+
 calcd for C29H17ClO7, 512.0663; found [M+H]
 +
, 513.3  
Iodo-Acremonidin E: To a reaction flask equipped with a stir bar was added 
acremonidin E (15 mg, 0.471 mmol). CH2Cl2 (0.5 mL) and 
MeOH (0.2 mL) were added to the flask, followed by 
calcium carbonate (14 mg, 0.141 mmol, 3 equiv.) and this 
mixture was stirred at 0ºC. Benzyltrimethylammonium dichloroiodate (18 mg, 0.0518 
mmol, 1.1 equiv.) was added to the reaction and the reaction was warmed to rt. The 
reaction was stirred for 3 days at rt. The reaction was quenched with water after this time 
and neutralized with 1M HCl. This mixture was extracted with CH2Cl2, washed with 
water and brine, dried over sodium sulfate, and concentrated in vacuo to a crude solid. 
The solid was purified by column chromatography (3:1 hecanes: ethyl acetate) to afford 
iodide (12 mg, 57%). Rf: 0.40 (3:1 hexanes: ethyl acetate).; IR (thin film): max  3416.3, 
3052.8, 2954.1, 2913.4, 2851.0, 2832.3, 1723.8, 1674.7, 1612.2, 1573.9, 1462.2, 1391.9, 
1296.4, 1197.1, 1051.0, 1034.5, 1002.1, 822.6, 760.0 cm
-1; 1H NMR (500 MHz, DMSO-
d6) δ 13.72 (s, 1H), 9.67 (s, 1H), 6.96 (d, J = 8.9 Hz, 1H), 6.84 (d, J = 8.8 Hz, 1H), 6.32 
(s, 1H), 3.58 (s, 3H), 2.32 (s, 3H).; 
13C NMR (126 MHz, dmso) δ 199.23, 167.73, 161.58, 
161.50, 160.11, 151.13, 149.96, 145.54, 130.57, 122.20, 117.81, 112.36, 109.11, 108.69, 
51.98, 28.71.; HRMS-ESI (m/z): [M]
+
 calcd for C16H13IO7, 443.4706; found [M]
 +
, 






















































































































































Synthesis of 2-2’-Anthraquinone Dimers 
4.1 Isolation of Anthraquinone Dimer Natural Products  
 We have previously described the significance of anthraquinones both in the 
biosynthesis of a wide variety of related structures and as natural products themselves. 
Many anthraquinone natural products have been isolated from soil samples located in 
Japan (Figure 4.1). The anthraquinone dimer chrysotalunin (1) was originally isolated by 
McGrath in 1970 from Japan.
144
 Since the isolation, it has been determined to be 
universally present in Japanese soils.
145
 This compound was recently isolated from 
Japanese volcanic soil along with the anthraquinones chrysophanol (2), physcion (3), the 
dimer biphyscion (4), and a previously unnamed compound, hinakurin (5). Interestingly, 
chrysophanol (2) and physcion (3) have been isolated from fungi and higher plant 
species, but the dimeric chrysotalunin (1) and hinakurin (5) have only been isolated from 
soil extracts. It is possible that these dimers are produced from microorganisms in the 
soil, which occur in different environments all over the world.
146 
Hauser has reported the 
first synthesis of (+/-)-biphyscion (4) employing a symmetrical Ullman product (Scheme 
4.1). Other syntheses of dimeric anthraquinones by Brimble (Scheme 4.2) and Kozlowski 





Figure 4.1: Recently Isolated Anthraquinone Natural Products 1-5. 
 
4.2 Literature Reported Syntheses of Anthraquinone Dimer Natural Products 
4.2.1 Hauser’s Synthesis of (+/-)-Biphyscion (4) via Ullman Coupling 
 Although many anthraquinone dimer natural products have been isolated, there 
remain few that have been synthesized. Hauser and coworkers reported the synthesis of 
(+/-)-biphyscion (4) through a novel two-directional annulation process from a hindered 
biaryl constructed by an Ullman reaction.
147
 Aryl iodide 6 was readily prepared from 
commercially available materials and was subjected to copper-bronze at 220 ºC to afford 
Ullman product 7 (72 %) (Scheme 4.1). The hindered Ullman product 7 was then 
deprotonated with LDA and quenched with bis-thiophenol to provide an intermediate 
thioether biaryl dimer. The thioether was then hydrolyzed under acidic conditions and 
oxidized with m-CPBA to provide the phenylsulfonyl isobenzofuranone biaryl dimer 8 as 
a mixture of diastereomers. The mixture was then deprotonated adjacent to the 





afford the protected anthraquinone dimer 10 (23 %). This compound was selectively 
deprotected to afford the configurationally stable compound (+/-)-biphyscion (4). This 
report represented the first literature example of multi-directional synthesis toward an 
anthraquinone dimer natural product.  









4.2.2 Brimble’s Synthesis of Dimeric Pyranonaphthoquinones Employing A Double 
Annulation/Oxidative Rearrangement Strategy 
 In a related strategy toward dimeric pyranonaphthoquinones, Brimble and 
coworkers developed a process wherein they prepared a symmetrical naphthol dimer and 
built out in two directions.
148
 Suzuki coupling of aryl bromide 11 and boronic acid 12 
provided the symmetrical naphthol 13 (Scheme 4.2). Benzyl deprotection followed by 
acetate reprotection afforded diacetate 14 which was subjected to thermal Fries 
conditions to afford diacetophenone 15. This compound was oxidized to the bis-
acylnaphthoquinone 16. Following an addition of TMS-siloxyfuran 17 and exposure to 
silica gel provided the double Diels-Alder adducts 18 and 19 as a 1:1 mixture (51 %). 
The mixture was subsequently oxidized with 4 equivalents of CAN in aqueous 
acetonitrile to afford a 1:1 mixture of hemiacetals, which were reduced by palladium on 
carbon in an atmosphere of hydrogen along with the -lactone moiety. The diacid was 
then methylated in situ with diazomethane to afford the final 1:1 mixture of dimeric 
pyranonaphthoquinones 20 and 21. This work describes the first synthesis of dimeric 












4.2.3: Kozlowski Synthesis of Bisanthraquinone (S)-Bisoranjidiol (27) and Analogs 
  Another class of related biaryl natural products is the 1-1’-linked axially chiral 
symmetrical bisanthraquinones.
149
 In 2012, Kozlowski reported the attempted biomimetic 
oxidative coupling of hydroxy-anthraquinone 22 to form dimer 23 using copper catalyst 
24. However, this reaction does not proceed due to the high oxidation potential of the 
anthraquinone moiety (Scheme 4.3).
150
 The authors altered their synthetic approach to 
utilize the observed enantioselective biaryl coupling of naphthol 25a/b under similar 
conditions to afford 8-8’-dihydroxylated binaphthol 26 in moderate yield and good 
enantioselectivity. The ee of 25a/b could be increased through recrystallization to >99 % 
in 78 % yield. Other catalyst systems were attempted on substrates lacking the methyl 
ester, however these reactions gave poor conversion and selectivity. This example 
represents the only reported case to date of an enantioselective coupling of a 2-naphthol 
derivative with significant steric hindrance peri to the site of C-C bond formation. This 
synthetic strategy was then implemented for the first enantioselective synthesis of the 





Scheme 4.3: Kozlowski’s Attempted and Successful Asymmetric Oxidative Couplings 
 
(S)-Bisoranjidiol (27) has been shown to act as a photosensitizer and generate excited 
singlet oxygen and the ground state radical anion upon irradiation with light. More 
recently 27 has been shown to be photodynamically active toward cancer cells, which 
necessitates further study.
150 
Enantiopure naphthol 26b was methyl protected, followed 
by removal of the methyl ester through a reduction/oxidation/deformylation sequence 
resulting in 63 % yield of protected naphthol 28 over four steps. Benzyl hydrogenolysis 











bis-para-quinone 29 in 63 %. Initial attempts to install the bis-anthraquinone moiety 
utilizing silyl diene 30 in a Lewis acid-directed (e.g. ZnCl2) Diels-Alder reaction resulted 
in the decomposition of 29 and low yields. Alternatively, halogens are also known to 
direct reactions between para-quinones and vinyl ketene acetals.
151
 A bromine moiety 
was installed via refluxing 29 in buffered acetic acid (95 %). This led to a 1:1 mixture of 
the desired product 31 and undesired 32. After optimization, it was determined that these 
isomers needed to be separated for successful cycloaddition with diene 30. Upon heating 
dibromoquinone 31 with diene 30 in toluene over two days, full conversion to the 
cycloadduct was observed. The adduct was immediately oxidized to the anthraquinone on 
silica gel. Subsequent deprotection with boron tribromide gave (S)-bisoranjidiol (27) in 
60 % yield over two steps. Dibromoquinone 32 was treated under the same conditions, 
but this reaction occurred much slower and resulted in some decomposition. The authors 
attribute this difference to the large steric interaction of the so-called ‘out-in’ arrangement 
of the Diels-Alder adduct of 30 and 32 versus the corresponding ‘out-out’ adduct of 30 
and 31. Further bisanthraquinone dimer analogs 34 and 35 were prepared through a 
similar synthetic route, expanding the number of potentially photodynamically active 
anthraquinone dimers. This route was the first enantioselective and most efficient 
synthesis reported for this family,
150
 which was highlighted by a selective 2-naphthol 







4.3 Synthesis of 2,2’-Linked Anthraquinone Dimers: Chrysotalunin (1) 
 In the previous chapter, we recovered a homodimerization product derived from a 
protected naphthol boronic acid during a Suzuki reaction (Table 3.2, Scheme 3.17). We 
later found literature reported conditions that could completely convert boronic acid 36 to 
its homodimer 37 (Scheme 4.5). Since we were able to use the protected naphthol moiety 
as a precursor to anthraquinone derivatives, we wanted to determine if it would be 
possible for 37 to be an intermediate of various anthraquinone dimers. A similar strategy 
was employed by Brimble and coworkers to access dimeric pyranonaphthoquinones from 
a symmetrical bis-naphthol through a double annulation/oxidative rearrangement 
(Scheme 4.3).
148
 To accomplish this goal, we set out to optimize the homodimerization of 
the boronic acid 36 and develop a route to the anthraquinone dimer chrysotalunin (1).  
Scheme 4.5: Initial Homodimerization of Boronic Acid 36 
 
 After searching for related processes in the literature, we chose several catalysts 
that may mediate the desired reaction. After an initial screen (entries 1-3, Table 4.1), we 
determined that Pd(OAc)2 was an effective catalyst resulting in full conversion of acid 36 
in less than an hour at room temperature. Although the product ratio was favorable, the 
isolated yield was still low (20-30 %). We then screened different polar solvent (entries 





optimal with respect to conversion and the product ratio, but the isolated yield remained 
low. When screening for conditions, the reactions were concentrated, then filtered  
Table 4.1: Catalyst and Solvent Screen to Optimize Formation of Homodimer 37. 
 
through Celite, and finally purified by column. However, when we scaled up the optimal 
condition and performed an aqueous work up after concentration, we observed the 





product mixture was determined to be a mixture of the over oxidized dimer and monomer 
byproducts by mass spectrometry.  
Ultimately, we elected to prepare homodimer 37 through Suzuki coupling of 
boronic acid 36 and aryl bromide 39 (Scheme 4.6). We found that 15 % Pd(PPh3)4 and 
2.5 equiv. of potassium phosphate in DMF at 90 ºC for 20 h cleanly provided compound 
37 in 85 % yield.  
Scheme 4.6: Suzuki Cross Coupling of Bromide 39 and Boronic Acid 36. 
 
After developing a reliable condition to prepare homodimer 37, we oxidized the 
protected hydroquinone with silver (I) oxide and nitric acid to provide the protected 
naphthoquinone dimer 40 in 65 % yield (Scheme 4.7). Deprotection of the remaining 
methoxy group was unsuccessful with BBr3 or BCl3 due to formation of halogenated 
byproducts. We found that four equivalents of AlCl3 in methylene chloride afforded the 
deprotected naphthoquinone 41 in 76 % yield. It is worth noting that we observed 
decomposition of naphthoquinone 41 if more than four equivalents of AlCl3 were used.  





70 ºC for 12 h. Subsequent treatment with 1M HCl in methanol hydrolyzed the ketal and 
induced aromatization to anthraquinone dimers 43 in 42 % yield. We observed a minor 
byproduct derived from a mono Diels-Alder reaction with diene 42 and 40. Analogously,  
Scheme 4.7: Formation of Naphthoquinone Dimers 40 and 41 and Double Diels-Alder 
Reactions to Anthraquinone Dimers 43 and 1. 
 
we added silyldienyl ether 42 to naphthoquinone dimers 41 and heated in toluene at 70 ºC 





induced aromatization to afford crude chrysotalunin (1). Due to insolubility and ease of 
purification, chrysotatulum (1) was converted to the corresponding tetra-acetate 44 for 
characterization (35 %, 3 steps). Tetra-acetate 44 matched the literature reported 
1
H NMR 
and mass spectral data.
144
 With access to chrysotalunin (1) in hand, we plan to send 1 for 
biological testing at the NCI in their 60 human tumor cell line assay. 
4.4 Proposal for the Synthesis of the Dimeric Anthraquione-Derived Torrubiellin A  
4.4.1 Isolation and Literature Background 
 With the synthesis of the 2,2’-linked anthraquinone dimer chrysotalunin (1) in 
hand, we envisioned employing a similar strategy for related natural products. 
Torrubiellin A (45) was recently isolated by Isaka and coworkers from the arthropod-
pathogenic fungal strain Torrubiella sp. BCC 28517 along with known chrysophanol (2) 
and aloe-emodin (46) (Figure 4.2a).
152
 The coisolation of anthraquinones chrysophanol 
(2) and aloe-emodin (46) suggest that torrubiellin A (45) is derived from two 
anthraquinone units. The rare C-4-C-5’ and C-11-C-10’ linkage of 45 is found only in the  
Figure 4.2: a) Anthraquinone-Derived Natural Products Isolated from Fungus 






related rubellin family of natural products, highlighted by rubellin B (47) (Figure 
4.2b).
153
 Torrubiellin A (45) exhibits moderate cytotoxicity in various human cancer cell 
lines (KB, 2.78 g/mL: NCI-H187, 7.05 g/mL; MCF-7, 16.9 g/mL). Interestingly, 
rubellin B (47) exhibits light-dependent antibacterial activity (i.e. Staphyloccus aureus 
MIC of >1000 (dark) vs 8 (light)). The authors attribute the photodynamic activity to the 
occurrence of hydroxyanthraquinone tautomerism in the presence of light, however no 
intermediates have been isolated.
153
 Torrubiellin A (45) has not been tested for such 
photodynamic activity. 
4.4.2 Proposed Retrosynthesis of Torrubiellin A (45) 
 Due to the fact that monomer anthraquinones chrysophanol (2) and aloe-emodin 
(46) were coisolated with torrubiellin A (45), it is likely that 45 is derived from a 
dimerization of two anthraquinones followed by a structural rearrangement. We propose 
compound 48, a C-4-C-5’ linked anthraquinone dimer, to be the precursor to torrubiellin 
A (45) (Scheme 4.8), which will be discussed further below. Intermediate 48 could arise 
from Diels-Alder cycloaddition of silyldienyl ether 42 and hydroxynaphthoquinone-
anthraquinone biaryl 49. This biaryl intermediate could be prepared from an analogous 
Diels-Alder cycloaddition of 42 and hydroxynaphthoquinone-naphthalene biaryl 50. The 
regioselectivity of both of the proposed Diels-Alder cycloadditions could be controlled 
through intramolecular H-bonding of the phenol moiety, similar to that previously 
described (c.f. Scheme 3.14, Scheme 4.7). Compound 50 could be assembled through a 
Suzuki coupling between known fragments bromonaphthoquinone
154
 51 and boronic acid 
52 derived from the corresponding known chloronaphthalene.
155





bond of 50 may have a hindered rotation, thus potentially allowing for an enantioselective 
Suzuki coupling with chiral ligands described previously (c.f. Figure 3.7).
123, 133
  
Scheme 4.8: Proposed Retrosynthesis of Torrubiellin A (45) 
 
 We believe that dimeric anthraquinone intermediate 48 may be converted to 
torrubiellin A (45) via a photo-mediated rearrangement (Scheme 4.9). Upon irradiation 
with light, compound 48 may form the diradical intermediate 53 which could abstract a 
hydrogen from the nearby benzylic position of the anthraquinone.  A DFT-optimized low 
energy conformer of anthraquinone dimer 48 illustrates the bisected conformation about 
the biaryl bond (dihedral angle of 89º) and displays the relative proximity (3.12 Å) of the 





54 may then undergo a Michael addition to form the five-membered ring and establish 
the syn relationship of the new carbon-carbon and carbon-hydrogen bonds. 
Tautomerization of diradical 55 may afford intermediate 56 which could be reduced to 
provide torrubiellin A (45).  







Figure 4.3: DFT Optimized Low Energy Conformer of 48 
 
4.5: Conclusion 
 In this chapter, we introduced a family of dimeric anthraquinone natural products 
isolated from soil sources all over the world. An initial total synthesis of (+/-)-biphyscion 
(4) by Hauser and coworkers was summarized, which was highlighted by an Ullman 
coupling/dimerization and a two-directional annulation strategy. We also described work 
by Brimble and coworkers and Kozlowski and coworkers, which consisted of the 
synthesis of dimeric pyranonaphthoquinones 20 and 21 and the enantioselective synthesis 
of (S)-bisoranjidiol (27) respectively. We have outlined our synthesis of a protected 
naphthalene dimer 36, initially discovered as a byproduct of a Suzuki reaction. We 
advanced 36 to the corresponding protected and deprotected naphthoquinone dimers 40 






anthraquinone dimers 43 and chrysotalunin (1) via a double Diels-Alder cycloaddition 
with silyldienyl ether 42. We then introduced related dimeric anthraquinone-derived 
natural products torrubiellin A (45) and rubellin B (47). We proposed a synthesis of 
torrubiellin A (45) featured by a novel photo-mediated rearrangement of an 
anthraquinone dimer 48.  
4.6 Experimental Section 
Instrumentation and methods-
1
H NMR spectra were recorded at 500 MHz at ambient 
temperature with CDCl3 (Cambridge Isotope Laboratories, Inc.) as the solvent unless 
otherwise stated. 
13
C NMR spectra were recorded at 100.0 MHz at ambient temperature 
with CDCl3 as the solvent unless otherwise stated. Chemical shifts are reported in parts 
per million relative to CDCl3 (
1H, δ 7.26; 13C, δ 77.0). Data for 1H NMR are reported as 
follows: chemical shift, integration, multiplicity (app = apparent, br = broad, par obsc = 
partially obscure, ovrlp = overlapping, s = singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet) and coupling constants. All 
13
C NMR spectra were recorded with complete 
proton decoupling. Infrared spectra were recorded on a Nicolet Nexus 670 FT-IR 
spectrophotometer. Crude mass spectra were obtained using a Waters Acquity Ultra-
Performance Liquid Chromatography (UPLC) system with PDA, ELC, and SQ detectors. 
High-resolution mass spectra were obtained in the Boston University Chemical 
Instrumentation Center using a Waters Q-TOF mass spectrometer. Melting points were 
recorded on a Mel-temp (Laboratory Devices). Analytical thin layer chromatography was 





using 200-400 mesh silica gel (Sorbent Technologies, Inc.). Yields refer to 
chromatographically and spectroscopically pure compounds, unless otherwise stated.  All 
other reactions were carried out in oven-dried glassware under an argon atmosphere 
unless otherwise noted. The Arthur
TM
 Suite Reaction Planner (Symyx Technologies, Inc.) 
was used for experimental procedure planning. All calculations were conducted using the 
SPARTAN 2010 Quantum Mechanics Program: (PC/x86) Release 1.0.1v4.  
Reagents and solvents 
HPLC grade tetrahydrofuran, methylene chloride, diethyl ether and hexanes were 
purchased from Fisher and VWR and were purified and dried by passing through a PURE 
SOLV
®
 solvent purification system (Innovative Technology, Inc.). Methanol was 
purchased from Fisher, distilled over magnesium iodide, and stored over 3 Ǻ molecular 
sieves. All alkyllithium solutions were used after being freshly titrated using 
diphenylacetic acid as indicator. All other reagents were used as purchased from Aldrich, 
Acros, Alfa Aesar, and Strem Chemicals.  
 Trimethoxynaphthalene dimer 37: To a dry flask equipped with a stir bar was 
added trimethoxynaphthalene boronic acid 36 (250 
mg, 0.954 mmol, 1.1 equiv.), trimethoxynaphthalene 
bromide 39 (260 mg, 0.870 mmol, 1 equiv.), 
potassium phosphate (405 mg, 1.91 mmol, 2.2 equiv.), 
and tetrakis(triphenylphosphine)palladium (0) (150 mg, 0.130 mmol, 0.15 equiv.). The 






and the solution was heated at 90 ºC for 24 h. Upon completion by TLC analysis, the 
reaction was cooled to rt and water was added. The mixture was extracted with CH2Cl2 
and then washed with water, brine, dried over sodium sulfate, and concentrated to a crude 
oil. The oil was purified by column chromatography (4:1 hexanes: ethyl acetate to 1:1) to 
afford 37 as a yellow solid (320 mg, 85 %). Rf = 0.50 (1:1 hexanes: ethyl acetate); IR 
(thin film): max  2993.6, 2930.8, 2833.5, 1610.8, 1600.5, 1502.1, 1468.7, 1407.0, 1335.6, 




H NMR (500 MHz, 
Chloroform-d) δ 8.07 (d, J = 8.7 Hz, 1H), 7.66 (d, J = 8.7 Hz, 1H), 6.81 (d, J = 8.4 Hz, 
1H), 6.77 (d, J = 8.4 Hz, 1H), 3.99 (s, 3H), 3.96 (s, 3H), 3.56 (s, 3H). ; 13C NMR (126 
MHz, cdcl3) δ 153.67, 150.46, 149.83, 130.29, 130.18, 128.62, 121.48, 117.39, 106.03, 
104.04, 77.41, 77.16, 76.91, 61.75, 56.91, 55.98; HRMSESI (m/z): [M+H]+ calcd for 
C26H26O6, 435.1808; found [M+H]
 +
, 435.1798 (+ 2.2979 ppm).  
Methoxynaphthoquinone dimer 40:  To a flask equipped with a stir bar was 
added naphthalene biaryl 37 (120 mg, 0.276 mmol) and 
acetone (3.0 mL) and the solution was stirred at rt. Silver 
(I) oxide (384 mg, 1.66 mmol, 6.00 equiv.) was added 
followed by a 40 % aq. HNO3 solution (1.5 mL) at 0ºC 
which immediately dissolved the silver to provide a clear solution. The reaction was 
warmed to rt and turned bright orange after 20 min. Upon completion by TLC analysis 
(30 min.), the reaction was quenched with water (5 mL) and extracted with CH2Cl2. The 






in vacuo to afford crude 40. The crude solid was purified with column chromatography 
(10 % EtOAc in CH2Cl2) to afford an orange solid (72 mg, 69 %).  Rf = 0.30 (10 % ethyl 
acetate in CH2Cl2); IR (thin film): max  2923.5, 2852.1, 1657.8, 1610.5, 1584.1, 1470.7, 





(500 MHz, Chloroform-d) δ 7.99 (dd, J = 7.9, 2.5 Hz, 1H), 7.72 (dd, J = 7.8, 2.4 Hz, 1H), 
6.96 (qd, J = 10.0, 2.4 Hz, 2H), 3.65 (s, 3H).; 
13
C NMR (126 MHz, cdcl3) δ 184.66, 
184.18, 157.96, 140.69, 138.85, 137.01, 136.65, 134.24, 124.59, 122.61, 62.23.; 
HRMSESI (m/z): [M+H]+ calcd for C22H14O6, 375.0869; found [M+H]
 +
, 375.0857 (+ 
3.1993 ppm).  
Hydroxynaphthoquinone dimer 41: To a dry flask 
equipped with a stir bar was added methoxynapthoquinone 
dimer 40 (40 mg, 0.107 mmol) and CH2Cl2 (1.5 mL). The 
solution was cooled to 0ºC and then aluminum trichloride 
(57 mg, 0.427 mmol, 4 equiv.) was added in one batch. The reaction was slowly warmed 
to rt. After 1 h, the reaction turned a deep blue color. The reaction was stirred at rt for 3 h 
and then quenched with methanol, which turned the mixture a purple color. The reaction 
mixture was diluted with CH2Cl2 (20mL and water (10mL), followed by 5 mL of 5 % 
Rochelle’s salt solution and 5 mL of 1M HCl. The mixture was stirred until a clear 
separation of organic and aqueous layers formed (2 hours). The organic layer was 
separated and washed with brine, dried over sodium sulfate, and concentrated to afford an 






CH2Cl2) to provide the hydroxynapthoquinone dimer 41 
(28 mg, 75 %). Rf = 0.80 (1:1 hexanes: ethyl acetate); IR 
(thin film): max  2923.6, 2853.5, 1665.8, 1638.5, 1592.8, 
1457.5, 1413.1, 1340.9, 1278.9, 1167.9, 1099.6, 1099.1, 




H NMR (500 MHz, 
Chloroform-d) δ 12.42 (s, 0H), 7.78 – 7.71 (m, 2H), 7.00 (s, 2H).; Due to insolubility in 
NMR solvents, we were unable to obtain a 
13
C NMR spectrum for 41. We converted it to 
the diacetate using the following procedure: Hydroxynapthoquinone dimer 41 was 
dissolved in 2 mL of CH2Cl2 and DMAP (1 mg, 0.1 equiv.), triethylamine (150 L, 10 
equiv.) and acetic anhydride (100 uL, 10 equiv.) were added successively at rt. The 
solution went from cloudy orange to clear brownish-yellow. Upon conversion by TLC 
analysis, the reaction was quenched with water and extracted with CH2Cl2. The organic 
layer was washed with brine, dried over sodium sulfate, and concentrated in vacuo to 
afford the diacetoxynapthoquinone dimer in quantitative yield. Rf = 0.30 (1:1 hexanes: 
ethyl acetate);
 1
H NMR (500 MHz, Chloroform-d) δ 8.10 (d, J = 7.9 Hz, 1H), 7.67 (d, J = 
8.0 Hz, 1H), 6.99 (d, J = 10.3 Hz, 1H), 6.89 (d, J = 10.3 Hz, 1H), 2.19 (s, 3H).; 
13
C NMR 
(126 MHz, cdcl3) δ 183.94, 183.56, 140.25, 137.44, 133.77, 124.64, 20.94.; (UPLC) 
LRMSESI (m/z): [M+H]+ calcd for C24H14O8, 431.1; found [M+H]
 +







 Chrysotalunin 1: To a reaction vessel equipped with a stir bar was added 
hydroxynaphthoquinone dimer 41 (30 mg, 
0.08 mmol) in toluene (1.3 mL). Silyldienyl 
ether 42 (45 mg, 0.24 mmol, 3 equiv.) was 
added and then the reaction was sealed and 
heated at 60 ºC for 6 h TLC. Upon 
conversion of the starting material by TLC 
analysis, the reaction was cooled to rt and the solvent was removed in vacuo. Methanol 
(1.5 mL) and 1M HCl (1.5 mL) were added to the crude oil and the reaction was stirred 
for 1 h. The reaction was diluted with water and extracted with CH2Cl2. The combined 
organic layers were washed with brine, dried over sodium sulfate, and concentrated in 
vacuo to a crude orange solid. The crude product was purified by column 
chromatography (3:1 hexanes: ethyl acetate) to afford chrysotalunin 1 (18 mg, 42 %). Rf 
= 0.75 (1:1 hexanes: ethyl acetate); IR (thin film): max  3431.5, 3278.8, 2957.2, 2923.6, 
2850.8, 1726.9, 1665.2, 1260.9, 1051.4, 
1099.6, 1099.1, 1051.2, 1005.9, 837.9, 730.2 
cm
-1 
; Due to poor solubility in NMR solvents, 
1 was converted to the corresponding tetra-
acetate 44 by the following procedure. 
chrysotalunin 1 was dissolved in 2 mL of 
CH2Cl2 and DMAP (1mg, 0.1 equiv.), triethylamine (150 L, 10 equiv.) and acetic 







TLC analysis, the reaction was quenched with water and extracted with CH2Cl2. The 
organic layer was washed with brine, dried over sodium sulfate, and concentrated in 
vacuo to tetra-acetoxyanthraquinone dimer 44 in quantitative yield (35 % from 41);
 
 Rf = 
0.30 (CH2Cl2); 
1
H NMR (500 MHz, Chloroform-d) δ 8.27 (d, J = 8.1 Hz, 1H), 8.05 (s, 
1H), 7.68 (d, J = 8.2 Hz, 1H), 7.24 (s, 1H), 2.53 (s, 3H), 2.42 (s, 3H), 2.19 (s, 3H).; 13C 
NMR (126 MHz, cdcl3) δ 182.10, 169.64, 150.35, 146.70, 134.75, 134.25, 130.98, 
126.10, 125.04, 123.49, 120.03, 21.90, 21.23, 21.04.; HRMSESI (m/z): [M+H]+ calcd 
for C38H26O12, 675.1503; found [M+H]
 +
, 697.1346 (+ 3.4427 ppm).  
 Methoxyanthraquinone dimer 43: 
To a reaction vessel equipped with a stir bar 
was added naphthoquinone dimer 40 (30 mg, 
0.08 mmol) in toluene (1.3 mL). Silyldienyl 
ether 42 (45 mg, 0.24 mmol, 3 equiv.) was 
then added. The reaction was sealed and 
heated at 60 ºC for 6 h. Upon conversion of the starting material by TLC, the reaction 
was cooled to rt and the solvent was removed in vacuo. Methanol (1.5 mL) and 1M HCl 
(1.5 mL) were added to the crude oil and the solution was stirred for an hour. The 
reaction was diluted with water and extracted with CH2Cl2. The combined organic layers 
were washed with brine, dried over sodium sulfate, and concentrated in vacuo to a crude 
orange solid. The solid was purified by column chromatography (3:1 hexanes: ethyl 






ethyl acetate); IR (thin film): max  3435.5, 2958.2, 2926.1, 2879.1, 2854.5, 1726.5, 




H NMR (500 
MHz, Chloroform-d) δ 12.45 (s, 1H), 8.24 (d, J = 8.3 Hz, 1H), 7.80 (d, J = 8.3 Hz, 1H), 
7.63 (s, 3H), 7.11 (s, 1H), 3.72 (s, 3H), 2.48 (s, 3H).; 
13
C NMR (126 MHz, cdcl3) δ 
187.43, 163.00, 162.58, 149.20, 139.30, 137.30, 136.78, 135.76, 134.61, 124.87, 123.58, 
122.84, 120.95, 120.51, 113.81, 62.24, 22.55.; HRMSESI (m/z): [M+H]+ calcd for 
C38H26O12, 675.1503; found [M+H]
 +
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